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Healthcare associated infections may arise from many sources, including patient‟s own 
skin flora and the clinical environment, and inflict a significant burden within the health 
service. Adequate and effective skin antisepsis and surface disinfection are therefore 
essential factors in infection control. Current EPIC guidelines recommend 2 % 
chlorhexidine (CHG) in 70 % isopropyl alcohol (IPA) for skin antisepsis however poor 
penetration has been reported. Eucalyptus oil (EO) is a known permeation enhancer, 
producing synergistic antimicrobial activity when combined with CHG. In this current 
study, the antimicrobial efficacy of EO and its main constituent 1,8-cineole were 
assessed against a panel of clinically relevant microorganisms, alone and in 
combination with CHG. The superior antimicrobial efficacy of EO compared with 1,8-
cineole, and synergistic effects with CHG against planktonic and biofilm cultures, 
confirmed its suitability for use in subsequent studies within this thesis. Impregnation of 
EO, CHG and IPA onto prototype hard surface disinfectant wipes demonstrated 
significantly improved efficacy compared with CHG/IPA wipes, with clear reductions 
in the time required to eliminate biofilms. Optimisation of the EO/CHG/IPA 
formulation resulted in the development of Euclean
®
 wipes, with simulated-use and 
time kill studies confirming their ability to remove microbial surface contamination, 
prevent cross contamination and eliminate biofilms within 10 minutes. The employment 
of isothermal calorimetry provided additional information on the type and rate of 
antimicrobial activity possessed by Euclean
®
 wipes. A clinical audit of the Euclean
®
 
wipes at Birmingham Children‟s Hospital, Birmingham, U.K. revealed divided staff 
opinion, with the highest cited advantage and disadvantage concerning the odour. 
Finally, skin penetration and cell toxicity studies of EO/CHG biopatches and Euclean
®
 
solution developed during this study, revealed no permeation into human skin following 
biopatch application, and no significant toxicity. These current studies enhance the 
knowledge regarding EO and its potential applications. 
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1.1. Healthcare associated infections 
1.1.1. Types, prevalence and implications 
Healthcare associated infections (HAI) are a major concern within the health service, 
and are defined as infections acquired either within hospitals, or as a direct result of a 
healthcare intervention (Department of Health, 2008a). They inflict a significant burden 
on the healthcare system due to increased morbidity and mortality rates, prolonged 
hospital occupancy and intensified treatment regimes to include repeated surgery and 
prolonged antibiotic therapy, all of which impose both financial and time constraints on 
trusts (Vilela et al., 2007; Weigelt et al., 2010). In 2008, the Department of Health 
(DoH) reported that the incidence of HAI within England was 8.2 %, comfortably 
within the range found across industrialised countries of between 5 and 10 % 
(Department of Health, 2008a). 
There are many types of HAI, with a few in particular accounting for the majority of all 
reported cases, these include; skin and soft tissue which account for 10.8 % of cases, 
primary bloodstream infections (BSI) often associated with indwelling medical devices 
make up 6.8 %, gastrointestinal account for 22 %, pneumonia causes 13.9 % and 
urinary tract infections (UTI) are responsible for 19.7 % of cases (Hospital Infection 
Society, 2007). Surgical site infections (SSI) are recognised as one of the most 
significantly important types of HAI, and according to the Health Protection Agency 
(HPA) are to blame for around 15 % of all HAI (Heath Protection Agency, 2010). It has 
been estimated that the development of an SSI leads to a patient incurring an average 
additional hospital stay of 6.5 days and doubled hospital costs (Plowman et al., 2001), 
with the drain on NHS funds an estimated 1 billion pounds per annum (Bagnall et al., 
2009). 
 
1.1.2. Catheter-related infections 
The management of critically ill patients is often accompanied by the insertion of one or 
more implanted prosthetic devices such as cerebrospinal fluid shunts or urinary, 
peritoneal or intravascular catheters, alongside other specialised prostheses including 
replacement joints, prosthetic valves, pacemakers and intraocular lenses (Piette & 
Verschraegen, 2009; Schierholz & Beuth, 2001). These devices are without doubt 
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crucial and often life saving, however patients are at increased risk from infections 
while these devices are in situ (Saginur et al., 2006), with intravascular catheters such as 
central venous catheters (CVC) often causing an array of catheter-related infections 
(CRI), ranging in severity from localised to systemic (Worthington & Elliott, 2005). 
There are four distinct types of CVC-related infection causing some of the most 
common detrimental effects of all such implanted devices; colonisation of the catheter, 
wound infection around the exit site, infection of the tunnel and systemic bloodstream 
infection known as septicaemia (Boersam & Schouten, 2010). It has been estimated that 
10,000 CVCs are utilised annually in the U.K., and that around 78 % of critically ill 
patients undergo insertion of a CVC during their treatment regime (Elliott, 2007; 
Vincent et al., 1995), and that of all catheter-related bloodstream infections (CRBSI), 
90 % of cases are linked to CVC (Wang et al., 2010), with the Health Service financial 
expenditure costing the equivalent of between £2,500 and £36,000 per patient with a 
CRBSI (Maki et al., 2006). The greatest risk of CRI arises from short-term, single- or 
multi-lumen central venous catheters that are non-cuffed and inserted into the 
subclavian or internal jugular vein (Worthington & Elliott, 2005). Chen et al. (2006) 
illustrated that the risk of a CVC-related infection developing is increased by a variety 
of factors, including catheterisation of greater than 7 days, total parental nutrition being 
administered, a single CVC having greater than 3 infusion lines, and insertion being 
performed on a ward rather than in surgery. Similarly, others have identified risk factors 
including CVC insertion into the femoral vein causing significantly more localised and 
bloodstream infections than insertion into the subclavian or jugular veins, with the 
subclavian being the vein of choice to use (Lorente et al., 2005). Prevention of CRI is 
therefore, far more desirable than treatment of an established infection, as this often 
requires a lengthy course of antimicrobials, with the possibility that removal of the 
contaminated implant will be necessary (Wu et al., 2003). 
 
1.1.3. Microorganisms 
There are many microorganisms associated with HAI, and whilst some are typically 
linked with particular sites or types of HAI, others are related less frequently. SSI 
causative microorganisms include both Gram-positive and -negative bacteria such as 
Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), coagulase 
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negative staphylococci (CNS), Enterococcus spp., Streptococcus spp., Klebsiella spp. 
and Pseudomonas aeruginosa, as well as yeasts such as Candida albicans, fungi and 
anaerobic microorganisms (Hospital Infection Society, 2007; Weigelt et al., 2010). In 
September 2010, the HPA published figures on 1,332 SSI cases recorded by 256 
hospitals over a 12 month period. It was established that S. aureus was the causative 
microorganism in 31 % of cases, and of those, 32 % were methicillin resistant. This is a 
proportion reduction from four years previous, when HPA surveillance reported S. 
aureus responsible for 53 % of SSIs, of which 64 % were resistant to methicillin 
(Health Protection Agency, 2006). The quarterly counts of MRSA bacteraemia 
infections displayed in Figure 1.l support these findings, and shows an overall reduction 
in cases over the 3 years of monitoring, with slight fluctuations around December and 
January; possibly due to increased hospital admissions during the winter of those more 




Figure 1.1. Quarterly counts of all reported MRSA bacteraemia cases from all NHS hospitals within the U.K. 
(April 2007 to March 2010), and trust appointed cases (April 2008 to March 2010), published by the HPA, 
March 2010a. 
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major nosocomial pathogen and thus is becoming more important in modern medicine 
(Piette & Verschraegen, 2009). 
 
1.1.4. Staphylococcus epidermidis and biofilms 
S. epidermidis is an opportunistic pathogen that is thought to account for over 90 % of 
the normal aerobic cutaneous and mucous membrane microflora, this allows diffusion 
onto the surface of an implanted device to occur easily during implantation (Cogen et 
al., 2008; Vuong & Otto, 2002). Indeed, this Staphylococcus is responsible for more 
foreign body and device related infections than any other microorganism, therefore is of 
particular research interest (von Eiff et al., 2005; Rohde et al., 2010). This is largely due 
to the ability of some strains to produce biofilms following phenotypic and enzymatic 
changes, allowing them to become attached, irreversibly onto living or nonliving 
surfaces, as well as to each other (Cho et al., 2002; Curtin & Donlan, 2006; Eftekhar & 
Speert, 2009). 
The biofilm, which is characterised by Saginur et al. (2006) as “high concentrations of 
organisms with little turnover,” acts protectively, containing the bacteria making them 
less susceptible to the effects of antimicrobial agents and host defence mechanisms, 
resulting in an increase of the organism‟s pathogenicity (Mack et al., 2004; Qin et al., 
2006). A biofilm, which may also be referred to as slime, is an extracellular matrix 
composed of many microcolonies, through which water channels pass (Schoenfelder et 
al., 2010). The biofilm matrix causes the embedded microorganisms to demonstrate 
altered phenotypes with regards to transcription of genes, rate of growth and sensitivity 
to antimicrobials (Costerton et al., 1995). The growth kinetics of a biofilm are 
controlled by clusters of cells and the growth rate is often slower in bacterial biofilms 
compared with that of planktonic cells due to the limited availability of nutrients 
(Kuehn et al., 1998; Olson et al., 2002). Microorganisms within a biofilm that are slow 
growing or not growing at all are more likely to display increased resistance to 
antimicrobial agents by virtue of their inactivity (Galanakos et al., 2009). 
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1.1.5. Biofilm formation 
There are a number of phases to the formation of a biofilm on an implanted device. The 
initial phase involves the primary attachment of the bacteria to the biomaterial after it 
has been exposed to the surface. Forces including active forces (e.g. chemotaxis), 
passive forces (e.g. gravity), non-specific forces (e.g. surface hydrophobicity, 
electrostatic forces and van der Waals‟ forces) and fluid flow play a role in exposure, 
and for S. epidermidis, attachment is initiated by polysaccharide and protein factors (Liu 
et al., 2008; Schoenfelder et al., 2010; Vuong & Otto, 2002). Accumulative growth of 
multiple layers and the formation of glycocalyx then follow during colonisation of the 
implant (Mack et al., 1999). Finally, the unbound daughter cells drift away from the 
initial site and repeat the colonisation process at a new site.  
The key molecule responsible for biofilm formation in S. epidermidis is poly-N-acetyl-
glucosamine (PNAG). It is also termed polysaccharide intercellular adhesin (PIA) and is 
coded for by the ica operon; the most comprehended biofilm development instigator 
(Fitzpatrick et al., 2005; Maira-Litran et al., 2002; McKenney et al., 1998). 
Extracellular polymers such as polysaccharides, glycoproteins and proteins are also 
present, with the polysaccharides comprising a mixture of homo- and 
heteropolysaccharides, mostly of fructose, pyruvate, mannose, galactose and glucose 
(Costerton et al., 1995). The many different bonds that are possible between these 
saccharides produce a diverse range of polysaccharides (Johansen et al., 1997; Olson et 
al., 2002). 
The amount of biofilm that is produced by a bacterial strain can vary considerably, with, 
among others, environmental factors influencing the quantity. This can therefore have 
an effect on the severity of the resultant infection (Mack et al., 2004). Thus, it is 
important that the complex mechanisms behind biofilm formation continue to be 
explored and understood, to allow for the possibility of aspects of the process to be 
targeted in order to prevent their development.  
 
1.1.6. Catheter care and resistance 
Catheters, particularly CVCs used to be maintained by twice daily washing with the 
anticoagulant heparin flushing solution but over time, preference changed to 
antimicrobial prophylaxis, however this lead to the development of increasing numbers 
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of resistant strains of microorganisms (Root et al., 1988). Antimicrobial lock therapy is 
sometimes used to remove bacteria suspected of growing inside the catheter by locking 
high concentrations of antibiotics within the catheter for a period of time while 
simultaneously delivering systemic antimicrobial agents (Bookstaver et al., 2010). 
Treatment of S. epidermidis biofilm-associated infection is particularly difficult, as 
bacteria growing in biofilms demonstrate an increased level of resistance to antibiotics 
when compared to the corresponding planktonic form (Schoenfelder et al., 2010). 
Saginur et al. (2006) found that clinical isolates of S. epidermidis and S. aureus were 
considerably more resistant to both bacteriostatic and bactericidal antibiotics when in a 
biofilm than planktonic mode of growth, and that the same was true whether the drugs 
were used alone or in combination. The exact cause is unclear, although it may be due 
to a range of factors including high bacterial density, slower growth rate, poor 
penetration, changes in cell wall composition, altered surface structures, or even that the 
antibiotic simply binds to the slime and so does not reach the bacterial cells (Rupp & 
Hamer, 1998; Saginur et al., 2006). Whatever the reason, which is likely to be multi-
factorial, the degree of increased resistance varies considerably between publications. 
Wu et al. (2003) reported that the resistance was 1,000 to 1,500 times greater in a 
biofilm-producing strain than a non-biofilm producing strain. Jabra-Rizk et al. (2006) 
stated resistance was enhanced 50 to 500 times, whilst Mah & O‟Toole (2001) reported 
a 10 to 1,000-fold increase. It is therefore obvious to see that antimicrobial agents 
effective against planktonic bacteria may have limited therapeutic value in patients with 
an infected prosthetic implant (Saginur et al., 2006). 
 
1.1.7. Biofilm treatment 
Due to the increasing prevalence of many methicillin-resistant CNS, including some S. 
epidermidis strains, guidelines still recommend the use of vancomycin to treat catheter-
related infections (Mermel et al., 2009). However, when used to treat S. epidermidis 
growing in a biofilm on a device, it has been unsuccessful in providing complete 
eradication of the organism (Wiederhold et al., 2005). Further to this, Monzon et al. 
(2002) reported that the age of the biofilm is also of significance, with drugs such as 
vancomycin reducing in efficacy against an aged biofilm of 48 hours, compared with a 
younger one of 24 hours for example. It is therefore vital that the appropriate drug 
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treatment be chosen if biofilms are to be eliminated from devices, thus preventing 
further infection complications. 
Antimicrobial agents may be used in combination to combat biofilm infections as they 
may act synergistically or reduce the risk of the causative organism developing multi-
drug resistance, which is an ever-increasing problem. Recent studies performed by 
Olson et al. (2010) demonstrated rifampicin to be efficacious against S. epidermidis 
biofilms, showing significantly reduced cell viability than vancomycin. Furthermore, 
combining rifampicin with daptomycin or vancomycin could further enhance biofilm 
removal of S. epidermidis due to the ability of the second antimicrobial to eliminate any 
subpopulation to develop rifampicin resistance. 
Susceptibility tests may be carried out to determine which antibiotic is optimal to use 
against a particular microorganism. However standard susceptibility test values are 
based on planktonic growth of organisms in suspension and do not include biofilms 
(Amorena et al., 1999; Monzon et al., 2001). The minimum inhibitory concentration 
(MIC) is a measure of a specific concentration of a given chemotherapeutic agent that is 
required to inhibit growth of bacteria, whilst the minimum bactericidal concentration 
(MBC) is that required to kill (Olson et al., 2002). However, as these measures are for 
planktonic microorganisms and the antibiotic resistance of individual cells, they do not 
give true representations of bacteria growing in biofilms (Monzon et al., 2001). The 
MIC and MBC are important indicators for the successful treatment of many life-
threatening infections, though treatment is often unsuccessful if employed to device 
related infections associated with a biofilm-producing microorganism. In recent years, 
some models have been made available for biofilm antibiotic susceptibility testing, 
although isolates that can be tested are severely restricted to a few strains of limited 
microorganisms, including P. aeruginosa, E. coli, S. aureus and S. epidermidis 
(Clutterbuck et al., 2007; Monzon et al., 2002). At present there is still no standard 
method for testing biofilm susceptibility to antibiotics. 
 
1.1.8. Novel strategies for biofilm treatment 
Many new approaches are being considered for the treatment of biofilm infections 
resulting from implanted devices. Antimicrobial lock therapy has long been used with 
heparin, as well as a wide range of antibiotics, in particular vancomycin, however new 
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combinations of antimicrobials are frequently being tested, and also alcohols such as 
ethanol (Qu et al., 2009). Other suggested strategies include combining the use of 
antimicrobials with biofilm matrix-cleaving enzymes which are capable of breaking 
apart polysaccharides, therefore reducing the structural integrity of the biofilm, allowing 
the antimicrobial to eliminate the infection (Estrela & Abraham, 2010). Also along 
these lines, is the possibility of using antimicrobials mixed with fatty acid compounds 
naturally present within biofilm-producing cells, that are responsible for cell signalling 
chances. The changes insight the reversal of the recipient cell state from biofilm-
producing to planktonic, by means of dispersing their slime, and has been effectively 
demonstrated for a range of microorganisms including S. aureus, E. coli and C. albicans 
(Estrela & Abraham, 2010). 
 
1.1.9. Prevention rather than cure 
Failure to achieve successful treatment due to biofilm resistance against many 
commonly used antimicrobial agents, often leads to the contaminated medical implant 
being removed. This often requires an already ill patient to undergo further surgery, 
which in turn can then lead to further complications (Wu et al., 2003). However, if left 
in place an indwelling device colonised with S. epidermidis can lead to chronic 
infections, with the implant acting as a septic focus, initiating complications such as 
osteomyelitis, acute sepsis and in the most severe cases, particularly if the patient is 
immuno-compromised, death can result (Kaplan et al., 2004). 
Preventing the initial colonisation and growth of biofilms on catheters and other 
implanted devices is a much more favoured approach to eliminate infection than 
persevering with a lengthy course of antibiotics, in an often unsuccessful attempt to 
treat an already existing infection (Polonio et al., 2001). It is in this direction that new 
technological advances are frequently focussed and have been for a number of years. 
One recent study conducted into the effect of chlorhexidine-impregnated wound 
dressings to reduce CRI concluded their use to significantly reduce infection rates 
amongst chemotherapy patients (Ruschulte et al., 2009). Another study by Maki (2010) 
reported internal biofilm occurrence within needleless connectors being prevented after 
incorporation of nanoparticle silver into the lining. A similar but older study by Logghe 
et al. (1997) combined chlorhexidine (CHG) and silver-sulfadiazine but found there was 
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no benefit after 20 days catheterisation. It is therefore possible that the effects were 
optimal for a maximum of around 10 days, after which time the anti-infective properties 
reduced. However, when designing anti-infective catheters, the consequences must be 
well thought out to ensure that whilst inhibiting bacterial growth, they do not permit nor 
promote fungal growth, such as that of Candida spp., which would prove just as 
problematic (Raad et al., 1995). They must also be able to overcome the inhibitory 
effect of the slime on antimicrobial agents while ensuring resistance does not develop. 
Many suggestions of antimicrobial agents that could be used as preventative measures 
against skin microorganisms responsible for CVC related infections have been made 
and studied. These include a range of polyantibiotic creams, biocides such as 
chlorhexidine, as well as many complementary and alternative medicines such as 
essential oils, which are regarded as mixtures of compounds that produce a flavour or 
aroma, and are from natural sources such as flowers, spices and aromatic herbs (Crnich 
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1.2. Laboratory testing methods 
1.2.1. ATP bioluminescence 
Adenosine triphosphate (ATP) bioluminescence enables the detection of ATP, the 
energy source from within viable cells, to be converted into a measurement of 
fluorescence providing an indicator of cleanliness levels from surfaces. Hand-held kits 
capable of providing rapid, real-time, reproducible results are widely available, and 
contain a swab that is wiped over a surface and inserted into the hand-held terminal 
where the enzyme luciferase catalyses the reactions between luciferin and the cellular 
ATP (Sykes & Avery, 2009). This reaction produces light which the terminal converts 
into a numerical value of fluorescence. The fluorescence reading is therefore directly 
proportional to the ATP concentration. ATP bioluminescence is a well established 
method for detecting microbial contamination that has been used within the food 
industry for many years, and has in recent years increased in popularity amongst 
healthcare settings following an escalation in clinical trials using the method as a means 
of illustrating baseline and improved hygiene levels (Carling & Bartley, 2010; 
Whitehead et al., 2008). There are however some limitations of these rapid detection 
kits, including an inability to attribute the source of the ATP to either microbial or other 
contamination (Moore et al., 2010). Also, it generates qualitative data as the readings 
generated do not equate to a specific number of microorganisms, therefore an initial 
baseline reading is required prior to any cleaning intervention in order for subsequent 
readings to provide information regarding improvements made by the intervention 
(Sherlock et al., 2009). 
 
1.2.2. Isothermal calorimetry 
Isothermal calorimetry (IC) is a technique that enables the study of the thermodynamics 
within a liquid. It is performed in an isothermal calorimeter which generates accurate 
readings, in real time of the heat changes within the system being investigated (O‟Neill 
et al., 2003). IC is frequently used for pharmaceutical applications such as aiding 
development of new drugs by assessing long term stability profiles (Beezer et al., 
2001). However, applications for microbiological purposes have until now been limited, 
with only a small number of studies using this technique as a means of establishing the 
efficacy of agents against microorganisms (von Ah et al., 2009; Morgan et al., 2001). 
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Calorimetry is based upon the principle that all processes involve a change in heat to or 
from their surroundings; it is these temperature changes that the IC monitors and 
records. Within the calorimeter there are two ampoule chambers, one contains the 
sample and the other is for reference. Both are surrounded by water set to an 
appropriately predetermined constant temperature in which the experiment can be 
facilitated (Jelesarov & Bosshard, 1999). Recordings of exothermic or endothermic heat 
changes between the ampoules are recorded as the units of power required to maintain 
the reference ampoule at the same temperature as the sample one while the reactions or 
processes inside the ampoule occur. As the external environment can be controlled, IC 
is capable of generating precise results with great sensitivity (Salim & Feig, 2009). 
Furthermore, the readings are taken every few seconds therefore if connected to 
graphical software, can be visualised almost instantaneously and attributed to a 
particular instigating event (O‟Neill et al., 2003; Trampuz et al., 2007).  
 
1.2.3. Toxicity testing 
Assessing the potential toxicity risk to humans is an important part of early product 
development for drugs, medications, inhalants and general skin-contact devices such as 
impregnated bandages (Collins et al., 2008). It is vital to ensure that no excessive, 
adverse reactions occur at a cellular level to chemical exposure. There are in vivo and in 
vitro methods of assessing toxicity risks, as well as more preliminary means whereby 
predictions are made based upon the properties of known toxicants and their use, or 
similarity to those used in the test product (Collins et al., 2008). In vitro assays offer 
greater benefits over in vivo trials, as they are often faster and less expensive to perform, 
and also eliminate products of especially high toxicity therefore reducing unnecessary 
testing on animals of products destined to breach regulation limits (Sayes et al., 2007). 
This was supported in 2007 by the United States National Research Council who 
proposed that toxicity testing should move towards tissue culture techniques and away 
from whole animal testing (Villeneuve & Garcia-Reyero, 2011). However, careful 
considerations need to be taken into account during the planning stages of toxicity 
testing to ensure suitable cell lines, doses and time parameters are used that represent 
those to be created by clinical use of the final product.  
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1.3. Antimicrobial antiseptic agents 
1.3.1. Alcohols 
Alcohols are volatile, flammable organic compounds that consist chemically of a 
functional hydroxyl group joined to a carbon atom. Whilst there are many types, 
aliphatic, short chain alcohols such as ethanol (ethyl alcohol), isopropyl alcohol 
(propan-1-ol) and n-propanol (propan-2-ol) are the most commonly employed alcohols 
for skin antisepsis (Guthery et al., 2005; Kampf & Kramer, 2004; Reichel et al., 2009). 
The first studies to suggest the use of ethanol as a potential skin disinfectant were 
published by Furbringer (1888) and explained his investigation of colonies observed in 
gelatine from physician‟s hands washed with potash soap and 80 % alcohol. In the 21st 
century, alcohols are recommended for multiple uses within the clinical environment; 
alcohol-based hand rubs are advised for general antisepsis, and alcoholic chlorhexidine 
gluconate solution is encouraged for cutaneous decontamination prior to catheter 
insertion (Pratt et al., 2007). 
Alcohol use for skin antisepsis has become more favoured over recent years due to their 
water soluble properties, reduced skin irritation compared with traditional washing 
using soaps and lack of microbial resistance reported to date (Kampf & Kramer, 2004; 
Loffler et al., 2007). However, contradictory publications reiterate the knowledge that 
ethanol acts as a permeation enhancer when applied topically to human skin, therefore 
may induce irritation and furthermore, may also possess carcinogenic properties 
(Lachenmeier, 2008). In addition to this, the flammability of alcohols makes them 
potentially hazardous within operating rooms; it is therefore paramount that any alcohol 
has completely evaporated from the skin prior to any surgical intervention (Hemani & 
Lepor, 2009). Weber et al. (2006) described one example in which second and third 
degree burns were suffered to the chest, shoulders and neck of a 62 year old male 
patient undergoing an awake-tracheostomy after DuraPrep
TM
, an isopropyl alcohol-
based skin antiseptic, was used for preoperative skin preparation. The patient was 
hirsute, and when electrocautery was used for incision, a fire ignited as a result of the 
hair impeding the antiseptic drying. 
Alcohols are non specific in their mode of action and deliver rapid antimicrobial 
efficacy against a wide range of bacteria, fungi and enveloped viruses, though are 
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generally regarded as not possessing any sporicidal activity (Messina et al., 2008; 
Rotter, 2001). They denature proteins and cause membrane damage, which in turn leads 
to cell lysis (McDonnell & Russell, 1999). The optimal concentration for ethanol 
efficacy spans 60 % to 95 %, with the range 60 % to 90 % deemed best in general for 
any other alcohol concentration. At higher concentrations the lack of water makes 
protein denaturing difficult, however at concentrations below 50 %, significant 
reductions in efficacy are observed (Bloomfield et al., 2007; McDonnell & Russell, 
1999). 
Of the three main alcohols, the antimicrobial efficacy of ethanol has been concluded to 
be less than that of isopropyl alcohol, which in turn is less than that exhibited by n-
propanol (Reichel et al., 2009; Rotter, 2001). Determination of which alcohol to use has 
been shown by Reichel et al. (2009) to be the most important factor in achieving 
optimum skin antisepsis, with the concentration and contact time of application 
following sequentially. However there are disadvantages to alcohol use for skin 
antisepsis. Alcohols do not possess prolonged endurance on the skin, therefore if used 
alone, are unable to deliver continued skin antisepsis over the periods of time required 
within the hospital or clinical environment. It is therefore, recommended that they are 
used in combination with preservatives such as chlorhexidine gluconate or iodine, with 
the result being enhanced longevity of antimicrobial efficacy (Guthery et al., 2005). 
 
1.3.2. Povidone-iodine 
Povidone-iodine (PVP-I) has been used for skin disinfection for over 50 years, and is a 
water soluble mixture of iodine and polyvinylpyrrolidone (Chiang et al., 2010; 
Shelanski & Shelanski, 1956). It possesses rapid, broad spectrum antimicrobial activity 
against bacteria, fungi and viruses by destroying proteins and DNA; however its 
bactericidal activity is inactivated by the presence of protein-rich biomaterials including 
blood and serum, as well as inhibited by pus, fat and even glove powder (Hemani & 
Lepor, 2009; Zamora et al., 1985). 
Like many antimicrobial agents, PVP-I has not managed to evade reports of 
disadvantages. Chiang et al. (2010) published a case study of a 2 year old female who 
developed chemical burns following application of PVP-I soaked padding underneath 
tourniquets applied to her arms, and in place for just 2.5 hours. 
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There are two common preparations of PVP-I for surgical use, these are 10 % aqueous, 
and 70 % alcohol; however, whilst rare in occurrence, testimonies of burns have been 
recorded from both (Lowe et al., 2006). Recent comparisons between 10 % aqueous 
PVP-I and 2 % CHG have demonstrated PVP-I to be inferior to CHG for the 
disinfection of venipuncture sites prior to blood sample collection, determined by 
comparisons of culture contamination rates (Suwanpimolkul et al., 2008). However, 
Guzel et al. (2009) suggested that pre-surgery skin preparation with CHG followed by 
PVP-I proved not only safe but also effective enough to potentially become the standard 
procedure for neurosurgical skin disinfection, as microbial flora were detected before 




Chlorhexidine is a found in many disinfectants and antiseptics as the main, active 
ingredient and is a cationic, chlorophenyl bisbiguanide that has been used for over 30 
years (Hibbard et al., 2002; Hope & Wilson, 2004). It can bind to skin and mucous 
membranes with little toxicity and possesses broad spectrum bactericidal activity 
against Gram-positive and -negative bacteria, as well as yeasts such as C. albicans, by 
causing enzyme inhibition and cell membrane damage which leads to a loss of structural 
integrity, resulting in irreversible discharge of cytoplasmic components (Hemani & 
Lepor, 2009; Hope & Wilson, 2004). The mechanism of action of chlorhexidine against 
fungi is primarily the same as that against bacteria, whereby cell plasma membrane 
disruption leads rapidly to increased permeation and cell rupture (Suci & Tyler, 2002), 
and unlike povidone-iodine, chlorhexidine is resistant to inactivation by proteinaceous 
products (Hemani & Lepor, 2009). The severity of cell damage caused escalates with 
increases in CHG concentration, with 0.2 % being deemed the most effective (Jones, 
1997). 
The chlorhexidine molecule (Figure 1.2) consists of a central hydrophobic 
hexamethylene chain, with a hydrophilic biguanidide group located at either end just 
prior to a hydrophobic phenyl ring at each terminus (Zeng et al., 2009). Chlorhexidine 
is available in base and salt forms, with chlorhexidine digluconate being a salt derived 
following dissolution of chlorhexidine into aqueous gluconic acid, which demonstrates 
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greatly enhanced water solubility properties compared to the base form (Lboutounne et 
al., 2002). The resultant molecule (Figure 1.3) consists of one chlorhexidine and two 
gluconic acid molecules, generating the chemical formula C12H30Cl2N10 ·2(C6H12O7) 
(Farkas et al., 2007). 
 
 
Figure 1.2. Chemical structure of chlorhexidine, with the molecular formula C22H30Cl2N10. 
 
  
Figure 1.3. Chemical structure of chlorhexidine digluconate illustrating bonding sites between chlorhexidine 
molecule and two gluconic acid molecules, with the resulting molecular formula C22H30Cl2N10 ·2C6H32O7. 
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Chlorhexidine is most commonly used in hand washing solutions, sanitiser gels and 
mouth washes, but has also been impregnated onto wet-wipes, and even applied to a 
sponge biopatch to suppress cutaneous flora around catheter insertion sites (Kaiser et 
al., 2009; Timsit et al., 2009). A variety of skin antiseptics are currently available to 
staff, visitors and patients for topical hand and preoperative use, with hospitals often 
using 0.5 % CHG in 70 % isopropyl alcohol (IPA) on skin (Adams & Elliott, 2007). 
However, guidelines for the Evidence-Based Practice in Infection Control (EPIC) 
recommend the use of 2 % CHG in 70 % IPA for skin antisepsis prior to insertion of 
intravascular devices, as well as for injection port disinfection (Pratt et al., 2007). 
Soothill et al. (2009) reported a significant reduction in the incidence of CRBSI at Great 
Ormond Street Hospital, from 12 per 1000 catheter days when 70 % isopropanol was 
used alone for catheter connection antisepsis, to just 3 per 1000 catheter days when the 
antiseptic was replaced with 2 % CHG in 70 % isopropanol. Furthermore, chlorhexidine 
has also been shown to elicit superior efficacy when compared with alcohol-based 
povidone-iodine in a study conducted by Mimoz et al. (2007), in which a 50 % 
reduction in catheter colonisation incidence was observed. These results may be due in 
part to the residue left by chlorhexidine solutions which may illustrate persistence of 
efficacy after use therefore continuing to be of antimicrobial benefit to potential 
contaminants following disinfection. 
Although chlorhexidine is an ideal skin antiseptic, its permeation into the deeper layers 
of the skin is poor (Hibbard et al., 2002; Karpanen et al., 2008a), therefore some 
cutaneous flora may remain in pores and hair follicles, allowing infection to develop as 
a result of catheter insertion, even after skin antisepsis has been performed. There is 
therefore a need for novel agents that can penetrate the deeper layers of the skin or act 
as carriers to direct antimicrobial agents to these sites. 
 
1.3.4. Essential oils 
Plants, herbs and flowers, along with their products have been used medicinally for 
thousands of years, with initial development and use thought to have originated in 
China as early as 2700 BC, before subsequently spreading across India, Egypt, the 
Eastern Mediterranean and finally Europe (Halm, 2008; Jones, 1996). Plant-derived 
essential oils offer an alternative approach to conventional pharmaceutical strategies of 
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infection control by means of antibiotic, antifungal and antiviral agents, as many have 
shown to possess an array of antimicrobial properties. Essential oils such as lemongrass, 
sage, coriander, peppermint, clove and cinnamon have elicited antimicrobial efficacy 
against both Gram-positive and -negative bacteria, as well as Candida spp., with other 
oils including lavender and grapefruit efficacious against one or more types of 
microorganism (Hili et al., 1997; Prabuseenivasan et al., 2006; Warnke et al., 2009). 
Nowadays, essential oils are used for an array of functions, from botanical fungicides to 
mouthwashes, to cosmetic ingredients and food preservatives, while also frequently 
used for both traditional and modern medicinal purposes to include skin antisepsis and 
treatments of wounds, aches, sore throats, inflammation, atherosclerosis and even 
cancer (De Corato et al., 2010; Edris, 2007; Eyob et al., 2008; Fisher & Phillips, 2008; 
Kejlova et al., 2010). Throughout the literature, much research has been undertaken to 
explore the antimicrobial aspect of essential oils, helped in part by the seemingly 
endless combinations possible between the large numbers of microorganisms and vast 
assortment of essential oils. 
Phenolic compounds are responsible for most of the antimicrobial activity of essential 
oils derived from herbs and spices, whereas secondary metabolites such as tannins, 
terpenoids, alkaloids and flavonoids possess the antimicrobial properties found in plants 
(de Sousa Araujo et al., 2008; Weerakkody et al., 2010). However, the quantities of 
these antimicrobial compounds within essential oils may vary with season or strain of 
plant increasing the complexity of generating reproducible batches of oil with the same 
antimicrobial efficacy (Delaquis et al., 2002). 
Essential oils used for antimicrobial purposes, in particular spray formulations, are 
frequently diluted in ethanol, which itself is a known antimicrobial. This often leads to 
disapproving critique about the true efficacy of the oil as the ethanol enhances volatility. 
This has been somewhat dispelled by Warnke et al. (2009), whom when testing a range 
of essential oils against a panel of microorganisms, used a 70 % ethanol control, and 
successfully demonstrated that the oils possessed superior efficacy over the solvent, 
thus concluding whilst ethanol alone was antimicrobial, the oil accounted for the 
majority of activity observed. Nonetheless, adjunctive use of essential oils appears to be 
advocated throughout the literature concerning dermal wound care and healing, 
however comprehension of the systemic pharmacodynamics and toxicity of such oils is 
not yet complete. Furthermore, the resistance potential of essential oils is unclear, as is 
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the mechanism by which oils and their components elicit antimicrobial effects (Halcon 
& Milkus, 2004; Hili et al., 1997; Warnke et al., 2009). Therefore, when this is 
combined with the knowledge that essential oils are volatile, have poor solubility and 
potentially seasonal variation in efficacy, common use of them in the healthcare 
profession will require further research to enable limitations in clinical application to be 
overcome (Delaquis et al., 2002; Halcon & Milkus, 2004). 
 
1.3.5. Eucalyptus oil 
The Myrtaceae family contains the large genus Eucalyptus, of which there are over 700 
species (Maciel et al., 2010). While Eucalyptus surpasses other tree populations within 
its native Australia, where it dominates landscapes throughout the country, it is now 
intensively managed on temperate climate plantations in Argentina, Chilli and Portugal, 
or in sub-tropical climes of Brazil, South Africa and India (Forrester et al., 2010). 
Eucalyptus oil (EO), a plant-derived essential oil is contained within the leaves of 
Eucalyptus and can be extracted using steam- or hydro-distillation (Batish et al., 2008). 
The oil can account for up to 5 % of the leaf mass and contains in the region 58 
constituents (Canhoto & Graca, 1996; Wildy et al., 2000). These can vary greatly 
between species and seasons but the main component is undoubtedly 1,8-cineole which 
is also known as eucalyptol, and has been reported to account for anything up to 92 % 
of the oil (Wildy et al., 2000). Other components often found in high quantities include 
camphene, α- and β-pinene, and p-cymene (Batish et al., 2008; Cimanga et al., 2002). 
Essential oils are volatile, and in the case of eucalyptus oil, this is due to alcohols, 
ketones, aldehydes, monoterpene hydrocarbons and terpenoids, of which the main 
constituents are terpinen-4-ol, α-terpineol and 1,8-cineole (Lee & Shibamoto, 2001). 
Terpenoids are derived from natural products of five-carbon isoprene units, and are 
divided into groups according to their carbon structures. They are also the most 
prevalent compounds in most essential oils (Trombetta et al., 2005). Terpinen-4-ol 
belongs to the monoterpenes group of terpenoids as it has ten carbons, and is a 
terpenoid that has been modified by cyclization reactions and affects bacterial cell walls 
(Papadopoulos et al., 2008; Warnke et al., 2009). 
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Eucalyptus oil is known to possess antibacterial and antifungal properties, however for 
Eucalyptus leaves to be of medicinal use, they must contain a minimum cineole content 
of 70 % (Goodger & Woodrow, 2008). 
The first reports documenting people benefiting from Eucalyptus told of Aborigines 
who had crushed leaves to heal wounds and fungal infections, and made broths with 
soaked leaves to heal sore throats (Ayepola & Adeniyi 2008; Gilles et al., 2010). In 
modern medicine, eucalyptus oil is often applied directly to the skin as a balm or rub, 
used in mouthwashes or inhaled as a spray or vapour. It has been, and still is used to 
treat or relieve symptoms of all manner of complaints including burns, neuralgia, 
coughs, ringworm, diabetes, asthma, genital herpes, cancer and arthritis (Tovar & 
Petzel, 2009). 
The mechanisms behind the antibacterial properties of EO are not clearly understood, 
but it is thought that the hydrophobicity of the oil causes the lipids of microbial cell 
wall, membrane and mitochondria to separate, leading to the structural stability of the 
cell being damaged, which in turn leads to an increase in membrane fluidity and 
permeability, and eventually cell rupture (Prabuseenivasan et al., 2006). Whilst the 
antimicrobial properties of eucalyptus oil are still being studied, the efficacy of the 
eucalyptus fruit oil has yet to be investigated, though it may prove to be a valuable oil 
as 1,8-cineole is abundant in the fruit oil, which is known to harbour antimicrobial 
efficacy (Mulyaningsih et al., 2010). 
 
1.3.6. 1,8-Cineole 
A potent monoterpene, containing only carbon, hydrogen and oxygen atoms, 1,8-
cineole is a cyclic ether and a known permeation enhancer (Anjos et al., 2007; Williams 
et al., 2006). Acting on the stratum corneum (SC) of the skin, 1,8-cineole temporarily 
affects both the polar head groups and lipid alkyl tails of the intercellular lipids, causing 
disruption from an organised state to a less ordered state of packaging, by mechanisms 
as yet not fully understood, allowing entry into the skin of otherwise impenetrable 
substances (Aqil et al., 2007; Williams et al., 2006). Such substances include medicated 
drugs, with which 1,8-cineole can be combined with an extensive repertoire as it is 
suitable for coupling with hydrophilic and lipophilic drugs (Aqil et al., 2007). 
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1,8-cineole is found in most plant- and herb-derived essential oils and is a major 
component within rosemary, lemon, lavender, grapefruit and peppermint oils (Yang et 
al., 2010). Antimicrobial studies of 1,8-cineole have confirmed broad spectrum efficacy 
against Gram-positive and -negative bacteria, as well as C. albicans when grown in 
planktonic cultures, furthermore efficacy was maintained when challenged with cultures 
in biofilm modes of growth  (Hendry et al., 2009). 
The physiochemical properties of different types of drugs needs to be considered when 
pairing with terpenes for transdermal drug delivery, as this can alter the permeation 
enhancing effects (Kang et al., 2007). The boiling point of 1,8-cineole is 173 °C 
therefore it is in a liquid phase at room temperature rather than solid, and it is a 
monoterpene (Figure 1.4), meaning it contains two isoprene units rather than a tetri- or 
tetra-terpene which contain three and four respectively. These particular physiochemical 
factors were determined by Kang et al. (2007) as likely to be possessed by terpenes with 
greater permeability coefficients. 
 
 
Figure 1.4. Chemical structure of the monoterpene 1,8-cineole, with the molecular formula C10H18O. 
 
Registered by the Food and Drug Administration (FDA) on the Generally Recognised 
As Safe (GRAS) list, many terpenes such as 1,8-cineole, are regarded as eliciting low 
levels of cutaneous irritation, with no skin toxicity, and have been permitted for use in 
cosmetics and hair colorants for many years (Aburjai & Natsheh, 2003; Aqil et al., 
2007). In particular, 1,8-cineole is reported to alter the side chain rather than the 
backbone of the SC proteins, which prevents conformational changes of these proteins 
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resulting in the observation of such low irritancy levels (Anjos et al., 2007). This makes 
them suitable for all manner of potential uses within the healthcare system related to 
enhanced skin permeation and antimicrobial efficacy. 
Koalas (Phascolarctos cinereus) and greater gliders (Petauroides volans) consume 
Eucalyptus leaves almost exclusively, with rare additions to their diet including the 
occasional consumption of tea tree or paperbark (Lunney et al., 2004). Eucalyptus 
leaves have shown to possess large amounts of 1,8-cineole, a substance that in such 
consistently high concentrations would be particularly toxic to humans if ingested in 
similar quantities to that by the koala, this has naturally raised questions about the 
toxicity threat posed to eucalypt folivores. Studies by Boyle et al. (2001) ascertained 
that a highly specific metabolic pathway, resulting in detoxification by oxidation on 
carbons 7 and 9, eliminates ingested 1,8-cineole, with 7-hydroxy-9-cineolic acid the 
main metabolite produced from a total of seven recovered in excrement. Further to this, 
the antimicrobial effects of 1,8-cineole do not appear to pose problems for the koala 
either, with microbial flora abundant within the gut and colon, and tannin-protein 
complex degrading bacteria particularly prevalent on the cecum and proximal colon 
epithelial surface (Stevens & Hume, 1998). 
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1.4. Human skin 
1.4.1. Properties of skin 
The skin is the largest organ in the human body, covering an area of around 2 m
2
 and 
accounting for around 4 % of the total bodies weight (Cevc & Vierl, 2010).  It contains 
many specialised cells and creates a physical barrier between the external environment 
and the inside of the body, acting as the first line of defence against chemical and 
physical damage, dehydration, heat loss, and infection. However, breach of this 
protective barrier function can leave the body exposed, and in particular vulnerable to 
microbial attack (Cevc & Vierl, 2010). The structure and physiology of the skin varies 
from person to person, with ethnicity, age and gender all affecting hair growth, hormone 
metabolism, sweat rate and surface pH, which is usually just above pH 5 (Cevc & Vierl, 
2010; Giacomoni et al., 2009). 
The skin harbours many resident microorganisms, including Staphylococcus spp., 
Corynebacterium spp., Pseudomonas spp., Streptococcus spp. and Propionibacterium 
spp. (Cogen et al., 2008). The normal microbial density differs greatly with body site, 
and can range from 10
2
 microorganisms per cm
2









 on areas of 
the skin that are covered, such as under surgical patches (Cevc & Vierl, 2010). The 
surface of the skin contains many niches ideal for microorganisms including pores, hair 
follicles and sweat glands, all of which provide suitable environments of pH level, 
temperature and moisture content for microbial survival (Grice et al., 2008).  
 
1.4.2. Structure and layers 
There are three main layers that make up the full thickness of human skin; the SC, the 
epidermis and the dermis. The SC is the outermost layer of the skin and varies between 
5 and 20 µm in thickness. It is the first defence barrier to drug absorption and 
penetration, and is comprised of a multilamellar lipid domain, embedded into which are 
corneocytes; dead cells filled with keratin (Anjos et al., 2007). These overlapping dead 
cells provide the waterproofing of the skin, whilst adding durability (Cevc & Vierl, 
2010). 
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The epidermis is the second layer of the skin and is around 2 mm in thickness (Cevc & 
Vierl, 2010). It is comprised of several sub-layers including the uppermost granular cell 
layer, the spinous cell layer in the centre, and the basal layer at the bottom. It is this 
basal layer that is responsible for replenishment of skin surface cells, as the basal cells 
undergo stages of differentiation during progressive movement up through the layers 
towards the SC, ultimately replacing the dead SC cells that have been shed (Blanpain & 
Fuchs, 2009). As the cells of the basal layer proliferate, some detach and begin to rise. 
Undergoing changes, they synthesise new keratins; the main structural protein of the 
epidermis. The keratins assemble together, forming intermediate filaments which link to 
form the cytoskeleton. The keratinocytes responsible for synthesising keratin also 
produce cytokines, which are triggered by injury and are important in inflammation, 
repair and growth (Powell, 2006). Cell to cell joining creates spiny desmosomes as the 
cells move up through the spinous layer. Finally, enzymes present within lysosomes of 
the granular cell layer, instigate cell death by destroying organelles including the 
nucleus. The squames that remain are the terminal differentiation of the cells and are 
subsequently shed once they have reached the surface of the SC (Alonso & Fuchs, 
2003). The entire process from basal layer to SC shedding takes around 28 days 
(Powell, 2006). 
The deepest layer of the skin is the dermis which is 2 to 4 mm thick and is separated 
from the epidermis by the epidermal-dermal junction or basement membrane, which is a 
convoluted layer of interconnected proteins, separating the two distinct cellular 
compartments and providing integrity whilst allowing nutrients to pass through from the 
dermis (Myung & Marinkovich, 2010). The dermis consists of two sub-layers, the 
papillary on the top and the reticular dermis below which contain mainly collagen (Cevc 
& Vierl, 2010). Vascular, lymphatic and nervous systems reside in the dermis, 
providing plentiful supplies of blood and nutrients to glands and hair follicles, as well as 
drainage and sensory provisions (Powell, 2006).   
Below the dermis is the panniculus adiposus known more commonly as the 
subcutaneous layer, and comprises largely of fat cells and loose connective tissue 
(Zolfaghari et al., 2009). Together, the dermis and subcutaneous fat provide insulation 
and protective cushioning (Powell, 2006). 
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1.4.3. Penetration into the skin 
Effective skin antisepsis is required prior to many medical procedures in order to 
effectively prevent infection, and applies to both patients and clinicians. Current EPIC 
guidelines recommend the use of 2 % CHG in 70 % IPA for adequate skin antisepsis 
(Pratt et al., 2007), however more concentrated solutions are often used for surgical 
scrubs. Present antiseptics are effective at removing microorganisms from the surface of 
skin, with some even leaving residual activity preventing recolonisation over a course of 
hours. However, it is known that microbial skin flora reside in pores and hair follicles, 
and therefore pose a great threat to skin antisepsis as many products used regularly 
within the clinical setting are inadequate at reaching these deeper layers. One such 
example is CHG, which whilst demonstrating broad spectrum antimicrobial activity, has 
shown poor penetration into the deeper layers of human skin, therefore allowing 
microbial survival despite completion of antiseptic practices (Karpanen et al., 2008a). 
In surgical theatres, additional measures including scrubbing with nail brushes used to 
be employed routinely with the aim of reducing microbial skin colonisation. However a 
study by Tanner et al. (2009) concluded the use of nail brushes or picks in combination 
with chlorhexidine caused no significant reduction in the number of colony forming 
units residing on hands 1 hour post procedure, compared with using chlorhexidine 
alone. Furthermore, the results suggested that CHG alone may actually provide better 
skin decontamination due to the potential of brushes and picks to draw out additional 
microorganisms from within the skin. Despite this, antiseptics capable of providing 
complete skin antisepsis, both on the surface and within the deeper layers of the skin, 
are still desired. 
Use of penetration enhancers is the most commonly employed technique for increasing 
percutaneous absorption, and is a suitable means of delivering antimicrobial agents into 
the deeper layers of skin, as well as administering transdermal medication. Such 
enhancers cause temporary and reversible disruption of the intercellular lipids of the SC 
barrier, as well as tight junctions and keratin domains thus diminishing the barrier 
properties of the SC (Sapra et al., 2008). Topical delivery of drugs that are not 
ordinarily skin-permeable confers numerous advantages, including avoidance of 
premature metabolism, low risk of systemic side effects and ease of use (Ghafourian et 
al., 2004). Furthermore, they are non-invasive and often able to release slowly over time 
periods of up to a week (Prausnitz & Langer, 2008). Often these drugs are packaged as 
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creams and lotions; however as the process and kinetics of applying medication to a 
coating that will later allow for release is becoming more understood, use of transdermal 
patches for delivery of various drugs is becoming used more widespread. 
 
1.4.4. Transdermal patches 
The first transdermal patch was approved in America in 1979, for the systemic delivery 
of the motion sickness drug scopolamine. This was followed ten years later by the 
development of the much publicised, nicotine patches for smokers, which contain 
permeation enhancers to aid dermal passage (Prausnitz & Langer, 2008). Between 2002 
and 2007, it was estimated that every 7.5 months, authorisation was given for a new 
transdermal delivery patch, with recent estimates in the region of over a billion patches 
manufactured each year for transdermal delivery, many of which contain one or more 
permeation enhancers to aid delivery through the skin (Prausnitz & Langer, 2008). 
Transdermal patches are used frequently for the delivery of hormones including; 
estrogen to relieve symptoms of menopause, parathyroid and human growth hormones 
to maintain endocrine regulation, and testosterone for deficiency treatment (Kumar & 
Philip, 2007). Combinations of hormones are also used, though largely for contraceptive 
purposes (Jick et al., 2007). Along with hormones, transdermal patches have proved 
especially successful for delivery, via the skin, of pain relief as they can be used in 
replacement of intravenous or oral medication therefore removing dosing confusion, 
replacing the use of needles and evading metabolism by the liver (Ghafourian et al., 
2004). First synthesised in 1960, fentanyl is a synthetic opioid analgesic that has, since 
the early 1990s, been incorporated into transdermal patches for the treatment of 
moderate to severe pain (Stanley, 1992). However, concerns about misuse of the 
fentanyl from within the reservoir patch led to the removal the original Durogesic
®
 
patch from the market, before alternative delivery mechanisms using matrices were 
developed (Kress et al., 2010). Finally, a number of transdermal patches have been 
developed incorporating nitroglycerin, and methylphenidate also known as Ritalin, for 
the prophylactic treatment of angina pectoris, and control of attention deficit 
hyperactivity disorder (ADHD) respectively (Keane, 2008; Wei et al., 2011). 
There have been many chemicals deemed suitable for use as permeation enhancers, 
ranging from alcohols to fatty acids and components of essential oils such as the terpene 
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1,8-cineole (Williams et al., 2006). 1,8-cineole has been used in many skin permeation 
studies involving both hydrophilic and lipophilic drugs, as it causes disruption to the 
stratum corneum allowing penetration, as well as other studies involving antimicrobial 
drugs although to a lesser extent, however as yet 1,8-cineole appears to have not been 
used in commercial transdermal patches (Liu et al., 2011). 
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1.5. Hand hygiene 
1.5.1. Purpose and compliance 
Another important component in infection control and reduction of HAI is effective 
hand hygiene. From childhood, hand hygiene becomes instilled in the majority of us, as 
part of daily life; however the multitudes of recent clinical studies highlighting the lack 
of compliance would imply this basic task is not encouraged to the same extent in all 
upbringings (Nicol et al., 2009). The knowledge that hand hygiene can have immense 
effects on the likelihood of infection prevalence and spread is comprehensive, 
particularly within the healthcare system, yet noncompliance remains a persistent issue. 
One study conducted within a neonatal unit of a Children‟s Hospital in Geneva, showed 
incidence of clonally related bacteraemia in very low birth weight babies was reduced 
by 60 % with compliance to a hand hygiene promotion, reinforcing the idea that hand 
washing breaks the cycle of transmission between patients (Pessoa-Silva et al., 2007). 
Despite this, adherence to hand hygiene protocols reveals inconsistencies between 
nursing staff, with one study by Burnett (2009) citing complexities in human behaviour 
as an explanation for nurse appreciation of infection dissemination.  
 
1.5.2. Campaigns for clean practice  
Over recent years, many local and national initiatives have been introduced in a bid to 
improve good hand hygiene practice within the National Health Service (NHS), 
including the „Clean Your Hands‟ campaign in 2004 which saw the introduction of 
alcohol-based hand rubs to patient bedsides and ward entrances; an undertaking costing 
£2.5 million, subsequently independently deemed by the National Audit Office (NAO) 
to have been a success (National Audit Office, 2009). In 2007, Scotland began the 
„Germs, Wash Your Hands of Them‟ campaign, at the same time as Wales commenced 
the „1000 Lives Campaign‟ which has since been followed up by „1000 Lives Plus‟ 
launched in May this year (Health Protection Scotland, 2007; Jewell & Wilkinson, 
2008). Unfortunately, compliance with hand hygiene regimes often drops shortly after 
the trial or incentive ceases; this may explain the reasoning behind the slightly different 
approach taken by the World Health Organisation (WHO). In 2006, WHO orchestrated 
one of the largest campaigns called „My Five Moments for Hand Hygiene‟ throughout 
all healthcare buildings, not just hospitals (Sax et al., 2007; World Health Organisation, 
~ 57 ~ 
 
2009). This improvement strategy emphasises five fundamental but crucial instances 
when healthcare workers need to clean their hands and is designed to be used in 
combination with current infection control programmes. It appears to be aiming 
ultimately, to transform the daily practice and habits of healthcare workers, as well as 
provide education to explain why hand washing is required before or after a particular 
task, rather than simply asking them, as so many previously promoted studies have done 
before, to increase their hand washing frequency. This combination approach has been 
used in other, similar studies where it was concluded to be more effective than 
campaigns which rely solely upon increasing awareness (Forrester et al., 2010). The 
five moments when hands should be cleaned are defined by WHO (2009) as: 
 Before touching a patient 
 Before aseptic procedures 
 After exposure to bodily fluids 
 After touching a patient 
 After touching patient surroundings 
 
1.5.3. Products and agents 
There are many different skin antiseptics available to staff, visitors and patients for use 
on hands, with the most commonly seen within hospitals comprising alcoholic hand 
rubs, often in a gel formulation. These agents are largely accepted as easier to use than 
soap washes, and are often more easily accessible than sinks and soap, as they can be 
easily located near beds, patients and doors, or even tied individually to nursing staff 
uniforms by elasticated cords attached to portable bottles (Goroncy-Bermes et al., 2010; 
Tavolacci et al., 2006). Whilst this seems to suggest alcoholic hand rubs are a perfect 
substitution for traditional soap washing, there are many factors that can reduce the 
efficacy of this practice, such as wearing jewellery, having long nails and using a 
reduced volume, which have demonstrated significant negative impacts on the 
effectiveness of hand rubbing (Hautemaniere et al., 2010). Furthermore, the first reports 
of burns from alcoholic gels have started to appear in the literature. One reported an 
unfortunate incident where a care worker suffered burns to her hands after a fire ball 
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was generated following her igniting a cigarette lighter she had just cleaned with 
alcoholic hand gel (O‟Leary & Price, 2010). However, another reported a burn obtained 
through less careless actions, whereby a nurse burnt her hand when static electricity 
from an electronic call system sparked with the alcohol gel she had just applied as she 
answered a call (Davis, 2008). 
 
1.5.4. Is hand hygiene alone sufficient to control infection 
transmission? 
Patient to patient transmission of infections has been shown in countless studies to be 
dramatically reduced with improved hand hygiene. However, one opinion that is 
becoming more widely acknowledged is that hand hygiene alone is not enough, as 
people, put simply, are dirty. Judah et al. (2010) concluded that amongst five U.K. 
cities, a total of 28 % of commuters had faecal-origin microorganisms on their hands. 
The incidence rate observed increased the further north the city, with the highest rates 
derived from Newcastle males, followed by males then females from Liverpool. Within 
the clinical environment, inadequate hand hygiene may be further exacerbated by the 
use of gloves. One study by Girou et al. (2004) focussed on the potential cross infection 
risks posed by improper glove use. They reported that nearly 65 % of all contacts 
between the gloved hand of a staff member and a patient were subsequently followed by 
further contact elsewhere before the glove was removed. This equated to 18.3 % of all 
contacts requiring aseptic handling potentially inducing microbial transfer. 
Despite continued efforts by individuals, healthcare trusts and governing bodies to 
encourage, bribe or even force staff to perform adequate hand hygiene procedures, HAIs 
remain a persistent concern. This is likely to be, as argued so comprehensively by 
Dancer (2008), that hand hygiene is not enough if not in conjunction with surface 
cleaning and disinfection, and that no matter how clean hands are in practice, if surfaces 
are contaminated, it is only a matter of time before transition to a patient occurs; thus 
highlighting the importance of effective surface cleaning and disinfection practices. 
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1.6. Surface disinfection 
1.6.1. Reasons and rationale 
Hospitals and other healthcare premises provide copious sites for microbial survival and 
multiplication. The spillage of bodily secretions and excretions onto healthcare surfaces 
instantly introduces microbial contamination, and furthermore then acts as a reservoir 
for potential pathogens; a problem that is further embellished by corners and crevices in 
which microorganisms can reside undisturbed (French et al., 2004; Rebmann et al., 
2009). At present, there is no standard method for measuring cleaning efficacy, and with 
microbial transfer thought to occur largely as a result of hand transmission, most efforts 
are focussed on improving hand hygiene rather than surface cleaning, which also 
provides the added benefit of being financially preferable (Dancer, 2004). 
Surfaces within the food industry must comply with strict regulations with regards to 
hygiene levels, however there is no such standard for hospital surfaces to suggest what 
may be an acceptable level of microbial presence. Dancer (2004) proposed that a total 
aerobic count of less than 5 colony forming units (cfu) per cm
2
 would be acceptable for 
hospital surfaces commonly touched by hands, and that a count of less than 1 cfu/cm
2
 
should be adopted for indicator organisms; that is those which pose a potential infection 
control risk to patients and included MRSA and Clostridium difficile. Despite such 
suggestions, there are to date still no legislative regulations concerning appropriate 
surface contamination levels, only guidelines to suggest that suitable monitoring should 
be upheld to maintain a sanitary environment (Siegel et al., 2007). 
On average, a patient is 73 % more likely to contract an infection from MRSA, C. 
difficile, vancomycin-resistant Enterococcus (VRE) or Acinetobacter baumannii if the 
previous patient to occupy that room was infected, compared with patients of another 
room (Carling & Bartley, 2010). This emphasises the need for satisfactory surface 
cleaning and disinfection in order to reduce the risk, something that the government has 
tried to address in recent years. 
 
1.6.2. National incentives 
In September 2007, the government launched „The Deep Clean Programme‟. Costing 
£57 million, the programme was aimed at encouraging hospitals to improve the 
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experiences of patients, by assessing the present environment to ascertain areas in need 
of a deep clean or restoration (Department of Health, 2008b). Completion of the deep 
clean would then give trusts a fresh starting point, upon which future cleaning protocols, 
having been amended and updated, could be more easily upheld and therefore effective. 
Subsequent surveys frequently reported improved patient perceptions of cleanliness, 
whilst many infection rates were shown to decrease, no doubt due in part to the 
completion of refurbishment works to floors, walls and window frames, as well 
replacement purchases of items such as commodes, basins and bedside lockers 
(Department of Health, 2008b). Upon cessation of „The Deep Clean Programme‟, it was 
hoped that trusts would continue to monitor and improve their environment and 
cleaning practices in a bid to limit potential occurrence of infection outbreaks. 
 
1.6.3. Disinfection and sterilisation products 
There are many products available to hospitals within the U.K. for cleaning purposes 
however there is no standardisation in which product to use. The choice of surface 
cleaning or disinfection product to use is often a decision left to individual wards, or the 
cleaning company contracted to the hospital. Agents are available in a range of forms, to 
include both concentrated and pre-diluted solutions, as well as in tablet form requiring 
dilution. These products are often focussed towards one of the two main cleaning 
purposes; disinfection or sterilisation. Disinfection refers to microbial removal of 
pathogenic organisms from objects and hard surfaces; it does not however include spore 
removal. Conversely, sterilisation eradicates all microbial contamination, including 
bacterial spores and is often facilitated by physical or chemical means including 
pressurised steam or gaseous hydrogen peroxide (Rutala et al., 2008). Products relating 
mainly to disinfection will be focussed on here, though this is by no means an 
exhaustive list. 
 
1.6.4. Alcohols and iodophors 
Alcohols such as ethyl alcohol and isopropyl alcohol and iodophors such as povidone 
iodine (all discussed previously) are rapidly bactericidal against Gram-positive and -
negative bacteria, as well as possessing fungicidal and virucidal activity. Alcohols and 
iodophors are used for surface disinfection within the clinical environment, however 
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this is seldom the case due to preference and suitability lending better to skin antisepsis. 
Furthermore, inactivation of iodine solutions by proteinaceous substances and limited 
surface material suitability e.g. incompatibility with fabrics, limits potential uses, 
therefore they will not be discussed further here. 
 
1.6.5. Chlorine 
Chlorine-based products possess antimicrobial activity against bacteria, fungi, viruses, 
mycobacteria and spores, however they are inactivated by the presence of organic 
matter (Rutala et al., 2008; Wheeldon et al., 2008). The most common chlorine-based 
disinfectants used within the healthcare profession are hypochlorites, with sodium 
formulations remaining suitable for use up to a month after preparation, unlike aqueous 
hypochlorites which deteriorate over such time periods. Their exact mode of action has 
not yet been fully clarified, though it is thought to be instigated by denatured proteins 
disrupting metabolic processes, as a result of multiple sites being targeted; this may 
explain the lack of resistance observed towards biocides (Fraise, 1999; McDonnell & 
Russell, 1999; Rutala et al., 2008). Hypochlorite disinfectants are used on furniture, 
patient equipment and surfaces to include bed frames, basins, drip stands, shelves and 
curtain rails, whilst general chlorine-based disinfectants are frequently used for damp-
mopping floors (National Patient Safety Agency, 2009). However they are not pleasant 
to use as the smell may be thought of as noxious and if inappropriately diluted can lead 
to respiratory irritation. 
 
1.6.6. Aldehydes 
Formaldehyde and glutaraldehyde are the main aldehydes used within the health 
service; however despite its wide range of efficacy, formaldehyde is now only used for 
disinfection of high risk areas due to toxicity regulations (Fraise, 1999). 
Glutaraldehydes can be acidic or alkaline and are particularly useful within the 
healthcare setting due to their biocidal properties, even in the presence of a soil load 
(Rutala et al., 2008). They cause deoxyribonucleic acid (DNA), ribonucleic acid (RNA) 
and protein synthesis to be changed providing efficacy against bacteria, fungi, 
mycobacteria, viruses and spores, however alkalising agents can be added to aqueous, 
acidic glutaraldehyde to activate the solution and convert it to an alkaline solution, 
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which then possess sporicidal activity (Rutala et al., 2008). Glutaraldehyde is often used 
for equipment disinfection such as endoscopes as it does not cause corrosion to metal, 
or damage to plastic or rubber. However, glutaraldehyde is toxic and a known irritant, 
and contamination on enemas or equipment used for endoscopy has in some instances 
induced chemical colitis; presenting with rectal bleeding and abdominal pain, and 
treated generally by supportive care alone (Ahishali et al., 2009). For this reason, 
orthophthalaldehyde and hydrogen peroxide are increasingly replacing the use of 
glutaraldehyde within the health service, yet knowledge concerning the potential of 
these agents to also induce sensitisation, remains limited (Rideout et al., 2005). 
 
1.6.7. Quaternary ammonium compounds 
Quaternary ammonium compounds (QUATS) were discovered in 1856, with the first 
germicidal properties reported in 1916; they were then introduced to the medical field in 
1933 for use in clinical practice (Russell, 2004; Russell 2002). They are one of the most 
important biocides used in hospital disinfection and are efficacious through cytoplasmic 
membrane targeting (Sutterlin et al., 2008). The pH at which QUATS are used is known 
to affect their efficacy, with optimum activity in alkaline rather than acidic pH (Russell, 
2004). QUATS are not sporicidal however are active against bacteria, enveloped viruses 
and fungi and are often used for floor cleaning, though it is recommended that they are 
used only on the day of reconstitution and not reused subsequently (Beilenhoff et al., 
2008; Rutala et al., 2008). 
 
1.6.8. Chlorhexidine 
Chlorhexidine (as discussed previously) possesses broad antimicrobial efficacy and 
therefore is often incorporated into disinfectant products. However, such products are 
frequently intended for the disinfection of device and equipment surfaces including 
dental implants (Kandaswamy et al., 2010). Furthermore, in recent years, chlorhexidine 
has been used largely for skin antisepsis rather than disinfection of hospital floors and 
hard surfaces therefore will not be discussed further here. 
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1.7. Care bundles 
High impact interventions (HII) were introduced into the NHS in June 2005 under the 
„Saving Lives Campaign‟, and comprise bundles of care, intended for use by all staff 
within the clinical setting. Bundles are structured care packages, designed to improve 
the treatment process and final patient outcomes from the cumulative effect of multiple 
evidence-based improvement interventions, with significant reduction in HAI the 
ultimate goal (Department of Health, 2006). There are many different bundles to cover 
completion of specific procedures such as central- or peripheral venous catheter 
insertion, upkeep and maintenance of surgical sites, and preventative measures for 
infections such as ventilator-associated pneumonia (VAP) and CRBSI (Bonello et al., 
2008). Introduction of care bundles has been shown to reduce hospital mortality rates. 
Robb et al. (2010) reported a significant reduction in the number of deaths following an 
intervention which included the implementation of eight care bundles, specifically 
targeted to diagnoses accounting for the greatest mortality rates in a North West 
London, acute hospital trust. Furthermore, Guerin et al., (2010) made the discovery that 
in a trust where care bundles were used for central venous catheter insertion with a high 
rate of conformity, a significant reduction in CRBSI could still be achieved with the 
introduction of post insertion care bundle. Measurement of bundle compliance is by 
way of „all or none‟ meaning that all aspects of the bundle need completion for 
recognition of accomplishment; failure to fulfil even one aspect condemns the bundle to 
failure (Vogeli et al., 2009).  
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1.8. New ideas 
1.8.1. Antibiotic approaches 
In order to continue reducing HAIs, new strategies for infection control are constantly 
being considered, including novel antimicrobial agents, cleaning products and methods. 
Modification of antibiotics already in existence has proved a useful means of generating 
more drugs, in particular, semi-synthetic ones capable of targeting microorganisms 
demonstrating resistance to the original, unmodified form; one such example is the 
conversion of tetracycline to the semi-synthetic tigecycline (Livermore, 2005). 
Furthermore, because many antibiotics are produced as secondary metabolites by 
microorganisms, genetic manipulation of the actual organism has lead to the 
development of altered antibiotics, boosting the total number of drug varieties available 
(Walsh & Fischbach, 2009). Finally, there are still many undiscovered and untested 
microorganisms, especially soil microbes that may also produce metabolites of potential 
antimicrobial use. 
 
1.8.2. Targeting surfaces 
New cleaning products, solutions and chemicals are continually being brought to 
market, each claiming to kill more microorganisms and last longer than the competitors. 
However, one method of improving cleaning practice within the healthcare setting is 
based on feedback rather than products and monitors cleaning efficacy using ATP 
bioluminescence. Surfaces can be swabbed and a numerical value for ATP obtained 
almost instantly following insertion of the swab into a hand-held terminal containing 
reagents that react with any ATP present. There are however, a number of limitations to 
this method as ATP is present not only in microorganisms, but also in bodily fluids and 
food therefore high readings may not necessarily indicate microbial contamination due 
to the inability to distinguish the source (Moore et al., 2010). Furthermore, readings 
need to be taken in context as there is no „cut-off‟ point at which a surface would be 
deemed acceptably clean or not, therefore readings need to be monitored over time to 
establish baselines, often meaning ATP bioluminescence is used as a means of 
highlighting how changes to disinfection regime can affect cleanliness levels. This 
method is often employed in the food industry and rarely used within the clinical 
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Hygiene Monitoring System has recently been approved for use in the clinical setting by 
the rapid review panel (Department of Health and NHS Purchasing and Supply Agency, 
2009a). Advanced surface development is another means of potentially reducing HAI 
by preventing viable cells surviving on surfaces they come into contact with. Many 
different antimicrobials have been incorporated into surfaces including zinc, copper, 
silver, biocides and antibiotics however resolutions that can withstand cleaning 
protocols and general wear and tear have proved harder to find; furthermore any 
potential product must be cost effective if it is to replace existing surfaces within the 
healthcare setting. One example of a disinfectant surface covering is photocatalytic 
coatings, which are also known as self cleaning and consist of a photo-excited 
semiconductor, frequently titanium dioxide. This semiconductor causes redox reactions 
which create reactive oxygen species (ROS), in turn these attack structural cellular 
proteins and result in cell death (Dunlop et al., 2010). Due to the mechanism of action, 
development of microbial resistance to photocatalytic coatings is thought to be unlikely, 
providing additional benefits to a system that already shows clinical potential from 
favourable efficacy results against an array of microorganisms, to include biofilm 
cultures (Dunlop et al., 2010; Goulhen-Chollet et al., 2009). 
 
1.8.3. Using metal 
Silver and copper have long been known to possess antimicrobial properties, and both 
have been, and continue to be, exploited for use within the clinical setting in a variety of 
properties. Huang et al. (2008) reported that addition of copper or silver ions to water 
demonstrated antimicrobial efficacy against a number of organisms known to cause 
HAI such as P. aeruginosa, and that moreover, if added together copper and silver ions 
generated synergistic results, however testing against biofilm cultures was not 
undertaken. Silver dressings for application to wound sites are available from many 
companies including world leaders such as Johnson & Johnson and Smith & Nephew. 
The silver can be easily impregnated into films or layered between sheets providing a 
sustained release of particles which eradicate wound microorganisms, however residual 
efficacy is limited and presence of organic matter can greatly reduce efficacy (Atiyeh et 
al., 2007). Other silver products include creams, solutions and even silver-impregnated 
fabrics such as pyjamas and bed sheets (O‟Hanlon & Enright, 2009). Copper products 
have also been trialled. Casey et al. (2010) replaced a number of high touch surfaces 
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including door push plates, tap handles and toilet seats within an acute medical ward 
with copper-containing substitutes. Throughout the trial comparisons were made 
between the microbial counts on the newly installed copper-containing surfaces and 
those on non-copper-containing controls with significant differences being found on tap 
handles and push plates indicating that the use of copper surfaces may aid infection 
control within the healthcare setting (Casey et al., 2010). One recent study investigated 
the use of a copper-based biocide applied to microfiber cloths and mops and showed a 
total viable count reduction of 56 % on surfaces, compared with a 30 % reduction by the 
water control. Furthermore, they observed residual activity of the copper-based biocide 
for up to two weeks (Hamilton et al., 2010). Titanium dioxide treated polyester fabrics 
have also shown to be antimicrobial and of potential use within the clinical setting to aid 
infection control (Dastjerdi et al., 2010). 
 
1.8.4. Hospital design 
Air, water, surfaces and equipment can potentially harbour many microorganisms and 
are therefore capable of acting as reservoirs, introducing microorganism into the 
healthcare setting and inducing transmission of infections. The possibility of microbial 
spread is now an aspect that is taken into account during the designing of modern 
hospitals. Sinks within each patients‟ room, additional to those in the en-suite, is one of 
the most commonly introduced features to newly designed facilities (Bartley et al., 
2010). Along with this, more single-patient rooms are often incorporated into the 
design. Ventilation and air flow considerations, including the installation of high 
efficiency particulate air (HEPA) filters and appropriate direction of air into, around and 
out of wards and rooms to minimise infection spread of microbial spores in particular, 
are also made during the design stage (Qian et al., 2010). Small details must also be 
taken into account when planning hospital layout with HAI minimisation in mind, 
including locations for placement of alcoholic hand rubs, designated areas for dirty 
linen and waste bins, flooring and surface material that allows for easy cleaning and 
even hinge direction on doors so they can be pushed rather than pulled if hands are 
contaminated (Stockley et al., 2006). Design features that allow for changes to occur 
throughout the lifetime of the hospital are beneficial, for example more single rooms 
will provide flexibility should an outbreak scenario occur as they can be easily 
transformed into isolation units (Lateef, 2009).  
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1.9. Aims of thesis 
The aims of this thesis were to: 
 Determine the antimicrobial efficacy of eucalyptus oil and 1,8-cineole both 
alone and in combination with chlorhexidine, against a panel of clinically 
relevant microorganisms grown in planktonic and biofilm cultures. The outcome 
from this part of the research would be used to determine the most efficacious 
agent with which subsequent studies of this thesis would be undertaken. 
 Investigate the antimicrobial efficacy of 10 % (v/v) eucalyptus oil-containing 
wipes for hard surface disinfection against a panel of microorganisms grown in 
planktonic and biofilm cultures. Time kill studies, microbial removal from 
surfaces, and potential of wipes to induce cross contamination would be 
assessed. 
 Study of the antimicrobial efficacy of novel hard surface disinfectant wipes 
comprising either 5 % or 2 % (v/v) eucalyptus oil with 2 % (v/v) chlorhexidine 
digluconate and 70 % (v/v) isopropyl alcohol designated Euclean
®
 wipes, 
against a panel of microorganisms grown in planktonic and biofilm cultures. 
Time kill studies, microbial removal from surfaces and potential of wipes to 
induce cross contamination would be assessed. 
 Explore the potential of isothermal calorimetry as an alternative to standard 
laboratory culture methods for assessment of antimicrobial efficacy of Euclean
®
 
hard surface disinfectant wipes against a panel of clinically relevant 
microorganisms. 
 Assess the opinions of NHS staff at Birmingham Children‟s Hospital, 
Birmingham, U.K., towards current cleaning products and Euclean
®
 hard surface 
disinfectant wipes by means of a clinical audit and questionnaire. 
 Develop a prototype transdermal biopatch containing 5 % (v/v) eucalyptus oil 
and 2 % (v/v) chlorhexidine digluconate, then assess its antimicrobial efficacy 
against a panel of clinically relevant microorganisms, release and skin 
penetration of the antimicrobial agents using Franz diffusion cells, high 
performance liquid chromatography (HPLC) and gas chromatography (GC), and 
establish the associated potential toxicity using tissue culture techniques. 




Antimicrobial Efficacy of Eucalyptus Oil, 
1,8-Cineole and Chlorhexidine Digluconate, 
Alone and in Combination against a Panel of 
Microorganisms in Planktonic and Biofilm 
Modes of Growth 
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2.1. Introduction 
Chlorhexidine (CHG) possesses rapid antimicrobial efficacy against both Gram-positive 
and -negative bacteria, yeasts and lipophilic viruses, and is the antimicrobial of choice 
recommended by EPIC guidelines for skin antisepsis (Pratt et al., 2007). However, 
penetration studies have demonstrated its less favourable attribute of poor permeation 
into the deeper layers of human skin (Karpanen et al., 2008a). This can result in 
incomplete skin antisepsis from microorganisms residing in pores and hair follicles, as 
well as those existing as biofilm-like microcolonies within the skin. During surgical 
procedures such as CVC insertion, the barrier properties of the skin become breached, 
allowing infectious complications to arise from these deeply resident microorganisms 
(Health Protection Agency, 2010c). Therefore, there is a need to develop a means of 
achieving effective skin antisepsis throughout all layers of the skin, potentially by 
combining current agents with other antimicrobial agents, and/or permeation enhancers.  
For many years, essential oils have been recognised as possessing a broad array of 
antimicrobial properties, furthermore some are now recognised to contain components 
that are known permeation enhancers (Edris, 2007). The addition of eucalyptus oil (EO) 
to CHG has recently shown to significantly enhance skin penetration of CHG into the 
epidermis and dermis (Karpanen et al., 2010). Eucalyptus oil has been studied by a 
number of groups investigating its antimicrobial properties, however it still remains 
unknown which, of the almost 60 constituents within the oil, are responsible for this 
efficacy and whether it is due to one component alone or the synergistic properties of 
many (Wildy et al., 2000). 
The main constituent within EO is 1,8-cineole; a potent terpene and notorious 
permeation enhancer (Chandra et al., 2009). Causing temporary disruption to the 
intercellular lipids of the stratum corneum, 1,8-cineole has been used in many 
penetration studies and is thought to aid delivery of some drugs through the skin via the 
„pull‟ effect, whereby it forms a complex with the drug and drags it through at the same 
rate (Heard et al., 2006). However, studies into the antimicrobial efficacy of 1,8-cineole 
are less readily available. 
Due to the potential enhanced permeation offered by EO and 1,8-cineole, it is possible 
that combining them with CHG will result in improved antimicrobial activity in the 
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deeper layers of the skin, however prior to this, the antimicrobial efficacy of the agents 
alone and in combination needs to be studied. 
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2.2. Aims of the study 
The aims of this study were to: 
 Assess the antimicrobial activity of EO, 1,8-cineole and CHG using zones of 
inhibition and determination of minimum inhibitorary concentrations (MIC) and 
minimum bactericidal concentrations (MBC) through microbroth dilution and 
the „scrape and wash‟ technique, against a panel of clinically relevant 
microorganisms, grown in both planktonic and biofilm cultures. 
 Determine the antimicrobial activity of EO and 1,8-cineole in combination with 
CHG, using a checkerboard method and adenosine triphosphate (ATP) 
bioluminescence, against a panel of clinically relevant microorganisms, grown 
in both planktonic and biofilm cultures. 
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2.3. Materials 
2.3.1. Microbial cultures 
National Collection of Type Cultures (NCTC) and American Type Culture Collection 
(ATCC) strains of microorganisms were selected. Staphylococcus hominis ATCC 
35982, Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis RP62A, 
MRSA N315, Pseudomonas aeruginosa ATCC 15442, Escherichia coli NCTC 10418 
and Candida albicans ATCC 76615 were stored on MicroBank beads (Pro-Lab 
Diagnostics, Cheshire, U.K.) at -70 °C until required. 
 
2.3.2. Microbiological media 
Mueller-Hinton agar (MHA), Mueller-Hinton broth (MHB), Sabouraud dextrose agar 
(SDA) and Sabouraud dextrose broth (SDB) were purchased from Oxoid (Basingstoke, 
U.K.), prepared as per manufacturer‟s instructions and sterilised at 121 °C for 15 
minutes. Agar was cooled to 50 °C before pouring and broths were stored at 4 °C until 
required. 
Letheen broth and agar bacteriological (agar no.1) were purchased from Oxoid 
(Basingstoke, U.K.). Neutralising letheen agar was made from letheen broth prepared as 
per manufacturer‟s instructions with the addition of 1 % (w/w) agar no.1, then sterilised 
at 121 °C for 15 minutes and cooled to 50 °C before pouring. 
Congo red agar was prepared initially in two parts with a ratio of 80:20 part one to two. 
Part one contained 3.75 % (w/v) MHB or SDB (Oxoid, Basingstoke, U.K.), 1.25 % 
(w/v) D-glucose (Fisher Scientific, Leicestershire, U.K.) and 1.875 % (w/v) agar 
number 1 (Oxoid, Basingstoke, U.K.) in double distilled water. Part two consisted of 0.4 
% (w/v) Congo red (Hopkins & Williams Limited, Essex, U.K.) in double distilled 
water. The two parts were autoclaved separately and cooled to 50 °C before part two 
was aseptically transferred into part one and plates were poured.  
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2.3.3. Chemicals 
2.3.3.1. Eucalyptus oil stock solution 
Stock solutions of EO (Sigma-Aldrich, Dorset, U.K.) were made fresh on the day of 
use, to a concentration of 512 mg/mL then further diluted as required. The concentration 
of EO was 0.910 g/mL; equivalent to 910 mg/mL, thus the stock solution consisted of 
56.26 % (v/v) EO, 5 % (v/v) dimethyl sulfoxide (DMSO) (Sigma-Aldrich, Dorset, 
U.K.) in sterile, double distilled water.  
 
2.3.3.2. 1,8-Cineole stock solution 
Stock solutions of 1,8-cineole (Sigma-Aldrich, Dorset, U.K.) were made fresh on the 
day of use, to a concentration of 512 mg/mL and further diluted as required. The 
concentration of 1,8-cineole was 0.924 g/mL; equivalent to 924 mg/mL, thus the stock 
solution consisted of 55.41 % (v/v) 1,8-cineole, 5 % (v/v) DMSO (Sigma-Aldrich, 
Dorset, U.K.) in sterile, double distilled water. 
 
2.3.3.3. Chlorhexidine digluconate stock solution 
Stock solutions of CHG (Sigma-Aldrich, Dorset, U.K.) were made fresh on the day of 
use, to a concentration of 256 µg/mL and further diluted as required. The concentration 
of the CHG solution obtained from Sigma was 200,000 µg/mL, thus the stock solution 
consisted of 12.8 % (v/v) CHG in sterile, double distilled water to give a concentration 
of 25,600 µg/mL, which then required a 1:100 dilution to achieve the desired stock 
solution concentration of 256 µg/mL. 
 
2.3.3.4. Alcian blue solution 
Alcian blue stain was made with 1 % (w/v) Alcian blue 8 XG (Sigma-Aldrich, Dorset, 
U.K.) and 3 % (v/v) acetic acid (Fisher Scientific, Leicestershire, U.K.) in sterile, 
double distilled water. 
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2.3.4. Equipment 
Optical density (OD) readings were taken using a Pharmacia LKB visible 
spectrophotometer, Novaspec II (Pharmacia, Freiburg, Germany). 
Fluorescence and OD of microtitre plates were measured using an EL808IU-PC 
microplate reader with Gen5 software (BioTek Instruments Ltd, Leeds, U.K.). 
Microscopy was performed with a Zeiss Axio Scope microscope fitted with a Zeiss 
AxioCam HRc camera and AxioVision software version 3.1 (Carl Zeiss Ltd, 
Hertfordshire, U.K.).  
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2.4. Methods 
2.4.1. Antimicrobial activity of eucalyptus oil, 1,8-cineole and 
chlorhexidine digluconate against microorganisms in 
planktonic mode of growth 
2.4.1.1. Standard curves of colony forming units using optical density  
Overnight cell suspensions of S. aureus, S. epidermidis, MRSA, P. aeruginosa and E. 
coli were prepared in MHB and incubated at 37 °C. C. albicans was grown at 30 °C in 
SDB. A range of serial and double dilutions were made of each cell suspension in either 
MHB or SDB as required in duplicate, and the OD of each was read in a 
spectrophotometer set to 570 nm following appropriate broth blanking. Cell suspensions 
were plated onto MHA or SDA using the drop count method (Miles & Misra, 1938) and 
incubated overnight at 37 and 30 °C respectively. The colony forming units (cfu) were 
determined for each microorganism and equated to cfu per millilitre (cfu/mL), then 
plotted against OD. 
 
2.4.1.2. Microbial inhibition by eucalyptus oil and 1,8-cineole solutions 
using agar diffusion 
Based on methods by Smith-Palmer et al. (1998), cell suspensions of S. aureus and E. 
coli in MHB were prepared containing 10
4
 cfu/mL and spread with a sterile cotton swab 
over MHA plates made from 25 mL to give a uniform thickness. Sterile glass pipettes 
were used to cut three wells from each plate. Neat, 50, 40, 30, 20 and 10 % (v/v) 
solutions of EO and 1,8-cineole were made using sterile, double distilled water and 5 % 
(v/v) DMSO. Sixty microlitres of each EO or 1,8-cineole dilution was added to 
triplicate wells cut from a single plate. Control plates containing EO alone, 1,8-cineole 
alone and 5 % (v/v) DMSO in water were also prepared. Plates were stored at 4 °C for 1 
hour then incubated at 37 °C overnight. Following incubation, inhibition zone sizes 
were measured as the distance between the edge of the well and visible growth.  
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2.4.1.3. Microbial inhibition by eucalyptus oil and 1,8-cineole solutions 
following direct application 
MHA plates were inoculated with S. aureus and E. coli as previously described (Section 
2.4.1.2) and the same dilutions of EO and 1,8-cineole were prepared, along with the 
controls. Duplicate 25 µL drops of each test antimicrobial or control were spotted onto 
each microorganism. Plates were dried at 4 °C for 1 hour then incubated at 37 °C 
overnight. Inhibition zone diameters were measured after incubation.  
 
2.4.1.4. Minimum inhibitory and bactericidal concentrations of 
eucalyptus oil, 1,8-cineole and chlorhexidine using microbroth dilution 
Double dilutions of EO and 1,8-cineole ranging from 512 to 0.25 mg/mL were made in 
MHB and SDB, from stock solutions (Sections 2.3.3.1 and 2.3.3.2). Dilutions of CHG 
were made from 128 to 0.0625 µL/mL also in MHB and SDB. Triplicate wells were set 
up in a clear, round bottom, 96-well microtitre plate (Fisher Scientific, Leicestershire, 
U.K.) (Figure 2.1) with 100 μL of test antimicrobial and 100 μL of 106 cfu/mL cell 
suspension, diluted from overnight broth inocula of all six microorganisms. Phosphate 
buffered saline (PBS) (Sigma-Aldrich, Dorset, U.K.) and DMSO controls ranging 20 % 
(v/v) to 0.625 % (v/v) were also set up for each microorganism. All plates were 
incubated overnight at 37 ºC; C. albicans at 30 ºC. The minimum inhibitory 
concentration (MIC) was determined as the lowest concentration to have no clearly 
visible button of growth in the well. The solution from each MIC well and those of 
higher all concentrations were plated onto neutralising letheen agar, spread with a 
wedge-shaped spreader and incubated overnight, as were the controls. Growth controls 
of each microorganism were also prepared on letheen agar. The minimum 
bactericidal/fungicidal concentration (MBC/MFC) was determined as the lowest 
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Figure 2.1. Diagram showing microtitre plate set up for the method entitled ‘MIC and MBC using microbroth 
dilution’. A range of concentrations of EO, 1,8-cineole or CHG are added to equal volumes of cell suspensions 
of each microorganism to determine MIC and MBC values. 
 
2.4.1.5. Checkerboard assay combining eucalyptus oil and 1,8-cineole 
with chlorhexidine using optical density 
Double dilutions of EO and 1,8-cineole were made in MHB or SDB ranging from 512 
to 0.5 mg/mL, and CHG from 256 to 0.125 µg/mL. For each of the six microorganisms, 
duplicate clear, round bottom, 96-well microtitre plates (Fisher Scientific, 
Leicestershire, U.K.) were set up (Figure 2.2) with 100 µL of CHG and 100 µL of EO 
per well, as well as duplicate plates of 100 µL of CHG and 100 µL of 1,8-cineole. For 
each plate, the highest concentration of CHG was added to the first column, the next 
concentration to the second column etc. The EO or 1,8-cineole was added in reducing 
concentrations to the first 9 wells of each row. Controls were set up of CHG alone, EO 
or 1,8-cineole alone, 5 % (v/v) DMSO in MHB or SDB as appropriate, and PBS alone. 
All wells were inoculated with 10 µL of a 10
6
 cfu/mL cell suspension. C. albicans 
plates were incubated overnight at 30 ºC, all others were incubated at 37 ºC. The MIC 
of each agent alone and in combination was determined as the lowest concentration to 
show no visible growth, and was verified with OD using a microplate reader set to 570 
nm, then analysed using Gen5 software. Pour plates of molten MHA and SDA cooled to 
50 °C were made containing the contents of the well determined as the MIC, and all 
those containing test agents of a higher concentration. The MBC was determined as the 
lowest concentration to show 99.9 % reduction in cfu/mL from that of the control. The 
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effects of the combinations were then determined as synergistic, indifferent or 
antagonistic by calculating the fractional inhibitory concentration (FIC) for the agents, 
and then the fractional inhibitory concentration indices (FICI) value for each 
combination (White et al., 1996). 
 
FIC   
MIC of antimicrobial in combination
MIC of antimicrobials alone
 
 
FICI   FIC of oil   FIC of chlorhexidine 
 
Where: FICI < 0.5 shows synergism 
FICI > 0.5 or < 4.0 shows indifference 
FICI > 4.0 shows antagonism 
 
  Concentration of Chlorhexidine (µg/mL) Controls 
  































512          
PBS 
128 512 
256          64 256 
128          32 128 
64          16 64 




16          4 16 
8          2 8 
4          1 4 
 
Figure 2.2. Diagram showing microtitre plate set up for the method entitled ‘Checkerboard assay’. Reducing 
concentrations of EO or 1,8-cineole are added to the rows, while reducing concentrations of CHG are added in 
equal volume to the columns. A small inoculum of concentrated cell suspensions of each microorganism is 
added to determine synergism, indifference or antagonism. 
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2.4.2. Antimicrobial activity of eucalyptus oil, 1,8-cineole and 
chlorhexidine digluconate against microorganisms in biofilm 
mode of growth 
2.4.2.1. Verification of biofilm production 
Overnight cell suspensions of all six microorganisms were quantified using previously 
established OD/cfu standard curves (Section 2.4.1.1), and diluted in MHB or SDB to 
10
5
 cfu/mL. Three millilitres of each microorganism were inoculated into four wells of a 
clear plastic, flat bottom, 6-well, tissue culture treated plate (Appleton Woods, 
Birmingham, U.K.). All plates were incubated for 48 hours at 37 ºC; 30 ºC for C. 
albicans. Following incubation, the broth was discarded and all wells were washed once 
with PBS. For each 6-well tissue culture treated plate, three wells (duplicate inoculated 
wells and one empty) were stained with 3 mL Alcian blue for 15 minutes, while the 
remaining three wells (also two inoculated and one empty) had 3 mL crystal violet stain 
(Reactifs RAL, France) for 5 minutes. Dyes were removed after the allocated exposure 
time and wells washed again with PBS. The wells of the 6-well plates were left to dry in 
air, then immersion oil was added and biofilm presence verified microscopically, using 
the phase plate and x40 objective of a Zeiss Axio Scope microscope fitted with a Zeiss 
AxioCam HRc camera (Carl Zeiss Ltd, Hertfordshire, U.K.). 
Congo red plates were inoculated with each microorganism from five identical colonies 
grown on MHA or SDA, and spread for single colonies using a sterile, metal loop. A 
negative control was also set up in the same manner using S. hominis. Plates were 
incubated overnight at 37 ºC; C. albicans at 30 ºC. A positive result was observed as 
black, crusty colonies. Pink colonies represented a negative result for biofilm 
production. 
 
2.4.2.2. Quantification of microbial cell numbers within a biofilm 
Wells of a clear plastic, flat bottom, 96-well microtitre plate (Thermo Labsystems, 
Franklin, U.S.A.) were inoculated with 200 µL of an overnight cell suspension of each 
microorganism, diluted in MHB or SDB to 10
4
 cfu/mL. Plates were incubated for 48 
hours at 37 ºC; C. albicans at 30 ºC. Following incubation, all broth was removed and 
wells were washed once with PBS. Into each well, 250 µL of PBS was added and plates 
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were sonicated in a 50 Hz water bath sonicator (Kerry Ultrasonics, Hertfordshire, U.K.) 
for 30 minutes. A sterile pipette tip was used to dislodge any remaining bound cells and 
the contents of 4 wells compiled into one eppendorf tube to produce 1 mL from four 
initial biofilms. Eppendorf tubes were mixed for 1 minute then serial dilutions made in 
MHB or SDB, and plated onto MHA or SDA using the drop count method (Miles & 
Misra, 1938). Following overnight incubation, colonies were counted and converted 
into cfu/mL of biofilm. The assay was performed in quadruplicate. 
 
2.4.2.3. Minimum inhibitory and bactericidal concentrations of 
eucalyptus oil, 1,8-cineole and chlorhexidine using the scrape and wash 
technique 
Biofilms of all six microorganisms were grown in microtitre plates as previously 
described for 48 hours (Section 2.4.2.2). After incubation, all broth was removed and 
wells were washed once with PBS. Double dilutions of EO and 1,8-cineole covering the 
range 512 to 0.25 mg/mL were made in MHB and SDB, from stock solutions. Dilutions 
of CHG were made from 128 to 0.125µl/mL. Wells were treated in triplicate with 100 
μL of double the required final concentration of test agent, and 100 μL of MHB or SDB. 
Controls of PBS and 5 % (v/v) DMSO were also set up for each microorganism. The 
plates were incubated overnight at 37 ºC; 30 ºC for C. albicans. The test antimicrobial 
agents were removed and the wells washed once with PBS before adding 250 µL fresh 
PBS to each well and subjecting the plate to 30 minutes sonication in a 50 Hz water 
bath sonicator (Kerry Ultrasonics, Hertfordshire, U.K.). All wells were scraped and 
washed (Adams, 2006) once to loosen the biofilm, then plated into molten MHA or 
SDA cooled to 50 °C and incubated overnight. The MIC was determined as the lowest 
concentration to show reduced growth from that of the control plate, and the MBC as 
the lowest concentration to show a 99.9 % reduction in the cfu/mL compared with that 
of the control. 
 
2.4.2.4. Standard growth curves using ATP bioluminescence 
Overnight cell suspensions of all six microorganisms were diluted to 10
5
 cfu/mL then 
200 µL of each microorganism inoculated into 15 wells of a white wall, clear bottom, 
tissue treated, 96-well microtitre plate (Fisher Scientific, Leicestershire, U.K.). 
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Following 48 hours incubation at 37 ºC or 30 ºC for C. albicans, the broth was removed 
and wells were washed once with PBS. Each well had 250 µL fresh PBS added then the 
plates were sonicated for 30 minutes in a 50 Hz water bath sonicator (Kerry Ultrasonics, 
U.K.). Wells were scraped and washed (Adams, 2006) once into a sterile universal 
bottle containing 1 g sterile, borosilicate solid glass beads, 3 mm (Sigma-Aldrich, 
Dorset, U.K.), and vortexed for 1 minute. This neat solution was serially diluted in 
MHB or SDB as appropriate, with double dilutions of these also prepared. Samples of 1 
mL of each dilution was added to a petri dish and pour plates made using molten MHA 
or SDA cooled to 50 °C. Duplicate wells of a fresh white wall, clear bottom, tissue 
treated, 96-well microtitre plate (Fisher Scientific, Leicestershire, U.K.) were inoculated 
with 100 µL of each dilution. Fifty microlitres of bactolyse from the ViaLight MDA 
plus detection kit (Cambrex, U.S.A.) was added to each well and left as described in the 
kit for 10 minutes. One hundred microlitres of adenosine tri-phosphate monitoring 
reagent (ATP-MR) was added to every well, left for 2 minutes then fluorescence was 
read on the microplate reader. Following overnight incubation of the pour plates, the 
colonies were counted and converted to cfu/mL, then plotted against the relative light 
units (RLU) of luminescence. 
 
2.4.2.5. Checkerboard assay combining eucalyptus oil and 1,8-cineole 
with chlorhexidine using ATP bioluminescence 
White wall, clear bottom, tissue treated, 96-well microtitre plates (Fisher Scientific, 
Leicestershire, U.K.) were inoculated with 200 µL per well of a 10
5
 cfu/mL cell 
suspension, diluted in MHB or SDB from an overnight cell suspension; three wells per 
plate were left empty. Plates were incubated for 48 hours at 37 ºC; 30 ºC for C. 
albicans. Following incubation, double dilutions of stock solutions were made of EO or 
1,8-cineole and CHG ranging from 512 to 1 mg/mL and 128 to 0.5 µg/mL respectively. 
All broth was removed from the microtitre plates and wells were washed once with 
PBS. Wells were set up with 125 µL EO or 1,8-cineole and 125 µL CHG such that EO 
or 1,8-cineole concentration reduced with each column and CHG concentration reduced 
with each row. Controls were also set up with 125 µL EO, 1,8-cineole or CHG and 125 
µL MHB or SDB. PBS and 5 % (v/v) DMSO controls were also made. Plates were 
returned to the appropriate incubator overnight. After incubation, all test antimicrobial 
agents were removed from the plates and wells were washed once with PBS. To each 
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well, 150 µL PBS and 50 µL bactolyse from the ViaLight MDA plus detection kit 
(Cambrex, U.S.A.) were added, then the plate was sonicated at for 30 minutes in a 50 
Hz water bath sonicator (Kerry Ultrasonics, Hertfordshire, U.K.). After sonication, 100 
µL ATP-MR was added to each well and left as required for 2 minutes before 
fluorescence was read on the microplate reader. 
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2.5. Results 
2.5.1. Antimicrobial activity of eucalyptus oil, 1,8-cineole and 
chlorhexidine digluconate against microorganisms in 
planktonic mode of growth 
2.5.1.1. Standard curves of colony forming units using optical density 
The standard curves for cell suspension quantification of each microorganism using OD 
produced linear graphs with R
2
 values of 0.9822 for S. aureus, 0.9986 for S. 
epidermidis, 0.9939 for MRSA, 0.9798 for P. aeruginosa, 0.9899 for E. coli and 0.9935 
for C. albicans (Figures A1-A6). 
 
2.5.1.2. Microbial inhibition by eucalyptus oil and 1,8-cineole solutions 
using agar diffusion 
Both EO and 1,8-cineole demonstrated antimicrobial activity against S. aureus and E. 
coli (Table 2.1). Overall however, EO gave significantly larger (P<0.001, Paired t-test, 
Instat3 GraphPad) zones of inhibition than 1,8-cineole, while significantly greater 
(P<0.001, Paired t-test, Instat3 GraphPad) sensitivity was observed by S. aureus than E. 
coli towards EO. The mean zone sizes and standard deviation (SD) for EO were 12.39 
and 7.33; for 1,8-cineole these were 0.53 and 1.06 respectively when data were 
compiled regardless of microorganism. The DMSO controls all had zones of <1 mm 
diameter, therefore were deemed as not contributing to any antimicrobial activity 
observed. 
 
Table 2.1. Antimicrobial efficacy of neat and diluted eucalyptus oil and 1,8-cineole against S. aureus and E. coli 
expressed as mean (n=3) sizes of inhibition zones observed using the agar diffusion method. 
  Inhibition zone (mm) for eucalyptus oil/1,8-cineole 
  Neat 50 % 40 % 30 % 20 % 10 % 
S. aureus 12/3 12/<1 11/<1 8/<1 6/<1 3/<1 
E. coli 7/2 6/1 5/<1 5/<1 2/<1 1/<1 
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2.5.1.3. Microbial inhibition by eucalyptus oil and 1,8-cineole solutions 
following direct application 
Overall, EO showed significantly greater (P<0.005, Paired t-test, Instat3 GraphPad) 
efficacy than 1,8-cineole when applied directly to S. aureus and E. coli (Table 2.2). The 
mean zone sizes and SD for EO were 10.96 and 8.46; for 1,8-cineole these were 3.63 
and 5.24 respectively when data were compiled regardless of microorganism. The 
DMSO controls all had zones of <1 mm diameter, therefore were deemed as not 
contributing to any antimicrobial activity observed. 
 
Table 2.2. Antimicrobial efficacy of neat and diluted eucalyptus oil and 1,8-cineole against S. aureus and E. coli 
expressed as mean (n=2) sizes of inhibition zones observed following direct application. 
  Inhibition zone (mm) for eucalyptus oil/1,8-cineole 
  Neat 50 % 40 % 30 % 20 % 10 % 
S. aureus 23/<1 20/<1 18/<1 14/<1 <1/<1 <1/<1 
E. coli 18/11 15/11 13/11 12/11 <1/<1 <1/<1 
 
 
2.5.1.4. Minimum inhibitory and bactericidal concentrations of 
eucalyptus oil, 1,8-cineole and chlorhexidine using microbroth dilution 
CHG demonstrated significantly greater (P<0.005, Wilcoxon signed rank test, Instat) 
antimicrobial activity than EO or 1,8-cineole against all six microorganisms tested, with 
the MIC and MBC values of CHG being a magnitude of 1000-times less than that 
obtained for EO and 1,8-cineole (Figure 2.3). The median MIC and MBC for EO were 6 
and 8 mg/mL respectively, for 1,8-cineole these were 48 and 192 mg/mL, and for CHG 
values of 2 and 2 µg/mL were recorded. P. aeruginosa demonstrated reduced sensitivity 
to EO and 1,8-cineole compared with the other microorganisms tested, with the highest 
concentration tested (256 mg/mL) of 1,8-cineole failing to inhibit growth. The MIC and 
MBC data were categorised into high or low using the midpoint of the observed range 
as the cut off value (Table A1), which showed the MBC values of EO to be significantly 
lower (P<0.05) than that of 1,8-cineole when applied to a Chi squared 2 by 2 
contingency table (Instat3 GraphPad). Collating the MIC and MBC results 
demonstrated that overall, there were significant differences (P<0.05, Chi squared 2 by 
2 contingency table, Instat3 GraphPad) between EO and 1,8-cineole, as well as between 
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both of these and CHG. The 5 % (v/v) DMSO control showed no antimicrobial activity 
against any of the microorganisms tested. 
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Figure 2.3. MIC and MBC median values (n=3) of EO, 1,8-cineole and CHG against a panel of six microorganisms, obtained using the microbroth dilution method. (# represents MIC or 
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2.5.1.5. Checkerboard assay combining eucalyptus oil and 1,8-cineole 
with chlorhexidine using optical density 
All except three combinations of EO or 1,8-cineole with CHG resulted in synergistic 
antimicrobial activity, with EO/CHG for S. epidermidis demonstrating indifference 
(neither synergistic nor antagonistic) with an FICI value of 0.625, along with both 
EO/CHG and 1,8-cineole/CHG for P. aeruginosa with FICI values of 0.750 and 0.516 
respectively (Table 2.3). 
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Table 2.3. Resultant antimicrobial efficacy of EO and 1,8-cineole when combined with CHG against planktonic growth of a panel of six microorganisms, using a checkerboard assay.  The 
results are shown in duplicate and expressed as Fractional Inhibitory Concentration (FIC) and FIC Index (FICI), where FICI ≤ 0.5 shows synergy, FICI > 0.5 or ≤ 4.0 shows indifference, 
and FICI > 4.0 shows antagonism. 
Microorganism/ 
Combination Tested 








Mean FICI Result 
S. aureus         
 EO + CHG 32/8 32/4 0.188 1/0.125 1/0.125 0.125 0.313 Synergy 
Cineole + CHG 128/4 128/4 0.031 1/0.25 1/0.25 0.250 0.281 Synergy 
S. epidermidis         
 
EO + CHG 8/1 8/1 0.125 2/1 2/1 0.500 0.625 Indifference 
 
Cineole + CHG 32/8 32/8 0.250 2/0.125 2/0.125 0.063 0.313 Synergy 
MRSA         
 EO + CHG 16/4 16/4 0.250 2/0.25 2/0.25 0.125 0.375 Synergy 
Cineole + CHG 128/8 128/4 0.047 0.5/0.125 0.5/0.125 0.250 0.297 Synergy 
P. aeruginosa         
 EO + CHG 16/4 16/8 0.375 4/2 4/1 0.375 0.750 Indifference 
Cineole + CHG 256/4 256/4 0.016 4/2 4/2 0.500 0.516 Indifference 
E. coli         
 EO + CHG 8/1 8/1 0.125 0.5/0.25 0.5/0.125 0.375 0.500 Synergy 
Cineole + CHG 32/8 32/8 0.250 0.5/0.125 0.5/0.125 0.250 0.500 Synergy 
C. albicans         
 EO + CHG 8/2 8/2 0.250 4/1 4/1 0.250 0.500 Synergy 
Cineole + CHG 32/4 64/4 0.094 2/0.5 2/1 0.375 0.469 Synergy 
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2.5.2. Antimicrobial activity of eucalyptus oil, 1,8-cineole and 
chlorhexidine digluconate against microorganisms in biofilm 
mode of growth 
2.5.2.1. Verification of biofilm production 
Crystal violet (Figure 2.4), Alcian blue (Figure 2.5) and Congo red agar (Figure 2.6) 
confirmed biofilm and slime production by all microorganisms. 
 
 
Figure 2.4. Biofilm production confirmed by each microorganism in tissue culture treated plates with Crystal 
violet dye, control (bottom right) observed as unable to retain dye. 
 
 
Figure 2.5. Biofilm of S. epidermidis (left) visible under x40 objective of light microscope (Zeiss Axio Scope 
microscope with AxioCam HRc camera, Carl Zeiss Ltd, Hertfordshire, U.K.) after Alcian blue staining, 
compared with control (right). 
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Figure 2.6. Slime production verified by growth of black, crusty colonies shown here by S. epidermidis on 
Congo red agar (top), compared with control of S. hominis (bottom) which is a known non-slime producer. 
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2.5.2.2. Quantification of microbial cell numbers within a biofilm 
Confluent biofilms were produced and quantified using the Miles and Misra (1938) 
method for all six microorganisms following 48 hour growth of 200 µL inocula in 96-
well microtitre plates (Figure 2.7). The mean biofilm per well ranged from 3.5 x 10
5
 cfu 
for C. albicans to 1.3 x 10
10
 cfu for P. aeruginosa. 
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2.5.2.3. Minimum inhibitory and bactericidal concentrations of 
eucalyptus oil, 1,8-cineole and chlorhexidine using the scrape and wash 
technique 
EO, 1,8-cineole and CHG exhibited some antimicrobial activity against a panel of 
microorganisms grown in biofilms (Figure 2.8). As previously observed with MIC and 
MBC results for planktonic cells (Section 2.5.1.4), the antimicrobial efficacy of CHG 
was significantly greater (P<0.005, Wilcoxon signed rank test, Instat) than that observed 
by EO or 1,8-cineole, with the results differing between mg/mL for EO and 1,8-cineole 
and µg/mL for CHG. However, no significant difference was observed in the efficacies 
of EO and 1,8-cineole (P>0.5 Wilcoxon signed rank test, Instat). The median MIC and 
MBC for EO against biofilms were 256 and 512 mg/mL respectively, for 1,8-cineole 
these were 512 and >512 mg/mL, and for CHG values of 80 and >128 µg/mL were 
recorded (Figure 2.8). When categorised (Table A1), there was a significant difference 
(P<0.05, Chi squared 2 by 2 contingency table, Instat3 GraphPad) between the MIC 
results of EO and CHG. The 5 % (v/v) DMSO control showed no antimicrobial activity 
against any of the microbial biofilms tested. 
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Figure 2.8. MIC and MBC median values (n=3) of EO, 1,8-cineole and CHG against a panel of six microorganisms, obtained using the microbroth dilution method. (# represents MIC or 
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2.5.2.4. Standard growth curves using ATP bioluminescence 
The standard curves for biofilm quantification of each microorganism using 
fluorescence generated linear graphs with the following R
2
 values: 0.9982 for S. aureus, 
0.9951 for S. epidermidis, 0.9983 for MRSA, 0.9980 for P. aeruginosa, 0.9998 for E. 
coli and 0.9914 for C. albicans (Figures A7-A12). 
 
2.5.2.5. Checkerboard assay combining eucalyptus oil and 1,8-cineole 
with chlorhexidine using ATP bioluminescence 
Combinations of EO/CHG resulted in synergistic antimicrobial activity for S. aureus, 
MRSA, P. aeruginosa and C. albicans. When 1,8-cineole was combined with CHG, 
synergy was determined for S. epidermidis, MRSA, P. aeruginosa and E. coli. 
Indifference was observed for EO/CHG against S. epidermidis and E. coli with FICI 
values of 0.725 and 0.750 respectively. For 1,8-cineole/CHG combinations, indifference  
was concluded for S. aureus and C. albicans with FICI values of 0.625 and 1.125 
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Table 2.4. Resultant antimicrobial efficacy of EO and 1,8-cineole when combined with CHG against biofilm growth of a panel of six microorganisms, using a ATP bioluminescence.  The 
results are shown in duplicate and expressed as Fractional Inhibitory Concentration (FIC) and FIC Index (FICI), where FICI ≤ 0.5 shows synergy, FICI > 0.5 or ≤ 4.0 shows indifference, 















S. aureus         
 EO + CHG 128/4 128/4 0.031 16/4 16/4 0.250 0.281 Synergy 
Cineole + CHG 256/32 256/32 0.125 16/8 16/8 0.500 0.625 Indifference 
S. epidermidis         
 EO + CHG 256/128 256/128 0.500 16/4 16/4 0.250 0.725 Indifference 
 Cineole + CHG 256/16 256/16 0.063 16/4 16/4 0.250 0.313 Synergy 
MRSA         
 EO + CHG 256/4 256/4 0.016 8/1 8/1 0.125 0.141 Synergy 
Cineole + CHG 128/4 128/4 0.031 16/4 16/4 0.250 0.281 Synergy 
P. aeruginosa         
 EO + CHG >256/32 >256/32 0.125 64/16 64/16 0.250 0.375 Synergy 
Cineole + CHG >256/4 >256/4 0.016 16/4 16/4 0.250 0.266 Synergy 
E. coli         
 EO + CHG 16/4 16/4 0.250 16/8 16/8 0.500 0.750 Indifference 
Cineole + CHG 64/4 64/4 0.063 16/0.5 16/0.5 0.031 0.094 Synergy 
C. albicans         
 EO + CHG 64/4 64/4 0.063 16/0.5 16/0.5 0.031 0.094 Synergy 
Cineole + CHG 16/16 16/16 1.000 16/2 16/2 0.125 1.125 Indifference 
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2.6. Discussion 
The therapeutic properties of essential oils have been recognised for thousands of years, 
with modern day thinking now challenging the impeding practicalities of use within the 
clinical setting. Assessment of the obstacles preventing realistic, daily use is underway, 
with research striving to gain comprehensive knowledge about the therapeutic potentials 
of oils to include detailed antimicrobial profiles, along with information regarding 
toxicity, longevity and residual activity, drug/chemical combination prospects, modes of 
action and resistance potential. 
This study adds to the current knowledge about prospective antimicrobial use of 
essential oils by testing microorganisms commonly associated with HAI, in particular 
CVC related infections, against eucalyptus oil and its main component 1,8-cineole in 
comparison with CHG; currently recommended by EPIC guidelines for skin antisepsis 
(Pratt et al., 2007). EO, 1,8-cineole and CHG were tested alone and in combination 
against planktonic and biofilm cultures of six clinically significant microorganisms in 
order to determine their potential for use within the healthcare system, as well as to 
establish if crude EO is really needed or if the efficacy observed is due to 1,8-cineole, in 
which case this simplified, single agent would go forth for further studies. 
The results of this study demonstrated that CHG, EO and 1,8-cineole possess 
antibacterial and antifungal activity, proving efficacious against Gram-positive S. 
aureus, S. epidermidis, and MRSA; Gram-negative P. aeruginosa and E. coli, as well as 
the yeast C. albicans. Furthermore, activity was not limited to just planktonic forms of 
microbial growth, but was observed against the more resilient form of growth within 
protective biofilm cultures. 
The use of essential oils within the healthcare setting has proved previously to be 
limited, with more attention having been focussed on the conceptual idea of using tea 
tree oil for the decontamination of MRSA-colonised skin (Thompson et al., 2008). 
However, there is an abundance of investigations focused on their potential 
antimicrobial use, with a number of studies similar to those of this chapter, in which the 
efficacy of essential oils has been trialled against a panel of microorganisms. One in 
particular by Warnke et al. (2009) focused on 13 different essential oils to include EO, 
which were tested against multiple strains of Staphylococcus spp., Streptococcus spp. 
and Candida spp. Furthermore, they also used CHG as one of their controls. However, 
unlike the results described in the present study, they found the CHG control gave larger 
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zones of inhibition than EO against S. aureus, S. epidermidis and C. albicans. This is 
possibly due to easier release of the agents from preloaded discs, compared with the 
methods described here whereby the agents needed to diffuse through the agar medium 
from wells cut within it, therefore inducing higher resistance and smaller zones of 
inhibition. 
The primary criticism regarding using essential oils in therapeutic practice centres upon 
their dilution in many studies being in the customary used ethanol, provoking dispute 
over the genuine source of efficacy. This was taken into account by Warnke et al. 
(2009) who reported its use as one of many controls, to be less efficacious than the oils 
in question, residing the observed efficacy to be derived from the oil not the solvent into 
which it is diluted. In this series of experiments, EO and 1,8-cineole were prepared in 
DMSO as it aids dissolution thus preventing precipitation which can lead to inconsistent 
and irreproducible results. Furthermore, the use of DMSO also allows the mixture to 
remain transparent, allowing results such as growth in microtitre plate wells from 
microbroth dilution to be more clearly interpreted. 
CHG demonstrated significantly greater antimicrobial efficacy compared with EO and 
1,8-cineole, when applied to planktonic cultures of the six microorganisms using a 
microbroth dilution technique. Furthermore, the differences between EO and 1,8-cineole 
were also concluded to be significantly different, with EO more efficacious. In one 
instance where testing was against P. aeruginosa, 1,8-cineole failed to achieve 
inhibition, confirming the contribution by other constituents within EO to efficacy. 
Significant differences between the efficacy of CHG and essential oils have also been 
observed in other studies, a large proportion of which have focussed on dental 
applications involving novel mouthwashes, toothpastes or denture adhesives for the 
control of plaque and gingivitis (Gunsolley, 2010; Van Leeuwen et al., 2010). However, 
the majority of studies appear to focus on either chlorhexidine, or one or more essential 
oil, making valid comparisons between the two difficult due to the vast discrepancies in 
results obtained from differences in experimental design (Fine, 2010). 
Despite the significant differences observed in this study, any MIC and MBC data must 
however be taken in context, as one study by Dryden et al. (2004) showed that tea tree 
oil (TTO) was more successful at removing MRSA from wounds and superficial skin 
sites than CHG, despite published MIC and MBC results proclaiming CHG efficacy to 
be greater than that of TTO (Karpanen et al., 2008b). The environment and structure of 
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the skin is likely to favour the penetration properties offered by the lesser efficacious 
TTO over CHG, suggesting that studies need to consider and simulate the intended use 
rather than focus solely on numerical figures. 
The decreased levels of susceptibility recorded for P. aeruginosa are not unusual. It is 
widely reported and accepted that this Gram-negative bacilli is characteristically 
problematic; repeatedly demonstrating increased tolerances to many antibiotics as well 
as chemical disinfectants including Triclosan, formaldehyde and QUATS (Chuanchuen 
et al., 2001; Meyer & Cookson, 2010). One study by Prabuseenivasan et al. (2006) 
reported findings highlighting EO to possess no antimicrobial activity at all against P. 
aeruginosa when tested using disc diffusion. Complications involving P. aeruginosa 
tolerance levels may be further exacerbated by the ability of many clinical strains to 
produce biofilms, in which the levels of resistance are known to rise. In addition to this, 
is the potential for many strains to become multi-drug resistant through the acquisition 
of chromosomally encoded or imported genetic mutations, or over expression of efflux 
pumps (Lister et al., 2009; Tam et al., 2010). In the clinical setting, this would create 
grave difficulties for infection treatment, making it all the more vital for new agents to 
be discovered or synthesised with efficacy against P. aeruginosa, to alleviate use of 
drugs to which resistance is beginning to emerge. 
Synergistic antimicrobial activity was demonstrated when CHG was combined with EO 
or 1,8-cineole against all microorganisms, with just three combinations being calculated 
as indifferent. These results concur with a previous study in which EO and CHG 
combined were concluded to give an indifferent result against planktonic cultures of S. 
epidermidis (Karpanen et al., 2008b). As previously mentioned, it was no surprise that 
P. aeruginosa showed less susceptibility to EO and 1,8-cineole than other 
microorganisms tested. One study by Cox & Markham (2007) focussed on the tolerance 
of Pseudomonas spp. to essential oils and concluded some strains were tolerant to 
numerous volatile plant components due to an ATP-dependant efflux mechanism 
responsible for ejecting toxic substances from inside the cell to the extracellular 
environment. Efflux pumps of many varieties are known to play a significant role in 
antibiotic resistance in numerous microorganisms, and are likely to be of possible 
concern with regards resistance to environmental biocides (Webber & Piddock, 2003). 
Healthcare associated infections caused by biofilm growth of skin related 
microorganisms on implanted, prosthetic devices such as CVCs are a major concern 
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within the healthcare system, and pose added complications to patient management, 
whilst creating extra financial burdens. Eradication of such infections would 
undoubtedly save lives, however accomplishment of such a feat is not proving to be 
simple. In the second part of this study, assessment of six microbial biofilm cultures 
was undertaken, as previously with planktonic cultures, in order to determine the 
antimicrobial efficacy or EO and 1,8-cineole alone and in combination with CHG. 
Initial verification of biofilm production by all six microorganisms was confirmed using 
culture onto Congo red agar and staining with Crystal violet and Alcian blue. The 
number of cells within a typical biofilm was also quantified prior to antimicrobial 
assessment of EO, 1,8-cineole and CHG. 
Congo red agar is a selective media that provides easy distinction between slime-
producing microorganisms commonly associated with biofilms, and non slime-
producing ones by creating visual differences in colony morphology, giving results that 
are both sensitive and reproducible (Freeman et al., 1989). Congo red is an acidic dye as 
the coloured portion of the dye is a negatively charged ion. Slime of S. aureus for 
example, is also negatively charged, causing it to repel the dye in the agar, pushing it 
away from the centre of the colony generating a build up around the edge of the slime 
(Cangelosi et al., 1999). This accumulation of dye creates a black, crusty appearance 
highly distinguishable from a negative control such as S. hominis which produces pink 
to red colonies. However, as reported by Zmantar et al. (2010), there is not always a 
correlation between slime production as seen on Congo red agar and actual biofilm 
formation. Therefore, the staining techniques employed aided confirmation as Crystal 
violet and Alcian blue are positively charged so bind to the negative surface of the cells 
and biofilm exopolysaccharides respectively (Serra et al., 2008). 
Biofilms are the most commonly found mechanism of microbial growth in nature and 
have only been recognised as a concern within hospitals in relatively recent years 
(Prakash et al., 2003). In nature, the number of cells within a biofilm varies greatly, and 
often there are multitudes of different microorganisms present in the same biofilm. 
However, laboratory growth of biofilms can generate pure, single-organism cultures, of 
relatively reproducible microbial quantity due to capabilities of nutrient and temperature 
management. This said, there were noticeable differences in the number of cells present 
in the 48 hour biofilms of each microorganism, having increased from the initial 
inoculum of 10
4




 cfu. Furthermore, the number of cells 
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within biofilms of Gram-negative microorganisms was more than within Gram-positive 
biofilms, this is in line with findings by Ceri et al. (1999) and Olson et al. (2002), and 
may be due to differences in growth rates or nutrient acquisition. There is no standard 
number of cells per biofilm of a specific microorganism as many factors such as water 
availability, space and age of biofilm can alter the rate of growth of such a dynamic 
system (Wang & Zhang, 2010). This may go some way to explaining the conflicting 
reports about exactly how many times more resistant biofilms are to agents, compared 
with corresponding planktonic growth. 
The results for the biofilm MIC and MBC showed a clear increase in resistance 
compared with those of their planktonic counterparts. This is widely supported within 
the literature through the knowledge that biofilms act as a physical barrier, protective of 
the cells within. As previously observed, the diminishing efficacy of the agents showed 
the same arrangement; CHG, EO then 1,8-cineole. There was however, no significant 
difference between EO and 1,8-cineole this time proposing that even known permeation 
enhancers may be hindered somewhat by biofilm presence. The efficacy of EO being 
greater than 1,8-cineole is in line with results published in 2001 by Inouye et al. who 
reported that of 6 respiratory tract microorganisms tested, the minimum gaseous dose of 
EO required for microbial inhibition was less than that of 1,8-cineole for 4 
microorganisms, the same for one and more for the final microorganism, indicating that 
other constituents in the oil aid efficacy. There were limitations to the scrape and wash 
method employed for the MIC/MBC determination which could potentially lead to 
inaccuracies in cfu counts. The cells within biofilms coagglutinate, making it possible 
for one colony on agar to have originated from either a single cell or a clump of 
microorganisms, with no means of distinguishing which. 
ATP bioluminescence is frequently used in the food industry as a means of assessing 
hygiene levels, although it has recently increased in popularity within hospitals 
following a number of trials using disposable ATP kits to measure cleaning standards 
(Carling & Bartley, 2010; Vilar et al., 2008). The ViaLight MDA plus ATP detection 
kit used in this study consisted of a bactolyse solution which lysed cells, causing the 
release of ATP. In turn, this cellular ATP then reacts with the luciferin and the enzyme 
luciferase within the ATP monitoring reagent, producing luminescence in relative light 
units proportional to the amount of ATP. This method is both rapid and reliable, giving 
sensitive and quantified results as confirmed by the almost perfectly linear relationship 
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between cfu and relative light units observed in the standard curve of each 
microorganism. 
Combination therapy is often used to combat the emergence of multi-drug resistant 
microorganisms. It may also be used to create synergistic effects whereby the effect of 
an antimicrobial used in isolation, is enhanced if used in combination. The biofilm 
checkerboard results in the latter part of this study supported earlier planktonic results 
confirming combinations of CHG with either EO or 1,8-cineole can lead to synergistic 
antimicrobial activity. CHG, EO and 1,8-cineole are all thought to target cell 
membranes thus possibly explaining the synergistic observations. The mechanisms 
behind this combined efficacy are as yet not fully understood, however it is possible that 
EO or 1,8-cineole alone are sufficient only to cause partial cell damage from lipid 
disruption hence the higher MIC and MBC results. When combined with CHG 
however, the partially damaged cells are more vulnerable to attack by that second 
combined agent, resulting in substantial irreparable damage to the cell membrane, 
resulting in loss of cellular components. This idea is supported findings by Carson et al. 
(2006) who noted that 1,8-cineole could induce higher antimicrobial properties in 
combinations as a result of its ability to facilitate entry for other, more active 
components. 
Microbial colonisation is not exclusive to living entities such as human skin, and often 
resides on surfaces particularly within the healthcare system where biofilms are 
prevalent. CHG is currently used routinely within the health service however the results 
of this study indicate that EO and CHG may provide a useful combined agent for 
improved antimicrobial decolonisation, including biofilm removal, to enhance skin 
antisepsis and potentially surface disinfection. 
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2.7. Conclusion 
EO, 1,8-cineole and CHG successfully demonstrated antimicrobial activity against a 
panel of six clinically important microorganisms, including Gram-positive and -
negative bacteria, as well as yeast, in both planktonic and biofilm modes of growth. The 
concentration required to kill by CHG was an order of magnitude less than that for EO 
and 1,8-cineole, whilst comparisons between the oil and its major constituent, 
concluded EO to possess better overall activity than 1,8-cineole against both modes of 
microbial growth. The synergistic antimicrobial efficacy observed with EO and 1,8-
cineole in combination with CHG may induce development of potentially beneficial 
applications for use within the healthcare setting. However, the increased efficacies 
presented by the combination of EO and CHG, bestow greater potential interest for 
clinical and therapeutic application, for example development of a surface disinfectant 
for possible enhanced removal and kill of microorganisms residing in biofilms, and 
improvement of current skin antisepsis procedures. 
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3.1. Introduction 
Combining EO with CHG has demonstrated within chapter 2 of this thesis, synergistic 
antimicrobial efficacy against a panel of microorganisms, in both planktonic and 
biofilm modes of growth (Hendry et al., 2009). This offers potential for the 
development of a novel skin antiseptic with enhanced efficacy, as well as improved 
surface disinfection, in a new, combined-agent product. 
Enhanced environmental cleaning and disinfection within the healthcare setting is 
becoming increasingly more appreciated as an integral component of infection control 
practice, and is often incorporated into care bundles (Griffith & Dancer 2009; Webber et 
al., 2010). Hospital cleaning and disinfection have dual purposes, firstly they preserve 
functionality and reinstate original appearance, and secondly they reduce microbial load 
therefore infection risk. Effective removal of microbial colonisation from surfaces is 
essential if the cycle of cross-contamination, which can lead to HAIs, is to be broken 
(Dancer, 2008). Further to this, any potentially pathogenic microorganisms adhering to 
cleaning products after removal from a surface should ideally be killed by the product in 
order to prevent deposition onto subsequently touched surfaces otherwise they would 
act solely as an inducer of cross-contamination (Bergen et al., 2009; Williams et al., 
2007). 
There are many cleaning products available for use within hospitals, with disposable 
wet-wipes frequently opted for due to ease of use. Those used most often within 
hospitals for high touch surfaces tend to contain alcohol as their basic active ingredient, 
such as Sani-Cloth
®
 products, which comprise a 70 % (v/v) alcohol base, with and 
without 2 % (v/v) CHG or a detergent. 
Whilst a mixture of agents may possess antimicrobial efficacy in a solution, there are 
many factors that can alter the activity once it has been converted into a product, 
especially if it is applied to a fabric or required for use over long time periods, as is the 
case with wet wipes (Bloss et al., 2010). Once applied to a fabric wipe and stored in a 
tub, the efficacy of a solution can change. The active ingredients may adhere, 
irreversibly to the fabric of the wipe through adsorption, hindering release and 
potentially eliminating all previously observed efficacy (Bloss et al., 2010). 
Furthermore, once a sealed tub has been opened, drying can occur, which along with 
degradation of agents, can result in diminishing activity over time. It is therefore 
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necessary that any agent intended for application onto, or conversion into a product, be 
thoroughly tested for efficacy in the desired, final product form. 
The enhanced antimicrobial efficacy against microbial biofilms achieved by combining 
EO and CHG, demonstrated in chapter 2 of the thesis, suggests that such combinations 
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3.2. Aims of the study 
The aims of this series of experiments were to: 
 Investigate the antimicrobial efficacy of various combinations of 10 % (v/v) EO, 
2 % (v/v) CHG and 70 % (v/v) IPA when impregnated onto viscose/ 
polypropylene (50:50) wipes. 
 Determine the bactericidal or bacteriostatic mode of action of the wipes as well 
as the associated time necessary for the wipes to exert such effect against a panel 
of clinically relevant microorganisms in planktonic and biofilm modes of 
growth. 
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3.3. Materials 
3.3.1. Microbial cultures 
Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis RP62A, MRSA N315, 
Pseudomonas aeruginosa ATCC 15442, Escherichia coli NCTC 10418 and Candida 
albicans ATCC 76615 were stored on MicroBank beads (Pro-Lab Diagnostics, 
Cheshire, U.K.) at -70 °C until required. 
 
3.3.2. Microbiological media 
Mueller-Hinton agar (MHA), Mueller-Hinton broth (MHB), Sabouraud dextrose agar 
(SDA), Sabouraud dextrose broth (SDB), Tryptone soya agar (TSA) and Tryptone soya 
broth (TSB) were purchased from Oxoid (Basingstoke, U.K.), prepared as per 
manufacturer‟s instructions and sterilised at 121 °C for 15 minutes. Agar was cooled to 
50 °C before pouring and broths were stored at 4 °C until required. 
 
3.3.3. Chemicals 
3.3.3.1. Neutralising solution 
Neutralising solution was prepared with 1.17 % (w/v) lecithin, granular, molecular 
weight (Mw) 750.00 Acros Organics (Fisher Scientific, Leicestershire, U.K.), 2 % (v/v) 
tween-80 (Sigma-Aldrich, Dorset, U.K.), 0.785 % (w/v) sodium thiosulphate 
pentahydrate (BDH Ltd, Poole, U.K.) and 0.1 % (v/v) triton X-100 (Sigma-Aldrich, 
Dorset, U.K.), made up to 1 L with double distilled water. The solution was sterilised at 
121 °C for 15 minutes and stored at 4 °C until required. 
 
3.3.4. Equipment 
Optical density (OD) readings were taken using a Pharmacia LKB visible 
spectrophotometer, Novaspec II (Pharmacia, Freiburg, Germany). 
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3.4. Methods 
3.4.1. Wipe impregnation process and combinations 
The solutions for wipe impregnation were each prepared to a total volume of 384 mL 
and contained various combinations of 10 % (v/v) EO, 2 % (v/v) CHG, 70 % (v/v) IPA 
and 0.1 % (v/v) tween-80 all purchased from Sigma-Aldrich (Dorset, U.K.) in sterile, 
double distilled water. In accordance with methods used by the wipe manufacturer PAL 
International (Leicestershire, U.K.), each solution was poured into a dispensing tub 
containing 200 blank, 23 grams per square metre (gsm), viscose/polypropylene (50:50) 
wipes provided by PAL International, and left for a minimum of 48 hours to allow 
saturation of the wipes before use. The combinations made were: 
 10 % (v/v) EO / 2 % (v/v) CHG / 70 % (v/v) IPA / 0.1 % (v/v) tween-80 
 10 % (v/v) EO / 2 % (v/v) CHG / 0.1 % (v/v) tween-80 
 10 % (v/v) EO / 70 % (v/v) IPA / 0.1 % (v/v) tween-80 
 2 % (v/v) CHG / 70 % (v/v) IPA  
 10 % (v/v) EO / 0.1 % (v/v) tween-80 
 2 % (v/v) CHG 
 70 % (v/v) IPA 
 Sterile, double distilled water (control) 
 
3.4.2. Verification of extraction methods for release of agents 
from eucalyptus oil-containing wipes 
Duplicate sections measuring 4 cm diameter were cut from the EO/CHG/tween-80 
wipes, and added to two universal bottles containing 10 mL PBS and 1 g sterile, 
borosilicate solid glass beads, 3 mm (Sigma-Aldrich, Dorset, U.K.) and were then 
mixed for 2 minutes. Control wipes were also set up in the same way. Sterile, cotton 
wool swabs were then dipped into cell suspensions of each microorganism at a 
concentration of 10
4 
cfu/mL and used to inoculate TSA or SDA plates as appropriate. 
For each microorganism, two separate 20 µL drops of the PBS solution from the 
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EO/CHG/tween-80 and control universal bottles were placed onto the previously 
inoculated TSA or SDA plates. Plates were stored at 4 ºC for 1 hour, and then incubated 
overnight at 37 ºC; 30 ºC for C. albicans. Following incubation, presence or absence of 
an inhibition zone was observed. 
 
3.4.3. Neutraliser efficacy within agar and broth media 
Following methods by Williams et al. (2007), TSA and SDA plates containing 10 % 
(v/v) neutralising solution were prepared with sections of wipe measuring 4 cm
2
 placed 
within the agar. A cell suspension of each microorganism was prepared in TSB or SDB 
from five identical colonies grown on MHA or SDA plates. A sterile cotton swab was 
used to inoculate the suspension over the agar to generate a semi-confluent lawn of 
growth. All plates were incubated overnight at either 37 °C or 30 °C for C. albicans, 
and then neutraliser efficacy was validated by the presence of microbial growth over the 
entire surface. In parallel to this, 4 cm
2
 sections of the wipes were added to TSB and 
SDB containing 10 % (v/v) neutralising solution and 1 mL of cell suspension containing 
10
7
 cfu/mL. Broths were incubated overnight at either 37 or 30 °C then microbial 
viability was confirmed visually following subculture onto TSA or SDA using the Miles 
& Misra (1938) technique. Both experiments were repeated in triplicate. The wipes 
tested were: 
 10 % (v/v) EO / 2 % (v/v) CHG / 70 % (v/v) IPA / 0.1 % (v/v) tween-80 
 10 % (v/v) EO / 2 % (v/v) CHG / 0.1 % (v/v) tween-80 
 10 % (v/v) EO / 70 % (v/v) IPA / 0.1 % (v/v) tween-80 
 70 % (v/v) IPA 
 Sterile, double distilled water (control) 
 
3.4.4. Neutraliser toxicity to microorganisms 
Based on methods described by Williams et al. (2007), a 4 cm
2
 section of 
EO/CHG/tween-80 wipe was added to duplicate universal bottles, each containing 1 g 
sterile, borosilicate solid glass beads, 3 mm (Sigma-Aldrich, Dorset, U.K.) and 10 mL 
neutralising solution. Control wipes were also set up in parallel. All universal bottles 
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were mixed for 2 minutes and after 30 minutes of contact, the wipes were removed and 
discarded. The OD of overnight cell suspensions of all six microorganisms was 
determined and adjusted to 10
7
 cfu/mL using previously established OD/cfu standard 
curves (Section 2.4.1.1), then 100 µL was added to each universal bottle of neutralising 
solution and mixed. After 30 minutes, serial dilutions were made in TSB or SDB as 
appropriate and pour plates made with molten TSA or SDA cooled to 50 °C. Following 
overnight incubation in air at 37 °C or 30 °C for C. albicans, toxicity was assessed by 
comparing the initial cfu/mL added and that recovered for each wipe. 
 
3.4.5. Microbial inhibition by eucalyptus oil-containing wipes 
using agar diffusion 
Using methods described by Williams et al. (2007), all six organisms were inoculated 
onto TSA or SDA plates using cotton wool swabs inoculated from a cell suspension 
containing 10
4 
cfu/mL. Squares measuring 20 mm by 20 mm were cut from 
impregnated wipes and applied to triplicate agar plates of each microorganism. Plates 
were incubated in air overnight at 37 ºC; 30 ºC for C. albicans, then inhibition zone 
sizes were measured as the distance between the edge of the wipe and visible growth. 
The wipes tested were: 
 10 % (v/v) EO / 2 % (v/v) CHG / 70 % (v/v) IPA / 0.1 % (v/v) tween-80 
 10 % (v/v) EO / 2 % (v/v) CHG / 0.1 % (v/v) tween-80 
 2 % (v/v) CHG / 70 % (v/v) IPA 
 10 % (v/v) EO / 0.1 % (v/v) tween-80 
 2 % (v/v) CHG 
 70 % (v/v) IPA 
 Sterile, double distilled water (control) 
 
~ 112 ~ 
 
3.4.6. Bacteriostatic/bactericidal testing of eucalyptus oil-
containing wipes 
Following completion of the previous experiment (Section 3.4.5), the wipes were 
removed from the surface of the agar and a section of agar measuring 10 mm by 10 mm 
was cut from underneath the wipe and inserted into a bijou bottle containing 1 mL 
neutralising solution. The bijou bottle was mixed for 1 minute, then after 30 minutes 
contact with the neutralising solution, 1 mL was removed into a petri dish and a pour 
plate made with molten TSA or SDA containing 10 % (v/v) neutralising solution, 
cooled to 50 °C. Plates were incubated in air at 37 ºC or 30 ºC for C. albicans and 
microbial viability used to determine bacteriostatic or bactericidal mode of action. 
 
3.4.7. Time-kill study of antimicrobial wipe solutions against 
microorganisms in planktonic mode of growth 
The following solutions were prepared as described previously (Section 3.4.1): 
 10 % (v/v) EO / 2 % (v/v) CHG / 70 % (v/v) IPA / 0.1 % (v/v) tween-80 
 10 % (v/v) EO / 2 % (v/v) CHG / 0.1 % (v/v) tween-80 
 2 % (v/v) CHG / 70 % (v/v) IPA 
 Sterile, double distilled water (control) 





cfu/mL for C. albicans) and 1 mL of each added to 9 mL of each of the test and control 
solutions listed above, then mixed. After 30 seconds, 1, 2, 5, 10, 30 and 60 minutes, 1 
mL of the inoculated test agent and control was removed and mixed with 9 mL of 
neutralising solution. Serial dilutions of all neutralising solutions were made in TSB or 
SDB and pour plates of TSA or SDA made. Plates were incubated overnight at 37 ºC or 
30 ºC as necessary. The time to kill was determined as the time resulting in a 99.9 % 
reduction in cfu/mL from that of the control. 
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3.4.8. Time-kill study of eucalyptus oil-containing wipes 
against microorganisms in biofilm mode of growth 
Overnight suspensions were prepared of each microorganism in MHB or SDB as 
required, then diluted to 10
4
 cfu/mL. Petri dishes were set up with a double thickness 
layer of a sterile cloth in the base, moistened with sterile, double distilled water. 
Stainless steel discs were cut to 1.5 cm
2
 and placed on the moistened cloth. Biofilms 
were grown on the discs following inoculation of 100 µL of the diluted cell suspension 
onto each disc, before the petri dishes were sealed with Sellotape
®
 to prevent drying, 
and incubated for 48 hours at 37 °C; 30 ºC for C. albicans to allow biofilm formation in 
conditions verified as appropriate in chapter 2 (Section 2.5.2.1). Following incubation, 
the excess broth was discarded from the discs and each was washed twice with PBS 
(Sigma-Aldrich, Dorset, U.K.). A sterile cotton swab dipped into 70 % (v/v) ethanol 
water was used to wipe the reverse of the disc before being washed once more with PBS 
and allowed to dry. The following wipes were tested: 
 10 % (v/v) EO / 2 % (v/v) CHG / 70 % (v/v) IPA, 0.1 % (v/v) tween-80 
 10 % (v/v) EO / 2 % (v/v) CHG / 0.1 % (v/v) tween-80 
 2 % (v/v) CHG / 70 % (v/v) IPA 
 70 % (v/v) IPA 
 Sterile, double distilled water (control) 
Sections of each wipe were added to the base of fresh petri dishes and the discs placed 
on top such that the biofilm was in contact with the wipe. A 10 g weight was then 
placed over the discs to ensure constant contact. After minute intervals up to 10 
minutes, 30 minutes, 1, 2, 4 and 6 hours, the discs were removed and added to 10 mL 
neutralising solution containing 1 g sterile, borosilicate solid glass beads, 3 mm (Sigma-
Aldrich, Dorset, U.K.) and mixed. Following 30 minutes contact, serial dilutions were 
made in MHB or SDB and pour plates of MHA or SDA made. Plates were incubated 
overnight at 37 ºC or 30 ºC as necessary. The time to kill was determined as the time 
resulting in a 99.9 % reduction in cfu/mL from that of the control. The experiment was 
repeated in duplicate. 
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3.4.9. Microbial transfer from wipes onto subsequently 
touched surfaces 
Based on methods described by Williams et al. (2007), 20 µL drops of overnight cell 
suspensions of S. epidermidis, E. coli and C. albicans, diluted to 10
8
 cfu/mL were added 
to 4 cm
2
 sections of the following wipes: 
 10 % (v/v) EO / 2 % (v/v) CHG / 70 % (v/v) IPA / 0.1 % (v/v) tween-80 
 10 % (v/v) EO / 2 % (v/v) CHG / 0.1 % (v/v) tween-80 
 10 % (v/v) EO / 70 % (v/v) IPA / 0.1 % (v/v) tween-80 
 70 % (v/v) IPA 
 Sterile, double distilled water (control) 
Each wipe was then pressed consecutively onto eight TSA or SDA plates containing 10 
% (v/v) neutralising solution with approximately 5 seconds between plates, before being 
added to 10 mL TSB or SDB with 10 % (v/v) neutralising solution. All plates and 
broths were incubated in air overnight at either 37 or 30 °C as required. The wipes were 
deemed as positive or negative for inducing surface cross-contamination dependent 
upon the presence or absence of growth on the TSA or SDA plates. Meanwhile, serial 
dilutions were preformed on the broths and then plated onto TSA or SDA using the 
Miles & Misra (1938) technique. Following a further overnight incubation, microbial 
viability was used to confirm neutraliser efficacy. The experiment was performed in 
triplicate. 
 
3.4.10. Removal and spread of microbial surface 
contamination by eucalyptus oil-containing wipes 
Following the methods of Williams et al. (2007), 20 µL drops of overnight suspensions 
of each microorganism diluted to 10
8
 cfu/mL were inoculated onto stainless steel discs 
cut to 1.5 cm
2
, and allowed to dry in air. The discs were then systematically wiped back 
and forth five times by hand to assess surface removal; the discs were subsequently 
added to neutralising solution containing 1 g sterile, borosilicate solid glass beads, 3 
mm (Sigma-Aldrich, Dorset, U.K.). After mixing for 1 minute and a total of 30 minutes 
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in contact with the neutraliser, serial dilutions were made in TSB or SDB and pour 
plates made with molten TSA or SDA cooled to 50 °C. Meanwhile, the contaminated 
wipes were pressed onto eight consecutive TSA or SDA plates containing 10 % (v/v) 
neutralising solution then added to TSB or SDB with 10 % (v/v) neutralising solution. 
The plates from the surface removal and adpression tests were incubated overnight at 37 
°C; 30 °C for C. albicans along with the broths containing the contaminated wipes. 
Following incubation, viable colony counts determined the number of cells that had 
failed to be removed from the discs by wiping therefore assessing the wipes‟ ability to 
physically remove microbial contamination from surfaces. Positive or negative growth 
results from the adpression plates were used to determine the potential of each wipe to 
induce surface cross-contamination, while the broths containing the wipes were 
subcultured into TSA or SDA plates using the Miles & Misra (1938) technique and 
further incubated overnight before microbial viability could be determined. Experiments 
were performed in triplicate for the following wipes: 
 10 % (v/v) EO / 2 % (v/v) CHG / 70 % (v/v) IPA / 0.1 % (v/v) tween-80 
 2 % (v/v) CHG / 70 % (v/v) IPA 
 Sterile, double distiller water (control) 
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3.5. Results 
3.5.1. Verification of extraction methods for release of agents 
from eucalyptus oil-containing wipes 
Antimicrobial activity was demonstrated by the PBS extraction solution, thus 
confirming the efficacy of the extraction method. Inhibition zones were observed for 
each microorganism with a mean radius of 20 mm (range 9 - 28 mm). The control did 
not show any antimicrobial activity. 
 
3.5.2. Neutraliser efficacy within agar and broth media 
The neutraliser was effective against all wipes in both broth and agar, for all 
microorganisms tested. Semi-confluent growth was observed over the surface of all agar 
plates, with no visible difference between the growth above the wipe and elsewhere on 
the agar. Microbial viability was visually confirmed from all subcultured broths. 
 
3.5.3. Neutraliser toxicity to microorganisms 
The neutraliser was not toxic to any of the microorganisms tested as there was no 
significant difference (P>0.05, ANOVA, Instat3, GraphPad) between the number of 
cells initially added and that recovered. This was the case for the EO/CHG/tween-80 
wipes as well as the control wipes. 
 
3.5.4. Microbial inhibition by eucalyptus oil-containing wipes 
using agar diffusion 
All wipes impregnated with a combination of agents as well as the CHG wipes, 
demonstrated antimicrobial activity (Table 3.1), however, the EO/tween-80 and the IPA 
wipes resulted in zones of <1 mm diameter, showing no difference in antimicrobial 
efficacy from that of the control wipes, which were deemed as not contributing to any 
antimicrobial activity observed. For all microorganisms, growth was clearly visible 
underneath the EO/tween-80, IPA and control wipes. Significant differences were 
observed between the antimicrobial efficacy of the CHG and the CHG/IPA wipes 
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(P<0.01, Paired t-test, Instat3 GraphPad) as well as between the CHG/IPA and the 
EO/CHG/IPA/tween-80 wipes (P<0.001, Paired t-test, Instat3 GraphPad). 
 
Table 3.1. Antimicrobial efficacy of test and control wipes against a panel of six microorganisms expressed as 
mean (n=3) sizes of inhibition zones observed using the agar diffusion method, and the standard deviation. 








EO CHG IPA Control 
S. aureus 9/1.0 6/1.7 9/1.5 <1/0 6/0 <1/0 <1/0 
S. epidermidis 8/1.0 7/1.2 12/2.0 <1/0 8/1.0 <1/0 <1/0 
MRSA 8/0.6 4/1.2 11/1.5 <1/0 7/0 <1/0 <1/0 
P. aeruginosa 1/0.6 <1/0 2/1.2 <1/0 3/1.2 <1/0 <1/0 
E. coli 5/1.0 6/3.0 7/2.5 <1/0 5/0 <1/0 <1/0 
C. albicans 6/1.7 <1/0 6/1.5 <1/0 7/0.6 <1/0 <1/0 
 
 
3.5.5. Bacteriostatic/bactericidal testing of eucalyptus oil-
containing wipes 
Bacteriostatic activity was determined following observation of microbial growth on 
agar by all six microorganisms when challenged by EO/tween-80 wipes, IPA wipes and 
control wipes. Bactericidal antimicrobial activity was demonstrated by CHG wipes 
against all six microorganisms, as well as by EO/CHG/tween-80 wipes against S. 
aureus, S. epidermidis and E. coli. The EO/CHG/IPA/tween-80 wipes showed 
bactericidal activity against all microorganisms except P. aeruginosa, for which 
bacteriostatic activity was concluded. 
 
3.5.6. Time-kill study of antimicrobial wipe solutions against 
microorganisms in planktonic mode of growth 
The CHG/IPA wipes, EO/CHG/IPA/tween-80 wipes, and the EO/CHG/tween-80 wipes 
killed planktonic cells of each microorganism in under 30 seconds. The control wipes 
did not possess any antimicrobial activity against any of the microorganisms. 
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3.5.7. Time-kill study of eucalyptus oil-containing wipes 
against microorganisms in biofilm mode of growth 
Variations in the time required to kill the cells within biofilms of each microorganism 
were observed (Table 3.2), however overall the EO/CHG/IPA/tween-80 wipes 
demonstrated significantly enhanced (P<0.05, ANOVA, Instat3, GraphPad) 
antimicrobial activity compared with EO/CHG/tween-80 wipes, and also control wipes, 
with considerably less time required. Whilst the difference between the efficacy of 
EO/CHG/IPA/tween-80 wipes and either CHG/IPA or IPA wipes was not statistically 
significant, there is an obvious distinction between their respective times, with the 
MRSA result for EO/CHG/IPA/tween-80 potentially affecting the statistical analysis as 
the CHG/IPA and IPA results are largely in terms of hours, while EO/CHG/IPA/tween-
80 is in minutes. 
 
Table 3.2. Antimicrobial efficacy of test and control wipes against a panel of six microorganisms grown in 
biofilms on stainless steel discs, expressed as mean (n=2) time to eradicate the biofilm. 
 
Time for wipe to eradicate biofilm 
 
EO/CHG/IPA EO/CHG CHG/IPA IPA Control 
S. aureus < 10 min < 6 hr > 6 hr > 6 hr > 6 hr 
S. epidermidis < 3 min > 6 hr < 9 min < 10 min > 6 hr 
MRSA < 4 hr < 4 hr > 6 hr > 6 hr > 6 hr 
P. aeruginosa < 1 min > 6 hr < 4 hr < 6 hr > 6 hr 
E. coli < 2 min < 4 hr < 10 min < 10 min > 6 hr 
C. albicans < 10 min < 6 hr < 4 hr < 6 hr > 6 hr 
 
 
3.5.8. Microbial transfer from wipes onto subsequently 
touched surfaces 
Cross contamination was demonstrated across all eight consecutively touched surfaces 
by all wipes tested, with all three microorganisms (Table 3.3). 
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Table 3.3. Potential for microbial transfer of three microorganisms, between surfaces by test and control 
wipes, expressed as mean (n=3) number of surfaces positive for contamination following adpression by an 
inoculated wipe over an approximate time period of 40 seconds. 
 
Number of positively cross contaminated surfaces by wipes 
 
EO/CHG/IPA EO/CHG CHG/IPA IPA Control 
S. epidermidis 8 8 8 8 8 
E. coli 8 8 8 8 8 
C. albicans 8 8 8 8 8 
 
 
3.5.9. Removal and spread of microbial surface contamination 
by eucalyptus oil-containing wipes 
Compared with the initial inoculum, all wipes demonstrated at least a 1-log reduction in 
the number of cells remaining on the discs after wiping, except for CHG/IPA against 
MRSA which showed only a 0.2-log reduction (Figure 3.1). Overall, 
EO/CHG/IPA/tween-80 wipes possessed significantly enhanced (P<0.05, AVONA, 
Instat3, GraphPad) removal ability against microorganisms dried onto a surface than 
both the CHG/IPA and control wipes, with a mean cfu reduction of 6.3-log compared 
with the 2.3-log reduction observed by CHG/IPA and control wipes. The adpression and 
viability results (Table 3.4) demonstrated that both test and control wipes possess the 
ability to induce cross-contamination between surfaces, with microbial viability 
remaining in many instances after all eight surfaces had been touched. Some differences 
however were observed in which cross-contamination had not persisted over all 8 
surfaces and microbial viability had not persisted. 
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Figure 3.1. Reduction in mean (n=3) cfu/disc of a panel of planktonic microorganisms following wiping with test and control wipes, with the log reduction from the initial inoculum and 


























































Initial inoculum EO/CHG/IPA CHG/IPA Control
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Table 3.4. Mean number (n=3) of surfaces positive for cross-contamination following adpression onto agar of 
wipes soiled with microorganisms (from the previous experiment), with microbial viability after broth culture 
of the wipes indicated by + for viable, and - for not viable. 
 
Surfaces positive for cross-contamination/Microbial viability 
 
EO/CHG/IPA CHG/IPA Control 
S. aureus 8/+ 8/+ 8/+ 
S. epidermidis 8/+ 8/+ 8/+ 
MRSA 8/+ 0/- 8/+ 
P. aeruginosa 8/+ 0/- 8/+ 
E. coli 4/- 8/+ 8/+ 




~ 122 ~ 
 
3.6. Discussion 
Infections resulting from hospitalisation or patients undergoing a healthcare intervention 
remain a persistent concern for both medical staff and patients alike. Whilst there have 
been many incentives to encourage hand hygiene particularly over recent years, 
cleanliness of surfaces often remains largely overlooked. Controversy continues over 
the contribution of environmental surfaces to HAI however it is clear that ensuring 
cleanliness of high touch surfaces can have a positive effect at reducing nosocomial 
infections (Hota, 2004; Webber et al., 2010). Many studies have confirmed the potential 
hazards posed by microorganisms on hospital surfaces, including Boyce et al. whom as 
early as 1997, brought to attention the discovery that staff entering the room of an 
MRSA positive patient, could subsequently be found with MRSA contamination of 
their gloves, despite having had no direct contact with that patient. Thus confirming a 
residing microbial population on environmental surfaces can lead to cross-
contamination and ultimately provide potential for infection dissemination. 
Within the healthcare system, cleaning regimes are set in place that suggest the 
frequency and degree with which objects and surfaces should be cleaned, such as daily 
cleaning of rooms and equipment, or weekly cleaning of patient care devices (Rutala et 
al., 2008). These guidelines take into consideration the likelihood of contamination 
occurring as well as the residual activity of the product with which cleaning is 
suggested. Research into the duration of microbial persistence on surfaces has shown 
that C. albicans can survive on dry surfaces, such as glass and stainless steel for up to 3 
days, and on fabric for over 14 days (Traore et al., 2002). Furthermore, the same study 
demonstrated recovery of 20 % of the original C. albicans inoculum applied to skin, for 
up to an hour after inoculation, allowing sufficient time for contaminated hands to 
transfer microorganisms to a surface. Another study by Otter & French (2009) 
confirmed viability and desiccation resistance of some other hospital pathogenic inocula 
including dried MRSA, VRE, C. difficile spores and Acinetobacter spp. after 6 weeks. 
It is assumed that there is an inversely proportional relationship between the survival 
time of a microorganism on a surface and the surrounding air temperature, whereby at 
lower temperatures such as around 6 °C, cells can remain viable longer than at higher 
ones of around 22 °C (Traore et al., 2002). This may explain differences observed 
between long viability durations on surfaces compared with shorter ones on skin. With 
such potentially long durations of microbial survival on surfaces, it is paramount that 
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good hand hygiene is continually enforced and that cleaning protocols are not only 
employed regularly, but that they are sufficient to remove and kill any pathogenic 
contaminants. 
The results of this study provide an indication of the potential efficacy of a biocide wipe 
developed at Aston University and designed for hard surface disinfection, and based 
upon the combination of agents found to show antimicrobial synergy in the previous 
chapter. In a solution, the combination of EO and CHG has previously demonstrated 
enhanced antimicrobial efficacy against a panel of microorganisms both in planktonic 
and biofilm cultures. The results of this study support the previous findings, with the 
added benefit of efficacy remaining following adaptations of the solution to include IPA 
and application of it onto a viscose/polypropylene wipe. 
The different wipes developed and tested in this series of experiments demonstrated 
mixed efficacy against the panel of microorganisms chosen for their clinical importance. 
EPIC guidelines by Pratt et al. (2007) currently recommend the use of 2 % CHG in 70 
% IPA for skin antisepsis due to its potent antimicrobial efficacy, something that was 
supported in the early stages of this study by the significant differences observed 
between this and CHG alone in the agar diffusion test. The addition of EO to CHG/IPA 
wipes appeared to slightly reduce the zone of inhibition. This may be due to slightly 
uneven diffusion of agents through the wipes during the impregnation process caused 
by partitioning of the oil from the mixture, impeded release of EO from the fabric of the 
wipes, or the heightened sensitivity of S. epidermidis and MRSA to wipes comprising 
CHG/IPA, compared with EO/CHG/IPA or CHG wipes, creating skewed data when 
tested statistically in groups of wipe components rather than microorganism and wipe 
components. It is also possible that EO is unable to diffuse through the agar to the same 
extent as the other agents, therefore restricting CHG and IPA movement and resulting in 
a reduced zone of inhibition. 
During formulation of the wipes, the solution of EO and CHG used in chapter 2 was 
amended to incorporate IPA and a replacement of DMSO with tween-80 was made. 
This addition of tween-80 may be responsible for observations of reduced efficacy by 
the EO-containing wipes compared with the CHG/IPA wipes, noticeable in the agar 
diffusion experiment. Tween-80 is frequently used as an ingredient within neutralising 
solutions and therefore potentially could have partially or entirely inactivated the CHG 
present within the EO-containing wipes, leading to reduced efficacy. The effect would 
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not have been observed in the CHG/IPA wipes however as the absence of EO prevented 
solution precipitation and therefore avoided the requirement for tween-80 addition. 
However, throughout the literature, the use of tween-80 alone as a neutraliser appears to 
not be common practice, with other agents and lecithin in particular, frequently added to 
the neutralising solution. Furthermore, one study by Kampf et al. (1998) reported that 
the combination of tween-80, cysteine, histidine and saponine were insufficient at 
quenching the activity of CHG, therefore supporting the probability that whilst the 
addition of tween-80 may have had a reducing effect upon the wipes‟ activity, it is 
unlikely to have been a significant impact. 
In line with common knowledge and previous findings, P. aeruginosa demonstrated 
decreased susceptibility to the bactericidal activity of EO/CHG/IPA wipes conferred by 
the other microorganisms tested with bacteriostatic activity being concluded. Yet again, 
the presence of EO led to a reduction in the overall efficacy against the panel compared 
with the CHG/IPA wipes however as the same wipes were used in the agar diffusion 
test, the possible justifications of outcome remain the same as previously described. 
Biofilm presence is a serious complication of any surgical procedure due to the extra 
resiliencies and resistances portrayed during physical or antimicrobial elimination. This 
can be highlighted somewhat if comparisons between the two time kill experiments are 
made. When applied to planktonic cultures of six microorganisms, the solutions used to 
impregnate the wipes were capable of achieving complete eradication of all cells within 
30 seconds. However, when biofilms of the same microorganisms were challenged with 
wipes impregnated with those same solutions, viable cells of some microorganisms 
persisted even after 6 hours of exposure to the wipes. This may be partly due to the 
change in form, from a liquid solution to a wipe in which the solution may be slightly 
contained, either delaying or preventing release. However, previous results confirmed 
the wipes do possess efficacy therefore the reminder of the justification may be 
attributed to the biofilm itself. 
Microfibre wipes are now used frequently within hospitals and are reported to possess 
superior cleaning properties compared with wipes and cloths of other materials such as 
cotton, sponge and paper towels (Diab-Elschahawi et al., 2010). Their surface area can 
be up to 40 times greater than that of a conventional cotton wipe due to their 
composition which is assembled from strands of synthetic fibre, less than one hundredth 
the thickness of a human hair, woven together (Diab-Elschahawi et al., 2010). 
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Furthermore, a study by Wren et al. (2008) concluded the ability of ultra-microfibre 
wipes, which contain even thinner fibres, to remove microbial contamination so 
triumphant, that complete or almost complete removal of bacteria and spores from 
rough tile, laminate and stainless steel surfaces could be achieved when only wetted 
with water. This recognises the importance held by cleaning product material however 
as yet, there are no guidelines for standards of cleaning equipment for clinical use 
despite many recommendations covering disinfectants (Diab-Elschahawi et al., 2010). 
All of the wipes used in this study were non-woven, and not microfibre therefore if 
produced in a different material, could potentially show improved results to those 
witnessed here. 
Hospital cleaning is aimed largely at removing contamination of microbial origin, to 
enable management of infection without risk of inanimate objects acting as reservoirs 
for transmission. However, poor cleaning practice can promote rather than conquer this 
by collecting, and then depositing elsewhere, any potential microbial pathogens picked 
up. In order to eliminate this, improvements to staff awareness of microbial 
transmission routes needs addressing through education. Along with this, advances in 
product development can ease the burden by simplifying how it is used. The results for 
the final parts of this study indicated that all wipes tested possessed some capability to 
transmit collected microorganisms onto multiple, subsequently touched surfaces. This 
may be due to a time aspect exclusive to the laboratory conditions in which the surfaces 
were touched in reasonably quick succession, therefore potentially failing to provide 
adequate time between wiping to permit successful biocidal activity. In clinical practice, 
this time period may be increased therefore provide adequate time for the wipes to kill 
collected microbial contamination between consecutive surface contacts. There are 
however, many studies that support the findings here whereby cloths act as carriers, 
increasing spread of microorganisms around multitudes of surfaces, and even some that 
report cloths to encourage microbial multiplication within them (Bartz et al., 2010). In 
the clinical setting, this could lead to infection outbreaks, as without bactericidal action 
the wipes would require folding to allow a fresh side to be the contact surface; however 
this adds potential complications for the user (Moore & Griffith, 2006). Therefore these 
EO-containing wipes would need to be aimed at single use so they are only used on one 
surface before being discarded.  
The final outcomes of the study appear promising with significant increases in 
efficiency demonstrated by the EO/CHG/IPA wipes compared with the CHG/IPA 
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wipes, when removal of dried microorganisms from surfaces was investigated. It is 
possible that the penetration properties of EO may have influenced this by helping with 
cell detachment from the surface, and would suggest a commercially produced product 
with such improved qualities from those currently available may have a place in the 
market within healthcare hard surface disinfectants.  
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3.7. Conclusion 
The results of this study confirm development of an EO-containing wipe, could have 
potential as a hard surface disinfection product, designed for the healthcare service. The 
enhanced antimicrobial efficacy of the EO/CHG combined solution from the previous 
study has remained present in this series of experiments, following adaptation of the 
solution to include IPA, and progression from a liquid into a wet-wipe format. The 
CHG wipes demonstrated bactericidal activity against all six microorganisms, and the 
CHG/IPA wipes killed planktonic cultures within the same time period as the 
EO/CHG/IPA wipes. However, the EO/CHG/IPA wipe demonstrated significant 
improvements over currently used CHG/IPA wipes for the removal of microbial 
contamination from surfaces, as well as a clear reduction in the time required to 
eradicate microbial biofilms from a surface. The clinical implications of microbial 
contamination on inanimate surfaces, and biofilm modes of growth, are substantial, 
therefore the prototype EO-containing wipe developed and assessed within this study 
demonstrated more suitability for clinical use and could provide an adjunct to current 
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4.1. Introduction 
Microbial contamination of environmental surfaces within the healthcare setting can 
impose additional risks to those potentially most at risk, such as already ill patients, 
with possible increased susceptibility to infection from pre-existing conditions or 
treatment regimes. Effective cleaning and disinfection is therefore of great importance 
within the entire package governing patient care, wellbeing and recovery. Furthermore, 
increases in prevalence of multidrug resistant microorganisms, drives the need for novel 
cleaning products with enhanced antimicrobial activity to aid combat of HAIs. 
Objects within the clinical environment that come into contact with intact skin are 
deemed low-level, non-critical items, and include bed rails, bedside tables, crutches and 
floors. Such items are often cleaned with IPA, sodium hypochlorite, QUATS or diluted 
iodophor detergents (Rutala et al., 2008). Whilst the expectation of these items to cause 
infection is lower than objects that come into contact with broken skin or mucous 
membranes, such as endoscopes and respiratory apparatus, the capability remains 
therefore such articles must not be overlooked during development of cleaning 
products. 
Eucalyptus oil, when combined with chlorhexidine, has demonstrated synergistic 
antimicrobial efficacy against planktonic and biofilm modes of growth (Hendry et al., 
2009). Moreover, studies in the previous chapter involving a prototype hard surface 
disinfectant wipe containing this combination of agents have shown promising results in 
their ability to remove microorganisms adhering to surfaces similar to those frequently 
observed on low-level, non-critical objects. 
New ideas for surface disinfectants are constantly coming to light however conversion 
from an initial prototype to an actual product, through the process of commercial up-
scaling can introduce unforeseen problems with formulation or processing, for example. 
It therefore follows that antimicrobial testing of the final product is required in addition 
to preliminary studies, to ensure adequate efficacy is maintained. 
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4.2. Aims of the study 
The aims of this study were to: 
 Develop further the preliminary research in chapter 3 to assess the antimicrobial 
efficacy of EO and CHG combined within a hard surface disinfectant wipe 
called Euclean
®
 wipes, developed with Insight Health Ltd, Wembley, U. K. The 
wipes contain a reduced concentration of EO and increased concentration of 
tween-80 than used previously, to resolve problems arising from the oil and 
other agents partitioning. 
 Assess the potential of 5 % Euclean® wipes which comprise 5 % (v/v) EO, 2 % 
(v/v) CHG, 70 % (v/v) IPA and 1 % (v/v) tween-80, and 2 % Euclean
®
 wipes 
comprising 2 % (v/v) EO, 2 % (v/v) CHG, 70 % (v/v) IPA and 1 % (v/v) tween-
80 to induce cross-contamination between surfaces. 
 Determine the bactericidal or bacteriostatic mode of action of the wipes as well 
as the time necessary for them to exert an antimicrobial effect against a panel of 
clinically relevant microorganisms in biofilm modes of growth. 
 Compare the antimicrobial efficacy of 5 % Euclean® wipes and 2 % Euclean® 
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4.3. Materials 
4.3.1. Microbial cultures 
Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis RP62A, MRSA N315, 
Pseudomonas aeruginosa ATCC 15442, Escherichia coli NCTC 10418 and Candida 
albicans ATCC 76615 were stored on MicroBank beads (Pro-Lab Diagnostics, 
Cheshire, U.K.) at -70 °C until required. 
 
4.3.2. Microbiological media 
Mueller-Hinton agar (MHA), Mueller-Hinton broth (MHB), Sabouraud dextrose agar 
(SDA), Sabouraud dextrose broth (SDB), Tryptone soya agar (TSA) and Tryptone soya 
broth (TSB) were purchased from Oxoid (Basingstoke, U.K.), prepared as per 
manufacturer‟s instructions and sterilised at 121 °C for 15 minutes. Agar was cooled to 
50 °C before pouring and broths were stored at 4 °C until required. 
 
4.3.3. Chemicals 
4.3.3.1. Neutralising solution 
Neutralising solution was prepared with 1.17 % (w/v) lecithin, granular, Mw 750.00 
Acros Organics (Fisher Scientific, Leicestershire, U.K.), 2 % (v/v) tween-80 (Sigma-
Aldrich, Dorset, U.K.), 0.785 % (w/v) sodium thiosulphate pentahydrate (BDH Ltd, 
Poole, U.K.) and 0.1 % (v/v) triton X-100 (Sigma-Aldrich, Dorset, U.K.), made up to 1 
L with double distilled water. The solution was sterilised at 121 °C for 15 minutes and 
stored at 4 °C until required. 
 
4.3.4. Equipment 
Optical density (OD) readings were taken using a Pharmacia LKB visible 
spectrophotometer, Novaspec II (Pharmacia, Freiburg, Germany). 




 disinfectant wipes 
4.3.5.1. 5 % Euclean
®
 wipes 
The 5 % Euclean
®
 wipes were produced by PAL International (Leicestershire, U.K.) by 
application of 5 % (v/v) EO, 2 % (v/v) CHG, 70 % (v/v) IPA and 1 % (v/v) tween-80 in 
water sprayed into tubs containing 200 blank, 23 gsm, viscose/polypropylene (50:50) 
non-woven wipes. Tubs were left standing for a minimum of 48 hours to allow 
saturation of the wipes before being delivered for use. 
 
4.3.5.2. 2 % Euclean
®
 wipes 
The 2 % Euclean
®
 wipes were produced by PAL International (Leicestershire, U.K.) by 
application of 2 % (v/v) EO, 2 % (v/v) CHG, 70 % (v/v) IPA and 1 % (v/v) tween-80 in 
water sprayed into tubs containing 200 blank, 23 gsm, viscose/polypropylene (50:50) 
non-woven wipes. Tubs were left standing for a minimum of 48 hours to allow 
saturation of the wipes before being delivered for use. 
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4.4. Methods 
4.4.1. Wipe impregnation process and combinations 
4.4.1.1. Chlorhexidine digluconate and isopropyl alcohol wipes 
The solution for wipe impregnation was prepared to a total volume of 384 mL and 
contained 2 % (v/v) CHG and 70 % (v/v) IPA both purchased from Sigma-Aldrich 
(Dorset, U.K.) in sterile, double distilled water. In accordance with methods used by the 
wipe manufacturer PAL International (Leicestershire, U.K.), the solution was poured 
into a tub containing 200 blank, 23 gsm, viscose/polypropylene (50:50) non-woven 
wipes provided by PAL International, and left for a minimum of 48 hours to allow 
saturation of the wipes before use. 
 
4.4.1.2. Control wipes  
The solution for wipe impregnation was prepared to a total volume of 384 mL and 
contained only sterile, double distilled water. In accordance with methods used by the 
wipe manufacturer PAL International (Leicestershire, U.K.), the solution was poured 
into a tub containing 200 blank, 23 gsm, viscose/polypropylene (50:50) non-woven 
wipes provided by PAL International, and left for a minimum of 48 hours to allow 
saturation of the wipes before use. 
 




Following the methods of Williams et al. (2007), 20 µL drops of overnight cell 
suspensions of MRSA, E. coli and C. albicans diluted to 10
8
 cfu/mL were inoculated 
onto stainless steel discs cut to 1.5 cm
2
, and allowed to dry in air. The discs were then 
systematically wiped back and forth five times by hand with either a 5 % Euclean
®
 
wipe, a 2 % Euclean
®
 wipe or a control (sterile, double distilled water) wipe to assess 
surface removal; the discs were subsequently added to neutralising solution containing 1 
g sterile, borosilicate solid glass beads, 3 mm (Sigma-Aldrich, Dorset, U.K.). After 
mixing for 1 minute and a total of 30 minutes in contact with the neutraliser, serial 
dilutions were made in TSB or SDB and pour plates made with molten TSA or SDA 
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cooled to 50 °C. Meanwhile, the contaminated wipes were pressed onto eight 
consecutive TSA or SDA plates containing 10 % (v/v) neutralising solution then added 
to TSB or SDB with 10 % (v/v) neutralising solution. The plates from the surface 
removal and adpression tests were incubated overnight at 37 °C, and 30 °C for C. 
albicans along with the broths containing the contaminated wipes. Following 
incubation, viable colony counts were undertaken to determine the number of cells that 
had failed to be removed from the discs by wiping therefore assessing the wipes‟ ability 
to physically remove microbial contamination from surfaces. Positive or negative 
growth results from the adpression plates were used to determine the potential of each 
wipe to induce surface cross-contamination, while the broths containing the wipes were 
subcultured into TSA or SDA plates using the Miles & Misra (1938) technique and 
further incubated overnight before microbial viability could be determined. Experiments 
were performed in triplicate. 
 
4.4.3. Microbial inhibition by Euclean
®
 wipes using agar 
diffusion 
Using methods described by Williams et al. (2007), all six organisms were inoculated 
onto TSA or SDA plates using cotton wool swabs inoculated from a cell suspension 
containing 10
4 
cfu/mL. Squares of 20 mm by 20 mm were cut from impregnated wipes 
and applied to triplicate agar plates of each microorganism. Plates were incubated 
overnight at 37 ºC, and 30 ºC for C. albicans, and inhibition zone sizes were measured 
as the distance between the edge of the wipe and visible growth. The wipes tested were: 
 5 % Euclean® 
 2 % Euclean® 
 Sterile, double distiller water (control) 
 
4.4.4. Bacteriostatic/bactericidal testing of Euclean
®
 wipes 
Following completion of the previous experiment (Section 4.4.3), the wipes were 
removed from the surface of the agar and a section of agar measuring 10 mm by 10 mm 
was cut from underneath the wipe and inserted into a bijou bottle containing 1 mL 
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neutralising solution. The bijou bottle was mixed for 1 minute, then after 30 minutes 
contact with the neutralising solution, 1 mL was removed into a petri dish and a pour 
plate made with molten TSA or SDA containing 10 % (v/v) neutralising solution, 
cooled to 50 °C. Plates were incubated and microbial viability used to determine 
bacteriostatic or bactericidal mode of action. 
 
4.4.5. Time-kill study of Euclean
®
 wipes against 
microorganisms in biofilm mode of growth 
Overnight cell suspensions were prepared of each microorganism in MHB or SDB as 
required, then diluted to 10
4
 cfu/mL. Petri dishes were set up with a double thickness 
layer of a sterile cloth in the base, moistened with sterile, double distilled water. 
Stainless steel discs were cut to 1.5 cm
2
 and placed on the moistened cloth. Each disc 
was then inoculated with 100 µL of the diluted cell suspension before the petri dishes 
were sealed with Sellotape
®
 and incubated for 48 hours at 37 °C; 30 ºC for C. albicans. 
Following incubation, the excess broth was discarded from the discs and each was 
washed twice with PBS (Sigma-Aldrich, Dorset, U.K.). A sterile cotton swab dipped 
into 70 % (v/v) ethanol water was used to wipe the reverse of the disc before being 
washed once more with PBS and allowed to dry. The following wipes were tested: 
 5 % Euclean® 
 2 % Euclean® 
 2 % (v/v) CHG / 70 % (v/v) IPA 
Sections of each wipe were added to the base of fresh petri dishes and the discs placed 
on top such that the biofilm was in contact with the wipe. A 10 g weight was then 
placed over the discs to ensure constant contact. At time zero, and every 5 minutes up to 
30 minutes, the discs were removed and added to 10 mL neutralising solution 
containing 1 g sterile, borosilicate solid glass beads, 3 mm (Sigma-Aldrich, Dorset, 
U.K.) and mixed. Following 30 minutes contact, serial dilutions were made in MHB or 
SDB and pour plates of MHA or SDA made. Plates were incubated overnight at 37 ºC 
or 30 ºC as necessary. The time to kill was determined as the time resulting in a 99.9 % 
reduction in cfu/mL from that of the control. The experiment was performed in 
triplicate. 
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4.5. Results 




Both 5 % and 2 % Euclean
®
 wipes induced a minimum 2-log reduction in the number of 
cells remaining on the disc after wiping, compared with that of the initial inoculum 
(Figure 4.1). Whilst there was no significant difference (P>0.05, ANOVA, Instat3, 
GraphPad) between the overall log reductions demonstrated by the two different 
percentage Euclean
®
 wipes and the control wipe, there was a significant difference 
(P<0.05, Paired t-test, Instat3 GraphPad) for each microorganism/wipe combination, 
between the cfu in the initial inoculum and that remaining after wiping. The adpression 
and viability results (Table 4.1) demonstrated that unlike the control wipes, neither 5 % 
Euclean
®
 nor 2 % Euclean
®
 wipes induced cross-contamination onto successively 
touched surfaces; furthermore, they had not permitted endurance of microbial viability. 
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Initial inoculum 5 % Euclean® 2 % Euclean® Control
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Table 4.1. Mean number (n=3) of surfaces positive for cross-contamination following adpression onto agar of 
wipes soiled with microorganisms (from the previous experiment), with microbial viability after broth culture 
of the wipes indicated by + for viable, and - for not viable. 
 




 2 % Euclean
®
 Control 
MRSA 0/- 0/- 8/+ 
E. coli 0/- 0/- 8/+ 
C. albicans 0/- 0/- 8/+ 
 
 
4.5.2. Microbial inhibition by Euclean
®
 wipes using agar 
diffusion 
Both the 5 % and 2 % Euclean
®
 wipes demonstrated antimicrobial efficacy by the 
presence of inhibition zones against a panel of microorganisms (Table 4.2). There was 
no significant difference (P>0.05, Paired t-test, Instat3 GraphPad) between the efficacy 
of the two Euclean
®
 wipes of 5 % and 2 % EO, however both were significantly more 
efficacious (P<0.05, Paired t-test, Instat3 GraphPad) than the control wipes which were 
deemed as not antimicrobial due to zone measurements of <1 mm diameter.  
 
Table 4.2. The antimicrobial efficacy of test and control wipes against a panel of six microorganisms expressed 
as mean (n=3) sizes of inhibition zones observed using the agar diffusion method. 
 




 2 % Euclean
®
 Control 
S. aureus 7 7 <1 
S. epidermidis 7 7 <1 
MRSA 7 7 <1 
P. aeruginosa 4 5 <1 
E. coli 7 6 <1 
C. albicans 5 4 <1 
 
 
4.5.3. Bacteriostatic/bactericidal testing of Euclean
®
 wipes 
The 5 % Euclean
®
 and 2 % Euclean
®
 wipes exhibited bactericidal antimicrobial activity 
against all six microorganisms tested as no microbial growth was recovered. Control 
wipes showed no inhibition of microbial growth. 
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4.5.4. Time-kill study of Euclean
®
 wipes against 
microorganisms in biofilm mode of growth 
Euclean
®
 wipes in both 5 % and 2 % concentrations demonstrated significantly quicker 
(P<0.05, ANOVA, Instat3, GraphPad) biofilm removal compared with the CHG/IPA 
wipes. The 5 % Euclean
®
 wipes killed biofilms of every microorganism in under 5 
minutes, except P. aeruginosa which took under 10 minutes (Table 4.3). The 2 % 
Euclean
®
 wipes took under 10 minutes to eliminate biofilms of S. epidermidis, P. 
aeruginosa and E. coli, and under 5 minutes for the other microorganisms, compared 
with CHG/IPA wipes which killed C. albicans in under 25 minutes but then failed to 
eradicate any other microbial biofilm in the 30 minute test time. 
 
Table 4.3. The mean (n=3) time required for test and control wipes to remove microbial biofilms of six 
microorganisms from stainless steel surfaces. 
 




 2 % Euclean
®
 Control 
S. aureus <5 <5 >30 
S. epidermidis <5 <10 >30 
MRSA <5 <5 >30 
P. aeruginosa <10 <10 >30 
E. coli <5 <10 >30 
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4.6. Discussion 
In this part of the research, the antimicrobial efficacy of 5 % Euclean
®
 and 2 % 
Euclean
®
 wipes was assessed. Despite uncertainties surrounding the number of HAIs 
stemming from environmental contamination on surfaces, it is now appreciated that 
surface colonisation is a contributing factor in infection occurrence. With many 
different products available and recommendations of cleaning processes differing 
between healthcare establishments, and sometimes even between wards or departments 
of the same hospital, it is easy to appreciate how inconsistencies in cleanliness levels 
can occur between locations. This can therefore have an obvious impact on the infection 
rates within that unit. 
The results of the first experiment within this study confirmed the physical wiping 
action to be largely responsible for the removal of microorganisms dried onto a surface, 
rather than the antimicrobial agent impregnated onto the wipes, which concurs with 
findings by Mehmi et al. (2009). The physical abrasion applied to the dried 
contamination, resulted in a significant reduction in the microbial load remaining on the 
discs for the control wipes and both of the Euclean
®
 wipes. However no significant 
difference was observed between the control wipes wetted solely with water and either 
of the antimicrobial Euclean
®
 wipes. Along with physically removing cells, the wetness 
of the wipes may have also contributed to the wipes ability to remove microorganisms. 
Studies have confirmed the wetness of a wipe to be important in its ability to remove 
microbes from surfaces, with one study by Diab-Elschahawi et al. (2010) concluding 
wet paper towels, microfibre, cotton and sponge cloths all showed significantly 
improved decontamination capabilities compared with their dry counterparts.  
The results of chapter 3 illustrated that the EO-containing wipes were capable of 
inducing cross-contamination between surfaces, however, in conjunction with the first 
experiment of this study, the subsequent results demonstrated that unlike the control 
wipes, both compositions of Euclean
®
 wipes did not induce any microbial cross-
contamination onto surfaces subsequently touched after the wipes had been used. 
Furthermore, no viable cells were recovered from the wipes. This difference in findings 
may be due to the altered formulation impregnated onto the Euclean
®
 wipes which 
comprised a greater tween-80 content, thus creating more uniform diffusion throughout 
the wipes as a result of a better mixed initial solution. It is also possible that the 
Euclean
®
 wipes were wetter as their commercial packaging consisted of an airtight seal 
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absent on the EO-containing wipes, designed to prevent desiccation. Both of these 
factors may have resulted in the Euclean
®
 wipes being more efficacious, despite the 
reduced concentration of EO, therefore inducing microbial death before collected 
microbial contamination could be deposited onto subsequent surfaces. When compiled 
with the inhibition zone presence in the agar diffusion and fully bactericidal results, the 
collection of data in this study confirms that both 5 % and 2 % Euclean
®
 wipes 
effectively cleared microbial contamination from a surface, and then killed the remains 
preventing deposition onto subsequent surfaces. In addition, there were no significant 
differences in the efficacy of the 5 % and 2 % Euclean
®
 wipes suggesting that the 
reduction in EO concentration had not compromised the efficacy of the antimicrobial 
combination. 
As discussed in chapter 3, the presence of tween-80 in the wipe solution may have 
impacted on the antimicrobial potential of the wipes through its possible neutralisation 
of CHG. Furthermore, to improve mixing and therefore solution diffusion through the 
wipes, the percentage content of tween-80 was raised from 0.1 % in the EO-containing 
wipes (chapter 3), to 1 % in the 5 % and 2 % Euclean
®
 wipes. One study has illustrated 
the use of tween-80 as a neutralising agent for CHG, however the CHG concentration 
used was 0.5 %, compared with the 2 % in the two compositions of the Euclean
®
 wipes, 
and the subsequent neutralisation of this CHG was performed by a great dilution of 1 in 
1000 into a neutraliser comprising both 1 % tween-80 and 1 % tween-20 (Jayakumar et 
al., 2011). It therefore follows that whilst CHG neutralisation was effectively carried 
out using tween-80 in the literature, the dilutions and concentrations involved differed 
greatly from those used within this study, therefore alone, may not truly represent the 
neutralisation activity by tween-80 within the Euclean
®
 wipes. Furthermore, another 
study by Zamany & Spangberg (2002) reported effective neutralisation of 2 % CHG 
was possible with 3 % tween in combination with 0.3 % lecithin, however 3 % tween-
80 alone was insufficient to quench the activity of 2 % CHG thus further supporting the 
likelihood that the 1 % tween-80 incorporated within the Euclean
®
 wipes, three times 
less than confirmed ineffective, would not result in inactivation of the 2 % CHG 
present. 
In 2004, a Rapid Review Panel (RRP) of specialists and clinicians affiliated with 
infection control was convened to impart guidance on new technologies that could, if 
introduced to the health service, reduce HAIs. Invitations were then extended for 
companies to come forward if they believed they had an idea that could aid reduction in 
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HAI rates. Subsequently, in 2008, the NHS and Department of Health collaborated and 
launched the Healthcare Associated Infection Technology Innovation Programme, to 
facilitate development and adoption of the new technologies previously assessed and 
deemed beneficial. Ideas granted RRP „category 1‟ were instantly implemented in 
showcase hospitals, and available throughout the NHS, those obtaining categories 2 or 3 
were provided assistance with further development and testing before deciding if it 
should be made widely available (Department of Health, 2010). Alongside these, ran the 
Smart Ideas Programme in autumn 2007 which involved NHS staff and aimed to gather 
opinion about what they felt could positively influence HAI rates. The response was 
immense with 157 ideas divulged, from which 10 believed to be the most promising 
were prioritised and in turn, underwent trials in pilot studies within showcase hospitals 
throughout eight U.K. trusts; the same hospitals RRP category 1 ideas were installed 
into for real-use examination. As a result of this entire collaborative programme 
encouraging creativity, many new products have been developed with the list of those 
becoming available to NHS trusts continually increasing. Some ideas arising from these 
programmes include amongst others a Hydrogen Peroxide Vapour System from 
Bioquell
®
 for room decontamination, and a hand held device for measuring microbial 
surface contamination called Clean Trace ATP Monitoring System by 3M
®
. Both of 
which have since been concluded as successful aids in reducing HAIs causing 
reductions in microbial presence as well as being favourable amongst staff (Department 
of Health and NHS Purchasing and Supply Agency, 2009a; Department of Health and 
NHS Purchasing and Supply Agency, 2009b). The knowledge that these ideas are 
believed by a whole panel including specialists from the health service and infection 
control leaders, to possess potential benefits for reducing HAIs, confirms that surfaces 
are increasingly being taken more seriously in the fight for controlling infection 
transmission. However, none of these new ideas focuses specifically on biofilms which 
are, as discussed previously, of significant concern within the healthcare system. 
Both the 5 % and 2 % Euclean
®
 wipes removed biofilm cultures from stainless steel 
discs significantly quicker than the CHG/IPA wipes, which permitted some biofilms to 
still remain after 30 minutes contact. However, there was a slight difference observed in 
this experiment between the 5 % Euclean
®
 wipes and the 2 % Euclean
®
 wipes. Five of 
the six tested microorganisms were successfully eradicated in under 5 minutes contact 
with the 5 % Euclean
®
 wipes, and the remaining microorganism (P. aeruginosa) was 
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killed within 10 minutes; compared with the 2 % Euclean
®
 wipes which destroyed three 
microorganisms within 5 minutes, and the remaining 3 within 10 minutes. 
EO is a known permeation enhancer and has previously presented increased potency 
against biofilm cultures when combined with CHG (Hendry et al., 2009). The 
permeation properties of EO are likely to be partly responsible for aiding biofilm 
removal, by penetrating deeper into the extracellular matrix than CHG or IPA alone, 
allowing the contained cells to be targeted by the EO, along with the CHG and IPA. 
This hypothesis is supported by research which has shown that EO can carry CHG into 
the deeper layers of human skin therefore is it possible the same pulling effect could 
occur in biofilm penetration (Karpanen et al., 2010). This permeation attribute would 
account for the difference in time taken by the 5 % and 2 % Euclean
®
 wipes to eliminate 
the biofilm as with less EO present, the permeation effect could be reduced therefore 
require longer time to achieve the same result.  
The results from this part of the study confirm that development from an idea into a 
prototype developed at Aston University and subsequently into a commercial product 
has, for this combination of agents, retained viability and antimicrobial efficacy. Some 
efficacy against biofilm removal was lost with the reduction in EO concentration 
however, even with this reduced efficacy, the 2 % Euclean
®
 wipes demonstrated 
significantly more antimicrobial efficacy than the CHG/IPA wipes similar to those often 
used throughout the health service at present. Due to the increased prevalence of 
biofilms, compared with planktonic cells on hard surfaces, these results bear 
significance to the application of the wipes and therefore the 5 % Euclean
®
 wipes will 
be used for future studies within this thesis.  
~ 144 ~ 
 
4.7. Conclusion 
Development from a prototype into a commercial product can create unforeseen 
complications and result in an altered final outcome. However, development from an 
EO-containing wet wipe assessed in chapter 3, into Euclean
®
 hard surface disinfectant 
wipes has proved successful. Both 5 % and 2 % varieties of Euclean
®
 wipes have 
demonstrated antimicrobial efficacy against a panel of six clinically important 
microorganisms adhered to surfaces, with no reduction in efficacy as a result of 
decreased EO concentration. Furthermore, they both possessed greater efficacy against 
microbial biofilms than that of the currently popular wipe containing CHG and IPA. 
However, the reduction in EO concentration did result in a slightly increased time 
period required to kill biofilms of S. epidermidis, P. aeruginosa and E. coli; prevalent 
nosocomial pathogens. As biofilms are more true to the mode of growth observed most 
commonly on hard surfaces, with recognition dating to the early fossil records (Branda 
et al., 2005; Chandra et al., 2001), the 5 % Euclean
®
 wipes show more suitability for 
use within the clinical setting than the 2 % Euclean
®
 wipes, and shall therefore be put 
forward for a clinical audit to assess opinion of them. 
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5.1. Introduction 
There is a vast repertoire of conventional laboratory methods employed for testing new 
antimicrobial products such as disinfectants, prior to reaching clinical trials and ultimate 
commercialisation (Williams et al., 2007). These can involve microbial exposure tests, 
time-kill experiments, studies in the presence of soil loads and resistance development 
potentials. An alternative method for testing the efficacy of a new agent, involves the 
use of calorimetry, however its application for assessment of antimicrobial agents, to 
date, has been limited.  
Advances in calorimetry have progressed immensely since first being used for 
biological applications in the 1780‟s when guinea pig metabolism was studied, with 
microcalorimeters now widely available (Chaires, 2008; Lavoisier & Laplace, 1780). 
Calorimetry provides information on the energy of a thermodynamic system, known as 
enthalpy, measured as „power‟ and converted into the SI units of Joules (Chaires, 2008). 
The two main types of calorimetry used are differential scanning calorimetry (DSC), 
and isothermal calorimetry (IC). Both types contain a sample and reference ampoule 
with the temperature difference between them monitored, however in DSC, the external 
temperature is increased at steady, actuate intervals whereas in an IC, it is kept constant 
(Jelesarov & Bosshard, 1999). 
In recent years, IC has been frequently used by the pharmaceutical industry to aid 
discovery, and development of drug products. In particular, the use of calorimetry can 
provide data on the long term stability of drugs from the highly sensitive results it 
generates over continued time periods (Beezer et al., 2001). 
Calorimeters rely on the knowledge that all processes, chemical and physical, involve 
an exchange of heat energy to or from their surroundings; it is this variable which is 
recorded with great sensitivity within the calorimeter. They are also non-specific in their 
operation, therefore will monitor and record all changes that are observed within a given 
test. Furthermore, the rate of heat exchange within the IC is measured in real time 
allowing the dynamic response of the system being challenged, to be monitored directly 
(O‟Neill et al., 2003). Some other advantages conferred by IC include superior 
sensitivity and versatility over many other classical analytical techniques (Salim & Feig, 
2009). They are capable of controlling the operating environment, which in turn results 
in any temperature changes being instantly observed if linked with a computer, and 
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attributed to an instigating event, such as microbial growth or death (Trampuz et al., 
2007).  
IC has previously been deemed effective in monitoring the bactericidal efficacy of other 
complex microbial systems, where traditional culturing techniques would have been 
difficult to employ accurately. Two previous studies have been undertaken exploring the 
efficacy of silver-containing wound dressings following addition of dressing sections to 
suspensions of S. aureus and P. aeruginosa. They confirmed the method to be more 
suitable for this type of assessment, as it eliminates plate counting complications whilst 
providing the additional benefits of real time results from a more accurately controlled 
system (Gaisford et al., 2009; O‟Neill et al., 2003). Another study used IC to determine 
the MIC of 12 antibiotics against five microorganisms, describing the method as 
accurate and reproducible, with its passivity allowing samples to remain undamaged 
and untouched, allowing for subsequent processing if required (von Ah et al., 2009). 
Previous research within chapter 2 of this thesis has confirmed that EO and CHG 
possess synergistic antimicrobial activity when combined together against both 
planktonic and biofilm modes of growth (Hendry et al., 2009). Following adaptation of 
the combined solution into the commercially produced 5 % Euclean
®
 hard surface 
disinfectant wipes (chapter 4), conventional laboratory experiments have confirmed 
efficacy to remain, with suitability for use within the clinical environment established, 
in particular against biofilms (Hendry et al., 2010). Employing isothermal calorimetry 
as an accompanying technique for the assessment of 5 % Euclean
®
 wipes, may provide 
additional information about their antimicrobial efficacy, specifically with regards to 
their speed of action and potential to permit or even encourage microbial growth. 
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5.2. Aims of the study 
The aims of this study were to: 
 Investigate the potential use of isothermal calorimetry for assessing 
antimicrobial activity, as an alternative or accompanying method to 
conventional laboratory culturing techniques and traditional time-kill assays. 
 Assess the antimicrobial efficacy of 10 % EO-containing wipes (chapter 3) and 
the commercially produced 5 % Euclean
®
 wipes (chapter 4), against a panel of 
clinically important microorganisms in planktonic cultures of both a moderate 
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5.3. Materials 
5.3.1. Microbial cultures 
Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis RP62A, MRSA N315, 
Pseudomonas aeruginosa ATCC 15442, Escherichia coli NCTC 10418 and Candida 
albicans ATCC 76615 were stored on MicroBank beads (Pro-Lab Diagnostics, 
Cheshire, U.K.) at -70 °C until required. 
 
5.3.2. Microbiological media 
Mueller-Hinton agar (MHA), Mueller-Hinton broth (MHB), Sabouraud dextrose agar 
(SDA) and Sabouraud dextrose broth (SDB) were purchased from Oxoid (Basingstoke, 
U.K.), prepared as per manufacturer‟s instructions and sterilised at 121 °C for 15 




5.3.3.1. Neutralising solution 
Neutralising solution was prepared with 1.17 % (w/v) lecithin, granular, Mw 750.00 
Acros Organics (Fisher Scientific, Leicestershire, U.K.), 2 % (v/v) tween-80 (Sigma-
Aldrich, Dorset, U.K.), 0.5 % (w/v) sodium thiosulphate pentahydrate (BDH Limited, 
Dorset, U.K.) and 0.1 % (v/v) triton-X 100 (Sigma-Aldrich, Dorset, U.K.), made up to 1 
L with double distilled water. The solution was sterilised at 121 °C for 15 minutes and 
stored at 4 °C until required. 
 
5.3.4. Equipment 
All static calorimetry experiments were performed in a TA Instruments 2277 Thermal 
Activity Monitor (TAM) (TA Instruments, Delaware, U.S.A.) set to 37 °C. The 
electrical substitution method was used to calibrate the instrument which was then 
verified using a chemical test and reference reaction (Beezer et al., 2001). On each 
occasion, the ampoules were allowed to reach thermal equilibrium in the calorimeter (± 
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10 minutes) before being lowered into the measuring position. Data were collected 
using the dedicated software package Digitam
®
, and analysed using Microcal Origin
®
 
Software Version 7.0. 
Flow calorimetry experiments were performed in a TA Instruments 2277-Flow Thermal 
Activity Monitor (flow-TAM) (TA Instruments, Delaware, U.S.A.) set to 30 °C. The 
instrument underwent simple calibration prior to each flow-through calorimetric 
experiment, and on each occasion, both the system and media were allowed to reach 
thermal equilibrium (± 10 minutes) before measurement commenced. It should be noted 
that movement of fluid in flow calorimetry introduces frictional heat, whilst the outward 
flowing fluid carries heat out of the system therefore calibration was required, however 
as the intention of these studies was for distinguishing between live and dead 
microorganisms, the thermodynamics of the system such as enthalpy of reaction, were 
not in this instance calculated. Data were collected using the dedicated software 
package Digitam
®
, and analysed using Microcal Origin
®
 Software Version 7.0. 
 
5.3.5. 5 % Euclean
®
 wipes 
The 5 % Euclean
®
 wipes were produced by PAL International (Leicestershire, U.K.) by 
application of 5 % (v/v) EO, 2 % (v/v) CHG, 70 % (v/v) IPA and 1 % (v/v) tween-80 in 
water sprayed into tubs containing 200 blank, 23 gsm, viscose/polypropylene (50:50) 
non-woven wipes. Tubs were left standing for a minimum of 48 hours to allow 
saturation of the wipes before being delivered for use.  
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5.4. Methods 
5.4.1. Wipe impregnation process and combinations 
The solutions for wipe impregnation were each prepared to a total volume of 384 mL 
for two sets of wipes: 
 10 % (v/v) EO / 2 % (v/v) CHG / 70 % (v/v) IPA / 0.1 % (v/v) tween-80 all 
purchased from Sigma-Aldrich (Dorset, U.K.) in sterile, double distilled water 
made in sterile, double distilled water 
 Sterile, double distilled water (control wipes) 
In accordance with methods used by the wipe manufacturer PAL International 
(Leicestershire, U.K.), each solution was poured into a tub containing 200 blank, 23 
gsm, viscose/polypropylene (50:50) non-woven wipes provided by PAL International, 
and left for a minimum of 48 hours to allow saturation of the wipes before use. 
 
5.4.2. Assessment of the antimicrobial efficacy of Euclean
®
 
solution against Candida albicans using flow calorimetry 
An overnight cell suspension of C. albicans was prepared in SDB and diluted using 
previously established OD/cfu standard curves to provide a 50 mL culture of 10
4 
cfu/mL. A magnetic stirring bar was added to the culture then it was placed in a heated 
water bath set at 33 °C to keep the culture maintained at 30 °C. The calorimeter used 
was a flow-TAM (TA instruments, Delaware, U.S.A.) calorimeter through which the 
culture was cycled for a minimum of 20 hours to generate a growth curve. The 
antimicrobial efficacy of the Euclean
®
 solution was then assessed by the addition of 2 % 
(v/v) Euclean
®
 solution (comprising 5 % (v/v) EO, 2 % (v/v) CHG, 70 % (v/v) IPA and 
0.1 % (v/v) tween-80, in sterile, double distilled water) to the growth culture just prior 
to the maximum peak of growth occurring. The culture was cycled through the 
calorimeter a further 18 hours before triplicate pour plates were made from 1 mL 
samples into molten SDA containing 10 % (v/v) neutralising solution to assess 
microbial viability. A control experiment was carried out with 2 % (v/v) Euclean
®
 
solution (made as described above) added to SDB circulating around the flow 
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calorimeter without microbial inoculum, to determine whether any effects observed in 
the earlier experiment were caused by fiction as the two agents combined. 
 
5.4.3. Antimicrobial efficacy of Euclean
®
 wipes against 
moderate and high density microbial suspensions using 
isothermal calorimetry 
Overnight cell suspensions of each microorganism were prepared in MHB or SDB from 
five identical colonies grown on MHA or SDA plates. Using previously established 
OD/cfu standard curves (Section 2.4.1.1), all cultures (excluding MRSA) were diluted 
in MHB or SDB as required to give final concentrations of 10
4
 cfu/mL and 10
7
 cfu/mL, 
while MRSA was diluted in MHB to 10
5
 cfu/mL and 10
7
 cfu/mL. Using the lower 
density cell cultures of each microorganism, growth curves were generated following 
inoculation of 3 mL microbial suspension into 4 mL stainless steel ampoules (TA 
Instruments, Delaware, U.S.A.). Ampoules were then hermetically sealed using a 
stainless steel closure, and following achievement of thermal equilibrium, were lowered 
fully into the recording position of the calorimeter. To determine the effect of wipes on 
microbial growth, 3 mL of cell suspension was added to the ampoules as described and 
a 4 cm
2
 section of wipe was rolled up and added to the ampoule prior to sealing and 
loading. The wipes tested were: 
 10 % (v/v) EO / 2 % (v/v) CHG / 70 % (v/v) IPA / 0.1 % (v/v) tween-80 
 5 % Euclean® 
 Sterile, double distilled water (control) 
Further testing of 5 % Euclean
®
 wipes was carried out using the same methods as 
described but with the higher density cell suspension containing 10
7
 cfu/mL. All 
experiments were carried out for a minimum of 20 hours. Finally, microbial viability 
was confirmed or refuted once the calorimeter process had concluded, by making pour 
plates from mixing 1 mL of the ampoule contents with molten MHA or SDA containing 
10 % (v/v) neutralising solution, cooled to 50 °C. Plates were incubated overnight at 37 
°C; 30 °C for C. albicans. All experiments were repeated in triplicate. 
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5.4.4. Time-kill study of Euclean
®
 wipes against moderate and 
high density microbial suspensions 
Overnight cell suspensions of each microorganism were diluted in MHB or SDB to the 
same final concentrations as used previously (Section 5.4.3). To replace the data lost by 
equilibrating the ampoules, time kill studies were carried out over a 30 minute time 
period for the scenarios tested in the calorimeter, with the conditions replicated by using 
the same temperature, volume and density of cell suspensions, and size of wipe for the 5 
% Euclean
®
 wipes. Samples were taken at time zero, minute intervals up to 5 minutes, 
and then every 5 minutes up to half an hour. Each sample was cultured into molten 
MHA or SDA containing 10 % (v/v) neutralising solution, cooled to 50 °C. Plates were 
incubated overnight at 37 °C; 30 °C for C. albicans and microbial viability determined 
by a 99.9 % reduction in cfu from the time zero control. 
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5.5. Results 
5.5.1. Assessment of the antimicrobial efficacy of Euclean
®
 
solution against Candida albicans using flow calorimetry 
The growth curve produced by C. albicans in the flow calorimeter reached a maximum 
power output signal of around 350 µW (Figure A13), however the addition of 2 % (v/v) 
of Euclean
®
 (5 %) solution into a growing cell suspension resulted in almost 
instantaneous cell death, subsequently confirmed by no visible growth following agar 
culture after the completion of the flow calorimetry experiment. The control experiment 
showed addition of Euclean
®
 solution into broth caused a small power output signal of 
around 75 µW, which accounted for only one quarter of the total power output of 300 
µW created when the solution was added to growing cells (Figure A14). However, due 
to recurring contamination issues with the flow method, static calorimetry was adopted 
for future experiments. 
 
5.5.2. Antimicrobial efficacy of Euclean
®
 wipes against 
moderate and high density microbial suspensions using 
isothermal calorimetry 
The power-time growth curves for each microorganism (Figures 5.1 to 5.6) initially 
showed escalating power output over time as the cell numbers increased producing heat, 
up to a maximum cell density. At which point, density peaked and began to fall due to a 
reduction in the rate of cell turnover, causing a decrease in power output as heat output 
reduced. The presence of a control wipe had little effect on the power-time curves, 
compared with the respective growth curve. However, in all instances, the addition of a 
10 % EO-containing wipe or 5 % Euclean
®
 wipe resulted in a flat line showing no 
power output equating to no heat output, thus eradication of growth. The same was 
observed when the wipes were added to the higher density cell suspensions. The 
viability testing of the ampoule contents concluded no growth at all, confirming 5 % 
Euclean
®
 wipes to be bactericidal in their mode of action, and verifying that a power 
output of zero is indicative of a bactericidal effect rather than bacteriostatic. 
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Figure 5.1. Power-time curves showing the calorimetric response of 104 cfu/mL S. aureus cell suspension when 
exposed to control (red), 5 % Euclean® (green) and 10 % EO-containing wipes (purple), as well as a 107 
cfu/mL cell suspension exposed to 5 % Euclean® wipes (blue), compared with a growth curve (black) in the 
absence of any wipe. 
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Figure 5.2. Power-time curves showing the calorimetric response of 104 cfu/mL S. epidermidis cell suspension 
when exposed to control (red), 5 % Euclean® (green) and 10 % EO-containing wipes (purple), as well as a 107 
cfu/mL cell suspension exposed to 5 % Euclean® wipes (blue), compared with a growth curve (black) in the 
absence of any wipe. 
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Figure 5.3. Power-time curves showing the calorimetric response of 104 cfu/mL MRSA cell suspension when 
exposed to control (red), 5 % Euclean® (green) and 10 % EO-containing wipes (purple), as well as a 107 
cfu/mL cell suspension exposed to 5 % Euclean® wipes (blue), compared with a growth curve (black) in the 
absence of any wipe. 
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Figure 5.4. Power-time curves showing the calorimetric response of 104 cfu/mL P. aeruginosa cell suspension 
when exposed to control (red), 5 % Euclean® (green) and 10 % EO-containing wipes (purple), as well as a 107 
cfu/mL cell suspension exposed to 5 % Euclean® wipes (blue), compared with a growth curve (black) in the 
absence of any wipe. 
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Figure 5.5. Power-time curves showing the calorimetric response of 104 cfu/mL E. coli cell suspension when 
exposed to control (red), 5 % Euclean® (green) and 10 % EO-containing wipes (purple), as well as a 107 
cfu/mL cell suspension exposed to 5 % Euclean® wipes (blue), compared with a growth curve (black) in the 
absence of any wipe. 
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Figure 5.6. Power-time curves showing the calorimetric response of 104 cfu/mL C. albicans cell suspension 
when exposed to control (red), 5 % Euclean® (green) and 10 % EO-containing wipes (purple), as well as a 107 
cfu/mL cell suspension exposed to 5 % Euclean® wipes (blue), compared with a growth curve (black) in the 
absence of any wipe. 
 
 
5.5.3. Time-kill study of Euclean
®
 wipes against moderate and 
high density microbial suspensions 
The results for the suspension time-kill demonstrated that insertion of the 5 % Euclean
®
 
wipes into the cell suspensions killed all microorganisms tested, including the higher 
density cell suspensions, within a contact time of less than 1 minute. 
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5.6. Discussion 
The 5 % Euclean
®
 wipes have previously demonstrated enhanced antimicrobial efficacy 
against planktonic and biofilm cultures of a variety of clinically important 
microorganisms, with the penetration properties of EO the most likely justification for 
facilitating the improved microbial elimination (Hendry et al., 2009; Hendry et al., 
2010). Furthermore, the results of this study have reemphasised the suitability 
demonstrated in chapter 4 of 5 % Euclean
®
 wipes for use within the healthcare setting, 
following confirmation of their rapid antimicrobial action. While conventional 
microbiological techniques have been employed previously to assess the antimicrobial 
properties of these wipes, in this study, the use of isothermal calorimetry was employed. 
Calorimetry allows continuous measurement of microbial metabolic activity over time 
without the need for external sampling. The TAM used in this study precisely controlled 
the experimental environment, therefore any temperature changes could not only be 
observed as they occurred, but credited to a triggering incident such as cell growth or 
death. This particular TAM measured changes in the power needed to match the 
temperature of the control ampoule, to that of the sample. Therefore, the use of „power‟ 
and „heat‟ become almost interchangeable; as microbial growth caused the heat in the 
sample ampoule rises, more power is needed to heat the reference up to the same 
temperature, as cells die heat reduces thus less power is needed to match the heat of the 
sample ampoule (Salim & Feig, 2008).  
The calorimeter is not destructive to the sample under observation, it is also non-
invasive hence the course of the experiment is not influenced by the calorimeter. This is 
a significant advantage conferred by isothermal calorimetry as it allows experiments to 
be performed on a test substance directly, regardless of its form or diversity. Such 
capabilities are particularly useful for the study of microbiological systems, which by 
their very nature, are complex. Having previously been confirmed as an effective means 
of monitoring the bactericidal properties of other similarly complex systems, the use of 
IC for this study was perceived as suitable, whilst providing additional beneficial data, 
unobtainable by conventional laboratory culture methods (Gaisford et al., 2009; O‟Neill 
et al., 2003). 
Microorganisms are known to grow at different rates, as confirmed in this study by the 
application of isothermal calorimetry. All of the six microorganisms investigated here 
showed a growth curve with at least two stages of growth. The double peaking of 
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growth curves found in this study, is supported by those obtained in other studies, and 
results from changes to the utilisation of a different metabolic pathway (von Ah et al., 
2008; Hou et al., 2010; O‟Neill et al., 2003). 
The results clearly demonstrate that both the EO-containing wipes and Euclean
®
 wipes 
possessed antimicrobial activity against all six microorganisms with the power outputs 
represented by flat lines rather than the curves previously witnessed. This was true 
irrespective of Gram classification or microbial origin such as bacteria or yeast. 
Furthermore, the antimicrobial efficacy of the wipes was maintained in the presence of a 
particularly challenging, increased microbial load. Subsequent agar culture confirmed 
the wipes to be bactericidal in their mode of action, eliminating complications seen with 
some wipes where the fabric can not only harbour collected microbial contamination, 
but induce growth within them (Diab-Elschahawi et al., 2010). This is an important 
feature for wipes intended for clinical applications, as cleaning surfaces with 
contaminated cloths that disperse microorganisms, could prove more harmful in the 
dissemination of potential pathogens than not cleaning in the first instance. These 
findings support previous research where EO and CHG have been shown to act 
synergistically to induce a bactericidal effect, possibly as a result of both targeting the 
cytoplasmic membrane leading to structural damage of the cell, and consequently 
increased permeability (Filoche et al., 2005; Prabuseenivasan et al., 2006).  
The sensitivity of modern calorimeters is such that a bacterial culture containing 10
4
 
cfu/mL is sufficient to generate a detectable signal through heat production (von Ah et 
al., 2009). Therefore, as growing microorganisms generate detectable heat, any 
antimicrobial effect generated in this study by 5 % Euclean
®
 wipes against any of the 
six microorganisms resulted in a reduced heat output. If the microorganisms are killed, 
there is no detectable signal from heat output. This was observed for all six 
microorganisms tested when EO-containing wipes and 5 % Euclean
®
 wipes were 
present, with the result being a flat-line graph, subsequently verified by culturing onto 
agar, as no viable cells remaining. There is however, one limitation of this method. 
Whilst it was possible to confirm bactericidal action by 5 % Euclean
®
 wipes, it was not 
possible to determine how rapidly this occurred following contact with the wipes. After 
loading the ampoules into the TAM and allowing 30 minutes for thermal equilibrium to 
be achieved, the baseline must return to zero before death can be confirmed, often 
resulting in no data for the first hour of contact. However, conventional microbiological 
testing used to replace this missing data has verified that 5 % Euclean
®
 wipes 
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sufficiently kill all the microbial suspensions described in this study with a contact time 
of less than 1 minute. This is in line with previous results whereby 10 % EO-containing 
wipes killed planktonic cells within 30 seconds (chapter 3), and results of the 
subsequent chapter in which 5 % Euclean
®
 wipes killed biofilms of all microorganisms 
within 5 minutes except P. aeruginosa which took under 10 minutes (chapter 4). 
The control wipes did not show any antimicrobial efficacy when compared with the 
growth curve for each microorganism. They did however result in a small reduction in 
the maximum heat output over the growth period, and in some instances, a slightly 
delayed growth curve was generated. This was possibly due to the very nature of the 
wipes physically containing and restricting cells, reducing their exposure to nutrients 
and space.  
Decontamination of hard surfaces within the healthcare setting plays an important role 
in reducing the spread of HAIs. Interventions, such as changes in disinfection product, 
education and feedback, applied to cleaning procedures have proved to induce 
reductions in microbial recovery from surfaces harbouring pathogenic contamination, 
including MRSA and VRE (Goodman et al., 2008). However, the cleaning method and 
protocol used need careful consideration if maximum efficacy is to be achieved. A 
recent study by Diab-Elschahawi et al. (2010) highlighted the importance of using moist 
cloths for cleaning due to the significantly reduced microbial removal by a dry cloth. It 
has also been noted that the fabric of the wipe has an effect on its efficacy, with 
microfibre cloths being recognised by many, as superior to cotton cloths (Rutala et al., 
2007). However, another recent study reported differences in efficacy between 
microfibre cloths, concluding most to be not significantly better than a paper towel at 
removing dried microorganisms in the presence of a soil load. This emphasised that 
using a microfibre cloth is not always indicative of superior performance, leading to 
questions regarding the justification of the extra cost, if current methods offer similar 
performance (Moore & Griffith, 2006). Euclean
®
 wipes are moist but not microfibrous, 
therefore their physical characteristics may contribute positively towards their efficacy 
but could potentially be improved. Furthermore, the unique combination of EO and 
CHG/IPA within the wipe allows for enhanced synergistic antimicrobial efficacy when 
compared with CHG/IPA alone (Hendry et al., 2009). 
Alcohol wipes are widely used within the health service at present however other types 
of cleaning products are also available. Research has confirmed that the method 
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employed can have an effect on the cleaning merit; this has been highlighted in a 
previous study by Panousi et al. (2008) who concluded that alcohol impregnated wipes 
performed much better when removing microbial contamination from surfaces than a 
dry wipe sprayed with alcohol and subsequently used. 
The results obtained in this study not only support, but also extend the information 
previously established regarding the antimicrobial efficacy and mode of action of EO-
containing wipes (chapter 3) and 5 % Euclean
®
 wipes (chapter 4).  
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5.7. Conclusion 
The results from this study support and extend those gained previously using 
conventional laboratory culture techniques. Here, Euclean
® 
wipes have again been 
confirmed to possess significant antimicrobial activity against both Gram-positive and -
negative bacteria, as well as yeast, which was successfully maintained when challenged 
with an increased microbial load. Furthermore, when combined with the use of more 
familiar culture methods, confirmation was obtained that Euclean
®
 wipes induced 
complete extermination of all viable cells for all six microorganisms investigated, 
including those of the higher cell density, in less than 1 minute, therefore further 
verifying their suitability as hard surface disinfectant wipes for use within the healthcare 
setting. Moreover, this study has highlighted the use of IC as a viable alternative to 
classical methods of analysis for the detection of wipe efficacy and microbial viability 
in cell suspensions of this nature. 
  




Clinical Audit of Euclean
®
 Hard Surface 
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6.1. Introduction 
The responsibility of cleaning and disinfection within the healthcare service falls upon a 
number of different staff members within the health service. External, contracted 
cleaning firms are recruited sporadically for intermittent deep cleans, however the duties 
of daily cleaning are usually split between ward cleaners responsible for large areas 
such as walls and floors, and nurses, whose remit includes high touch surfaces such as 
drip stands, bedside tables and lockers, along with intricate clinical equipment (Dancer, 
2009). However, overlaps in obligation can easily lead to confusion with some surfaces 
potentially remaining missed. Where cleaning is concerned, understaffing can 
exacerbate the burden imposed on others, increasing the chances of executing rushed 
technique or last minute reallocation of responsibilities, creating disorder and 
potentially omitting cover entirely for some areas. As concluded by Hugonnet et al. 
(2007) and Dancer et al. (2006), staff shortages, which are all too frequent within many 
hospitals, are linked to the undesirable resultant outcome of increased infection risk in 
critically ill patients. Add to this cost cutting measures, and a keen emphasis on 
reducing waiting lists which can often lead to overcrowding, and the problem of 
infection spread is further intensified (Dancer, 2008). 
Within the literature, there appears a shortage of information covering proven benefits 
of cleaning in the U.K., with many studies only instigated following an infection 
outbreak (Dancer, 2009). Furthermore, there appears to be nothing in the way of 
opinion from healthcare workers regarding their thoughts on the cleaning products and 
methods they employ daily. This is surprising as opinions have been sought on other 
important issues concerning infection control, such as hand hygiene policies and 
procedures (Harris et al., 2000). Furthermore, dislike of a product is more likely to 
induce evasive behaviour towards it, therefore it should be imperative that staff are not 
only asked their thoughts concerning a new product, but that their feedback is listened 
to and acted upon. 
Following stringent and extensive testing using both conventional laboratory culturing 
techniques and isothermal calorimetry, Euclean
®
 wipes have demonstrated great 
potential for use within the clinical setting. However, cleaning of high touch surfaces 
requires regular repetition therefore products need to fulfil a number of criteria in order 
to ease this process. Favourable attributes include ease of use, suitable moistness/drying 
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time and skin friendly, i.e. they must not induce irritation. However the weighting of 
importance attributed to each characteristic may differ from one person to the next.  
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6.2. Aims of the study 
The aims of this audit were to: 
 Design a questionnaire to collate the opinions of healthcare workers regarding 
the use of cleaning and disinfection products. 
 Liaise with ward staff and infection control managers at Birmingham Children‟s 
Hospital to facilitate administration of a cross-over study to ascertain their 
opinion, by means of a questionnaire, on their current cleaning and disinfection 
products, followed by commercially produced Euclean
®
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6.3. Materials 
The 5 % Euclean
®
 wipes were provided by PAL International (Leicestershire, U.K.) and 
comprised 5 % (v/v) EO, 2 % (v/v) CHG, 70 % (v/v) IPA and 1 % (v/v) tween-80 in 
water, sprayed into tubs containing 200 blank, 23 gsm, viscose/polypropylene (50:50) 
non-woven wipes. Tubs were left standing for a minimum of 48 hours to allow 
saturation of the wipes before being delivered and subsequently distributed to five 
wards at Birmingham Children‟s Hospital. 
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6.4. Methods 
6.4.1. Ethical approval 
Prior to undertaking the Euclean
®
 clinical audit, ethical approval was obtained by the 
Chair of the Aston University‟s Ethics Committee (Image A1), and clearance was 
granted by the Research and Development Department of Birmingham Children‟s 
Hospital (Image A2). Contact with the National Research Ethics Service (NRES) 
confirmed ethical approval at trust level was not required due to the questionnaire being 
classified as an audit. 
 
6.4.2. Questionnaire design and structure 
The questionnaire (Image A3) was designed in collaboration with Dr Chris Langley 
(Senior Lecturer in Pharmacy Practice, Aston University) and consisted of 28 questions, 
split into two sections; the first included the demographics and questions regarding 
hard-surface disinfection products currently being used on that ward. The second 
concentrated on Euclean
®
 wipes. The majority of questions were closed-ended; denoted 
by tick boxes, restricting the answers to a list of possible options. However, there were 
also some open-ended questions where opinion was requested, as well as some filter 
questions where further explanation was only required following a specified answer 
being given previously. The combination of question styles used would therefore 
generate both quantitative and qualitative data.  
 
6.4.3. Questionnaire format and appearance 
In order to maximise response rate, the overall format and appearance of the 
questionnaire was carefully considered. The questionnaire was completely anonymous 
so as to avoid receiving distorted answers through staff displaying feelings of their work 
or ability being under investigation or scrutiny which can lead to biases (Boynton, 
2004). Both the title and completion instructions were clear and concise, using basic 
vocabulary to avoid confusion or initial reluctance to partake (Uher & Goodman, 2010). 
The wording of questions has been shown to impact on the quality of responses 
(McColl et al., 2001), therefore, the language used was simple and direct, with guidance 
given on how to answer e.g. tick one, tick all, with listed answers being alphabetised to 
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avoid biased emphasis being placed on particular answers. The length of the 
questionnaire was kept to the minimum required to obtain the desired information, as 
lengthy questionnaires generate lower response rates than shorter ones (Nakash et al., 
2006). Finally, while the colour of the paper has been summarised as unimportant by 
some researchers (Booth, 2003), others have found it can impact significantly on 
response rates. Pucel et al. (1971) found a 7.1 % increase in response rate when using a 
green questionnaire compared with a white one. It was therefore decided that pastel 
green paper would be used for the clinical audit of Euclean
®
 wipes, as it represented the 
green colour of Myrtaceae trees leaves from which eucalyptus oil is derived, while on a 
practical level, improved visibility of the questionnaire to staff if filed amongst other 
papers, thus hopefully increasing compliance, and therefore response rate. 
 
6.4.4. Sample population 
Ward participation within the Euclean
®
 audit was on a voluntary basis; however some 
wards such as the intensive care unit (ICU) were prohibited from inclusion due to 
infection control policies. Of eight potential wards, the following five wards took part in 
the audit: 
 Ward 4; Neonatal Surgery 
 Ward 5; Burns Centre 
 Ward 6; Medical Ward 
 Ward 10; Neuro-Surgery 
 Ward 11; Heart Unit 
As any member of staff from these wards was eligible to complete the audit and 
questionnaire, a maximum of 167 replies could be achieved. 
 
6.4.5. Data collection 
The guidelines on the front of the questionnaire and on the informative poster (Image 
A4) instructed staff to complete the audit in two phases. Phase 1 of the cross-over study 
would last one week and required no changes to be made to their current practices of 
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hard-surface disinfection. At the end of the week they were asked to complete the first 
16 questions. Phase 2 of the cross-over study would then begin with the replacement of 
all previous hard-surface cleaning products on the ward with Euclean
®
 wipes. This 
phase would also last one week, during which, only Euclean
®
 wipes would be used, 
with the final 12 questions then being answered at the end of that week. In this study, 
the term cross-over referred to a controlled trial in which there was balance between the 
number and duration of treatments, however the sequence of those treatments was not 
random.  
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6.5. Results 
6.5.1. Data collection 
A total of 167 staff members from 5 wards at Birmingham Children‟s Hospital were 
eligible to complete the Euclean
®
 clinical audit. Sixty-two (37 %) out of the 167 
responded. Of the 62 questionnaire replies received, 8 were discounted due to partial 
completion, while the remaining 54 responses were ascertained useable; this represents 
a final response rate of 32 %. The demographics highlighted that 53 responses were 
from female participants, with only one from a male participant, the ages and job roles 
of the participants are shown in Figure 6.1. The duration spent working in their current 
role varied greatly from 1 month to 20 years, with the mean and median time periods as 
almost 4 yrs and exactly 2 years respectively. 
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The final demographic result concluded the individual wards‟ response rate to the 
Euclean
®
 clinical audit varied from 13 % to 27.8 % as demonstrated in Table 6.1.  
 
Table 6.1. Euclean® clinical audit response rates of individual wards at Birmingham Children’s Hospital. 
Ward Number and Speciality Response rate (% of ward) 
4 - Neonatal Surgery 14.8 
5 - Burns Centre 22.2 
6 - Medical Ward 27.8 
10 - Neuro-Surgery 13.0 
11 - Heart Unit 22.2 
 
 
6.5.1.1. Phase 1 of the cross-over study: Current cleaning and 
disinfection wipes used within Birmingham Children’s Hospital 
The Euclean
®
 clinical audit revealed that disinfectant wet wipes are used daily by 
98.1% participants (n=53), and monthly by 1.9 % as part of their routine work in 
practice, with a total of eight different wipes identified as being in-use within the 
hospital. Sanicloth-70 was by far the most common, used by almost 48 % of 
participants (Figure 6.2), however 37 % of those questioned reported using more than 
one type of wet wipe for surface disinfection. 
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Disinfectant wet wipes were used by participants to clean every surface option from a 
list of 30 suggestions, and whilst some surfaces were ticked by almost every participant 
such as cots and bedside cabinets, others were only indicated by one or two; these 
included toilets, windows and floors (Figure 6.3). The option of „other‟ invited 
responses which included intravenous trays (n=9), dressing trolleys (n=5), trolleys 
(n=4), drip stands (n=2), couches (n=1) and baths (n=1). 
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The most common materials to make up the wiped surfaces were plastic and metal with 
52 and 41 participant responses respectively, conversely copper was not recorded by 
any respondent (Figure 6.4). The option of „other‟ brought about the responses of 
laminate from two participants and cloth from one another, the fourth did not specify a 
material. The size of surface that could be cleaned before the disinfectant wet wipe 
needed replacing produced a rather large range of responses from 4.5 cm
2
 to 300 cm
2
. 
The mean size was 89 cm
2
 and the mode and median were both 40 cm
2
. Sixteen 
participants did not enter a size measurement, and 5 stated „it varies‟. 
 
 
Figure 6.4. Number of responses by staff at Birmingham Children’s Hospital when asked what material the 
surfaces wiped by disinfectant wet wipes are made from. 
 
Skin irritation from the disinfectant wet wipes was experienced by 3 (5.6 %) of the 54 
participants, with the symptoms reported consisting of redness, stinging, eczema and 
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suggested 9 advantageous themes and 6 disadvantageous (Table 6.2). Overall, when 
asked to rate the wipes on a 1 to 10 scale, a mean of 7.5 was achieved covering the 
range 4 to 10. The median and mode were both 8 with a resultant final total „score‟ of 
403. However, 85.2 % of participants said they would be prepared to change from their 
current disinfectant wet wipes to an alternative wipe. 
 
Table 6.2. Staff comments of the advantages and disadvantages of their current disinfectant wet wipes for 
surface cleaning within Birmingham Children’s Hospital, followed by the number of staff to suggest each. 
Advantages Disadvantages 
 Ease of use (13)  Smell (7) 
 They clean well (9)  Dry out quickly (6) 
 Smell either nice or fragrance free   Difficult to get out of dispenser (4) 
(6)  Does not get rid of tough stains (3) 
 High alcohol content makes them 
good for disinfection (2) 
 Use a lot so not as environmentally 
friendly (1). 
 Remove stubborn stains (1)  Sting if hands cut (1) 
 No need for soap and water (1) 
  Does not leave smears (1) 
  Stay wet (1) 
  Does not leave hands rough (1) 
  
 
6.5.1.2. Phase 2 of the cross-over study: Use of Euclean
®
 hard surface 
disinfection wipes used within Birmingham Children’s Hospital 
Euclean
®
 wipes had been used daily by 98.1 % of participants during the second week 
of the audit, and only once by 1.9 % (n=53:1). There was no difference in the types of 
surfaces cleaned by Euclean
®
 wipes compared to those previously recorded in the first 
half of the questionnaire. Bedside cabinets and cots were again the most frequently 
declared with 46 responses each, whilst toilets, windows and floors were again the least 
(Figure 6.5). The option of „other‟ invited the following responses: intravenous trays 
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As was found in the responses from the first half of the questionnaire, the most common 
materials to make up the wiped surfaces were plastic and metal with 53 and 46 
participant responses respectively, on the contrary copper was only recorded by one 
respondent (Figure 6.6). The option of „other‟ brought about the same responses as 
previous (laminate, cloth and not specified). As previously demonstrated with the 
disinfectant wet wipes, the size of surface that could be cleaned before the Euclean
®
 
wipe needed replacing produced a vast range of responses from 20 cm
2
 to 300 cm
2
. The 
mean surface size was 82 cm
2
 while the mode and median were both 40 cm
2
. Twenty-
two participants did not enter a size measurement, and 4 stated „it varies‟. 
 
 
Figure 6.6. Number of responses by staff at Birmingham Children’s Hospital when asked what material the 
surfaces wiped by Euclean® wipes are made from. 
 
Participants preferred the existing packaging of Euclean
®
 wipes with 46 choosing the 
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demonstrated some popularity with 11 and 10 votes respectively. The single „other‟ 
response simply requested two sizes of packaging to be available. The size of the 
Euclean
®
 wipes was categorised as „just right‟ by 85.2 % of participants, with 11.3 % 
and 3.7 % describing them as „too small‟ and „too big‟ respectively. The thickness was 
also deemed to be „just right‟ by the majority with a 77.8 % response rate, whilst the 
remaining 22.2 % concluded the wipes to be „too thin‟. None of the participants thought 
the Euclean
®
 wipes were too thick. 
 
Table 6.3. The number of staff at Birmingham Children’s Hospital in favour of various types of packaging for 
Euclean® wipes. 
Packaging Number 
Flexible plastic pouch with re-sealable peal back opening 10 
Individually wrapped sachets 4 
Larger tubs 11 
Other 1 
Smaller tubs 5 
Tubs (as currently packaged) 46 
 
Skin irritation and discomfort from the Euclean
®
 wipes was experienced by 7 (13 %) of 
the 54 participants, with an array of symptoms reported including itchy and watery eyes, 
wheezing, rash, stinging eyes and throat, sore hands and headache. When asked for their 
opinion on the disinfectant Euclean
®
 wipes, participants suggested 10 advantageous 
themes and 7 disadvantageous (Table 6.4). Overall, when asked to rate the wipes on a 1 
to 10 scale, a mean of 6.3 was achieved covering the full range (1-10). The median was 
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Table 6.4. Staff comments of the advantages and disadvantages of Euclean® wipes for surface cleaning within 
Birmingham Children’s Hospital, followed by the number of staff to suggest each. 
Advantages Disadvantages 
 Smell nice (16)  Smell (30) 
 Cleaned well (3)  Dried out too quickly (7) 
 Quick and easy to use (2)  Irritant/caused rash (3) 
 Dry quickly (2)  Needed more than normal to clean  
 Stays wet longer (2) an area (1) 
 Stronger wipe (1)  Left smears (1) 
 Easy to remove from tub (1)  Does not clean as well (1) 
 Removed sticky patches (1)  Not easy to open wipe fully (1) 
 Did not leave streaks (1) 
  No need for soap and water (1) 
  
Finally, participants were invited to leave any general feedback or comments with 
regards to Euclean
®
 wipes; of the many that did, a large proportion commented either 
for or against the smell, or on the inability of the wipes to remain moist over long 
periods of time; however a selection of some of the more interesting statements are 
listed below. 
 
“I felt the wipes did the same job as the wipes already used, but as stated earlier the 
general feeling on the ward was that the Euclean
®
 wipes had a nasty smell to them. 
Unless cost is an issue I see no advantages in changing over. It would be interesting to 
see research on bacteria on surfaces following the use of present wipes vs. Euclean
®.” 
 
“The wipes had an overall better cleaning ability; however on some tough stains extra 
scrubbing was needed (stain not known). The fragrance of the wipes is more pleasant 
and acceptable in a ward environment.” 
 
“Smell much nicer than original alcohol smell. Also good for clearing blocked nose! 
Takes away from other smells on ward e.g. if used to clean bed after child vomits as it 
over powers the vomit smell.” 
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“The smell is very strong and they seem to be quite dry, but they still do the job, so if 
they have fewer chemicals than the other wipes they are ok.” 
 
“It's very good, does not leave any streaks on surfaces. It's not as moist as the other ones 
we used. Too strong of eucalyptus but leaves a fresh scent/smell after.” 
 
“Overwhelming odour, this can be quite strong to small babies especially when used in 
heated baby incubators.” 
 
“I liked the smell more than others, didn't smell so "hospital" and "clinical" as others.” 
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6.6. Discussion 
Over recent years, the use of disinfectant wet wipes for cleaning hard surfaces within 
the healthcare setting has increased vastly, with an assortment of brands now available. 
There are a number of advantages of using these types of wet wipes for disinfection 
over conventional products. Already impregnated with antimicrobial solutions, wet 
wipes require no additional preparation such as dissolving tablets in liquid, therefore are 
easier to use and can be available for instant use whenever needed. Furthermore, their 
compatibility with neat packaging means they can be stored handily in pocket sachets or 
in wall mounted tubs, encouraging use. However, wet wipes are, like so many other 
disinfectant products, not without their drawbacks. Uncertainty regarding longevity of 
either an individual wipe or an opened packet can lead to wipes dying out and therefore 
losing efficacy. Furthermore, some evidence has pointed out the potential of some 
wipes to induce surface cross contamination if they are not bactericidal or used on 
multiple surfaces when design favours a single use application (Bartz et al., 2010). 
This study aimed to ascertain healthcare workers opinions towards the wipes they 
currently use during their daily practice, and determine how they compared to Euclean
®
 
wipes. As a result of this study, the opinions gathered could assist and guide further 
development of the wipes, to enable production to be of a product favoured by those for 
whom it has been designed.  
The response rate for this study, defined as the percentage of useable, returned 
questionnaires from the number of eligible respondents, was 32 %, which compared 
poorly to other voluntary studies involving health professionals, where rates of over 50 
% have been reported (Aiken et al., 2002). However, a review published by Asch et al. 
(1997) noticed how the response rates published in medical journals differed between 
physicians and non-physicians, with mean values of 54 % and 68 % respectively. As the 
majority of those eligible to partake in this study were non-physicians, this further 
disparages the response rate obtained. Response rates are important in questionnaires, as 
the higher the response rate, the more serious a study is taken as it offers a better 
representation of the thoughts of the entire group.  
One study by Nakash et al. (2006) concluded that shorted questionnaires of between 7 
and 47 questions resulted in a 9 % increase in response rates compared with longer ones 
of between 36 and 123 questions. In addition to this, they also noted that implementing 
follow up efforts were likely to increase response rate yet surprisingly, the use of 
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incentives bore no significance. The Euclean
®
 questionnaire contained only 28 
questions and follow up calls and visits were conducted, therefore it would be right to 
assume more replies should have been generated. However, the two surgical wards 
caring for critically ill patients generated the lowest rates, therefore it is possible that 
prioritisation simply detracted attention away from the questionnaire. 
The demographics concluded that the typical respondent would be a 32 year old, female 
nurse with around 4 year‟s service in that post. All but one member of staff declared 
daily use of wet wipes for surface disinfection, with the only exception being a doctor 
whose job role, unlike that of the nurses, is unlikely to include ward cleaning duties. 
This emphasises the commercialisation potentials for developing a product chosen by 
hospitals for use on their wards. Furthermore, the results of preferred packaging type 
suggested that a variety of small, resealable pouches and larger tubs would make 
suitable additions to the current sized tub, therefore generating a wider range and 
increasing the consumer‟s choice. 
The results of this study showed that Euclean
®
 wipes almost completely divided 
opinion; with a nearly fifty-fifty split in those apparent to love and loathe them. The 
wipes found to be most commonly used by staff at Birmingham Children‟s Hospital, 
were Sanicloth-70, which are impregnated with 70 % alcohol and 2 % CHG; the same 
composition as in Euclean
®
 wipes, but without the EO. As these are the wipes of choice, 
it can be assumed that they are generally well-liked. Therefore, the division in opinion 
towards the Euclean
®
 wipes suggests that the presence of EO is the source of the 
unfavourable feedback. 
Almost 40 % of staff admitted they used more than one type of disinfectant wipe 
therefore, whilst three people mentioned they had suffered from some degree of skin 
irritation, it cannot be assumed that the Sanicloth-70 wipes were the cause. The numbers 
reporting skin irritation rose to seven during the week of the Euclean
®
 wipe use. There 
are two possible reasons for this; one being that they have sensitive skin and therefore 
normally use more delicate wipes thus would be most likely to suffer irritation upon 
changing product, and the second could be linked with the presence of the eucalyptus 
oil in the Euclean
®
 wipes. EO is a known permeation enhancer and is capable of 
causing temporary, reversible disruption of the intercellular lipids in the stratum 
corneum. This can permit entry of otherwise impenetrable substances into the skin, 
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which can in turn lead to drying of the skin and therefore increased risk of irritation 
occurring (Aqil et al., 2007; Williams et al., 2006). 
The replacement from their regular wipes to Euclean
®
 wipes, did not result in any great 
change in the types of surfaces cleaned, in particular there was no observation of any 
surfaces becoming completely excluded. Nor did they results in a significant change to 
the size of the area cleaned before needing replacing. Furthermore, the ergonomics 
including size and thickness of the wipes were rated by most as „just right‟. Therefore, it 
can be assumed that Euclean
®
 wipes were considered suitable by staff for use on all the 
usual items requiring disinfection and would prove favourable if large scale production 
were to commence. The most frequently reported surfaces cleaned (those depicted by 30 
or more staff), can be classed as high touch surfaces. These are often very close to 
patients such as at their bedside, and are touched repeatedly by the patients themselves, 
healthcare workers and visitors. Therefore, such surfaces are prone to higher levels of 
microbial colonisation than objects less regularly touched by potentially contaminated 
hands, such as plug sockets and radiators (Dancer et al., 2009). Thus it follows that 
cleaning protocols would include these objects in daily, if not more frequent cleaning 
and so more staff would be likely to clean them at some stage. 
When asked to give a numerical score of the disinfectant wipes currently used and the 
Euclean
®
 wipes, staff scored the Euclean
®
 wipes slightly less, with a mean of 6.3 
compared with 7.5. However, this alone does not show the entire picture as the most 
common scores given for the original and Euclean
®
 wipes were 8 and 9 respectively, 
illustrating an opposing preference to that obtained by comparisons of the means.  
Within the questionnaire, staff were invited to offer any advantages or disadvantages of 
both current and Euclean
®
 wipes, as well as any further comments at the end of the 
survey. Interestingly, when grouped into themes, the subject of smell which generated 
the most responses as an advantage also generated the greatest result in the disadvantage 
category. Respondent opinion was divided with some finding the smell extremely 
pleasant, while others found it overwhelming, especially if used for long periods of time 
or in a confined space. Similar attitudes were noted by Tovey & McDonnald (1997), 
who, while discussing the use of eucalyptus oil in washing detergents in Australia, 
mentioned that it is considered „pleasant‟ by most people, however the residual scent 
which can last up to 3 days may be a source of annoyance to some. 
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Finally, some interesting comments made reference to the cost effectiveness and 
chemical content of Euclean
®
 wipes, revealing some practical issues that could be 
considered in future development. One respondent had no preference for the current or 
Euclean
®
 wipes, but stated that if Euclean
®
 wipes were more cost effective, they would 
be more likely to convert. At present, it is likely that Euclean
®
 wipes will be slightly 
more expensive than those currently used therefore cost reducing mechanisms could be 
investigated. Euclean
®
 wipes contain eucalyptus oil which is a natural product therefore, 
depending on personal opinion, it may not necessarily be considered an added chemical, 
but as a natural, organic substance, thus on the contrary, Euclean
®
 wipes could signify a 
more holistic product with similar advantages to those offered by alternative and 
complimentary therapies. 
Whilst the data generated by the Euclean
®
 wipe audit was overall, encouraging, some 
areas for potential improvement of the product were highlighted. The major 
disadvantage expressed by some staff was the smell which indicates that further 
improvements could be made in this area possibly by reducing the EO concentration, 
providing it is not to the detriment of the antimicrobial efficacy. This could also provide 
an additional benefit for commercialisation, as the reduction in EO content would not 
only reduce the intensity of the smell, but also the manufacturing costs related to 
Euclean
®
 wipes. Furthermore, a decrease in EO could reduce the additional reports of 
skin irritation generated by Euclean
®
 wipe use, yet further investigations into skin 









 wipe audit at Birmingham Children‟s Hospital generated data which 
could be used in further development and refinement of the product. The most 
significant result came from the division in opinion towards Euclean
®
 wipes, with the 
smell being described as the major advantage, as well as the greatest disadvantage. Wet 
wipes were used daily by all-but-one of the healthcare workers on an array of surfaces, 
with alcohol based wipes used more so than any other disinfectant wipes. The 
conversion to Euclean
®
 wipes did not instigate any changes to the objects cleaned or the 
typical area that could be wiped before replacing. The overall rating of Euclean
®
 wipes 
generated a mean numerical score of 6.3 out of 10, compared with 7.5 for the currently 
used wipes, however the result generated most frequently for Euclean
®
 wipes was 9/10 
compared to 8/10 for the initial wipes. The frequent comment regarding the 
„overwhelming‟ smell suggests further formulation developments to reduce the EO 
content would be favoured, potentially reducing the intensity of the smell, 
manufacturing costs and skin irritation, providing the antimicrobial efficacy is not 
compromised. 
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7.1. Introduction 
Infectious complications arising from implanted medical devices inflict additional 
complications on patient care. Devices such as central venous catheters (CVC) puncture 
the skin, breaching its barrier properties and immediately providing a point of entry for 
microorganisms. The most commonly observed microorganisms colonising these sites 
are associated with the skin and are often opportunistic pathogens of previously resident 
microflora such as S. epidermidis (Rohde et al., 2010). Additional complications can 
arise from the capability of these microorganisms to grow within a biofilm, which 
provides a physical barrier preventing penetration of antimicrobial agents and immune 
system detection (Mack et al., 2004; Qin et al., 2006). Adequate skin antisepsis prior to 
catheter insertion is therefore required however recent studies have shown poor 
penetration of the EPIC recommended solution, 2 % CHG in 70 % IPA, into the skins‟ 
deeper layers, thus allowing some viable microorganisms to remain in pores and hair 
follicles even after following the recommended directions for antisepsis (Karpanen et 
al., 2008a). It therefore follows that there is a need for enhanced antiseptic activity or 
performance that can eliminate all surface and deeper-residing microorganisms, to cease 
development of many preventable infections. 
The use of essential oils for medicinal purposes has been long standing; however recent 
research has demonstrated that some combinations of oil and CHG can result in 
synergistic antimicrobial activity, with the results for eucalyptus oil appearing 
particularly promising (Karpanen et al., 2008b). Subsequent studies have verified 
antimicrobial synergism by EO/CHG combination, against a panel of skin-associated 
microorganisms, with particular focus on its enhanced biofilm removal; furthermore the 
combination of EO/CHG/IPA has also demonstrated significantly enhanced skin 
penetration compared with CHG/IPA (Hendry et al., 2009; Karpanen et al., 2010). 
The delivery of agents into the skin has often been overcome with the application of 
creams or lotions however their use can induce complications including difficulty in 
accurately measuring dosage and accidental removal by washing. These issues can be 
circumvented by the use of transdermal patches, with many varieties now widely 
available. These are capable of delivering sustained and controlled release of medication 
into or across the skin and are frequently supplemented with permeation enhancers 
(Prausnitz & Langer, 2008). One patch currently available from Johnson & Johnson 
incorporates CHG into impregnated sponges, and is designed for use as a dressing to 
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surround intravascular catheters. Results obtained from clinical trials cited reductions in 
bloodstream infection rates related to central venous catheters following introduction of 
these CHG biopatches to a number of intensive care units (Timsit et al., 2009). 
EO is a recognised permeation enhancer, largely due to its major component 1,8-
cineole, which has been used in previous studies for enhancing dermal delivery (Liu et 
al., 2011). Therefore, bringing together the knowledge that EO and CHG provides 
deeper skin penetration than current recommendations, possesses synergistic 
antimicrobial activity against a number of skin microorganisms and acts synergistically 
against biofilms, it is possible that application of this combination into a dermal patch, 
could provide enhanced skin antisepsis prior to insertion of an intravascular device, and 
furthermore, could continue to impart antimicrobial protection around the insertion site 
to prevent and eliminate biofilm infection. However, application into a dermal patch 
would require development as well as appropriate, comprehensive testing to include 
release studies, verification of antimicrobial efficacy, compatibility testing with CVC 
plastic and assessment of skin toxicity using tissue culture techniques. 
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7.2. Aims of the study 
The previous chapters within this thesis have focused upon the antimicrobial activity of 
EO and CHG with emphasis on the development of a novel hard surface disinfectant. 
The aims of this final series of experiments were to: 
 Expand the concepts of this thesis further, by assessing the potential of polyvinyl 
alcohol and chitosan as biopatch films, into which EO and CHG could be 
incorporated. 
 Investigate the antimicrobial efficacy of polyvinyl alcohol and chitosan biopatch 
films. 
 Study the release of EO and CHG from a polyvinyl alcohol biopatch through 
skin penetration studies, using high performance liquid chromatography and gas 
chromatography for analysis. 
 Determine to potential toxicity of 5 % and 2 % Euclean® solutions using tissue 
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7.3. Materials 
7.3.1. Microbial cultures 
Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis RP62A, MRSA N315, 
Pseudomonas aeruginosa ATCC 15442, Escherichia coli NCTC 10418 and Candida 
albicans ATCC 76615 were stored on MicroBank beads (Pro-Lab Diagnostics, 
Cheshire, U.K.) at -70 °C until required. 
 
7.3.2. Cell lines 
Airway epithelial cells (AEC) C38 CF-corrected cells were purchased from the 
American Type Cultures Collection (ATCC), and human pulmonary fibroblasts (HPF) 
were purchased from PromoCell (Heidelberg, Germany). 
 
7.3.3. Microbiological media 
Airway epithelial cell growth medium (AEM) and fibroblast growth medium 2 (FGM2) 
were purchased from PromoCell (Heidelberg, Germany). 
 
7.3.4. Chemicals 
7.3.4.1. Chlorhexidine digluconate stock solution 
Stock solutions of chlorhexidine digluconate (CHG) (Sigma-Aldrich, Dorset, U.K.) 
were made fresh on the day of use, to a concentration of 256 µg/mL and further diluted 
as required. The concentration of CHG was 200,000 µg/mL, thus the stock solution 
consisted of 12.8 % (v/v) CHG in PBS (Sigma-Aldrich, Dorset, U.K.) to give a 
concentration of 25,600 µg/mL, which then required a 1:100 dilution to achieve the 
desired stock solution concentration of 256 µg/mL. 
 
7.3.4.2. Neutralising solution 
Neutralising solution was prepared with 1.17 % (w/v) lecithin, granular, Mw 750.00 
Acros Organics (Fisher Scientific, Leicestershire, U.K.), 2 % (v/v) tween-80 (Sigma-
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Aldrich, Dorset, U.K.), 0.785 % (w/v) sodium thiosulphate pentahydrate (BDH Ltd, 
Poole, U.K.) and 0.1 % (v/v) triton X-100 (Sigma-Aldrich, Dorset, U.K.), made up to 1 
L with double distilled water. The solution was sterilised at 121 °C for 15 minutes and 
stored at 4 °C until required. 
 
7.3.4.3. Mobile phase 75:25 for high performance liquid 
chromatography 
Isocratic mobile phase containing methanol: water in a ratio of 75:25 was prepared with 
75 % (v/v) HPLC grade methanol (Fisher Scientific, Leicestershire, U.K.), 0.2 % (v/v) 
diethylamine (Sigma-Aldrich, Dorset, U.K.) and 0.005 M sodium 1-heptane sulfonate 
(Sigma-Aldrich, Dorset, U.K.) made up to 1 L with double, distilled water. Glacial 
acetic acid HPLC grade (Fisher Scientific, Leicestershire, U.K.) was added gradually to 
lower the pH to pH 4. The mobile phase solution was then degassed with a vacuum 
pump, and stored in a brown jar for use that week. 
 
7.3.4.4. Mobile phase 65:35 for high performance liquid 
chromatography 
Isocratic mobile phase containing methanol: water in a ratio of 65:35 was prepared with 
65 % (v/v) HPLC grade methanol (Fisher Scientific, Leicestershire, U.K.), 0.2 % (v/v) 
diethylamine (Sigma-Aldrich, Dorset, U.K.) and 0.005 M sodium 1-heptane sulfonate 
(Sigma-Aldrich, Dorset, U.K.) made up to 1 L with double, distilled water. Glacial 
acetic acid HPLC grade (Fisher Scientific, Leicestershire, U.K.) was added gradually to 
lower the pH to pH 4. The mobile phase solution was then degassed with a vacuum 
pump, and stored in a brown jar for use that week. 
 
7.3.4.5. Methanol water for high performance liquid chromatography 
Flush for the HPLC was made with 50:50 HPLC grade methanol (Fisher Scientific, 
Leicestershire, U.K.) in double distilled water then degassed with a vacuum pump, and 
stored in a brown jar for use that week. 
 




 and chlorhexidine digluconate/isopropyl alcohol 
solutions for tissue culture 
Euclean
®
 solutions were prepared to 5 % (v/v) and 2 % (v/v) concentrations, in both 
airway epithelial cell growth medium (AEM) (PromoCell, Heidelberg, Germany) and 
fibroblast growth medium 2 (FGM2) (PromoCell, Heidelberg, Germany). Euclean
®
 
solutions contained 5 % (v/v) or 2 % (v/v) EO with 2 % (v/v) CHG, 70 % (v/v) IPA and 
1 % (v/v) tween-80 in AEM and FGM2. The CHG/IPA solution was also prepared in 
both cell growth media and comprised 2 % (v/v) CHG and 70 % (v/v) IPA in AEM and 
FGM2. 
 
7.3.5. Polyvinyl alcohol film preparation 
Polyvinyl alcohol (PVA) powder was purchased from Sigma-Aldrich (Dorset, U.K.) in 
three different molecular weights; low Mw 47,000 Dalton (Da), medium Mw 125,000 
Da and high Mw 205, 000 Da. The powder was dissolved in sterile, double distilled 
water while stirring for 4 hours at 95 °C. It was then cooled to 30 °C and EO and/or 
CHG and/or tween-80 were added as required before casting onto acrylic boards 
(Perspex Distribution, Tamworth, U.K.) to a thickness of 1000 µm using an Erichsen 
Film Applicator, Multicator 411 (Erichsen, Hemer, Germany). 
 
7.3.6. Chitosan film preparation 
Chitosan powder of a medium Mw was purchased from Sigma-Aldrich (Dorset, U.K.). 
The powder was dissolved in sterile, double distilled water and varying concentrations 
of HPLC grade glacial acetic acid (Fisher Scientific, Leicestershire, U.K.) while stirring 
overnight at room temperature as described in methods by Chi et al. (2006). It was then 
cooled to 30 °C and EO and/or CHG and/or tween-80 were added as required before 
casting onto acrylic boards (Perspex Distribution, Tamworth, U.K.) to a thickness of 
1000 µm using an Erichsen Film Applicator, Multicator 411 (Erichsen, Hemer, 
Germany). 
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7.3.7. Skin samples 
The skin samples used were provided by The Stephen Kirby Skin Bank (Queen Mary‟s 
Hospital, London, U.K.) and were full thickness human skin, acquired from patients 
undertaking breast reduction surgery. The skin samples were frozen on the day of 
excision and stored at -70 °C until required. Prior to the study commencing, full ethical 
approval was obtained (REC 2002/169). 
 
7.3.8. Equipment 
High performance liquid chromatography (HPLC) was performed using an Agilent 
1200 series high performance liquid instrument (Agilent Technologies, West Lothian, 
U.K.) with ultraviolet (UV) detection. The HPLC was fitted with a CPS-2 Hypersil 
reverse phase chromatography column (Thermo Scientific, Northumberland, U.K.) 
measuring 150 x 4.6 mm, with 5 µm particle size. The other columns used during 
optimisation were an ODS-2 Hypersil reverse phase chromatography column (Thermo 
Scientific, Northumberland, U.K.) measuring 150 x 4.6 mm, with 5 µm particle size, 
and a Pinnacle DB Cyano chromatography column (Restek International, 
Buckinghamshire, U.K.) measuring 250 x 4.6 mm with 5 µm particle size. 
Gas chromatography (GC) was performed using an HP5890 series II, capillary gas 
chromatograph with flame ionization detector (FID) and split injector (Hewlett Packard, 
Berkshire, U.K.) programmed with injector and detector temperatures at 200 and 250 ºC 
respectively. Samples were run through an HP-INNOWax column, measuring 30 m in 
length with a film thickness of 0.25 µm and column ID 0.32 mm (Hewlett Packard, 
Berkshire, U.K.). The internal standard used was based on methods described by 
Milthorpe et al. (1998) and consisted of spiking samples with 50 µL of a solution made 
with 40 % (w/v) n-tetradecane (Sigma-Aldrich, Dorset, U.K.) dissolved in chloroform 
(Sigma-Aldrich, Dorset, U.K.). Data were analysed using HP Chemstation Software 
Rev.A.04.01 (Hewlett Packard, Berkshire, U.K.). 
Polyvinyl alcohol and chitosan biopatch films were cast to a thickness of 1000 µm using 
an Erichsen Film Applicator, Multicator 411 model (Erichsen, Hemer, Germany). 
Franz diffusion cells (made in-house) were connected to a Techne Circulator C-85A 
circulating water-heating pump (Bibby Scientific Limited, Staffordshire, U.K.) and 
stirred using an IKAMAG
®
 RO10 power magnetic stirrer (IKA
®
 Werke, Staufen, 
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Germany) for the skin penetration studies. Prior to use, the Franz diffusion cell receptor 
chambers and sampling ports were washed thoroughly; twice with 70:30 acetone 
(Sigma-Aldrich, Dorset, U.K.):water, twice with Virkon
®
 (Fisher Scientific, 
Leicestershire, U.K.), twice with PBS (Sigma-Aldrich, Dorset, U.K.) then a final wash 
with double distilled water. A moisture resistant film (Parafilm M
®
, Alcan Packaging, 
U.S.A.) was then used to cover the receptor chambers and sampling ports. 
The fluorescent plate reader used for the cell toxicity experiments was a Spectra Max 
Gemini XS (Molecular Devices, California, U.S.A.) set up for a 24 well plate, with 
excitation and emission wavelengths of 560 nm and 590 nm respectively, auto-mix on, 
and machine temperature set to 37 °C. Data were analysed using Softmax Pro V5 
(Molecular Devices, California, U.S.A.).  
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7.4. Methods 
7.4.1. High performance liquid chromatography 
7.4.1.1. Development of optimum high performance liquid 
chromatography methodology 
A range of triplicate CHG dilutions were made in PBS (Sigma-Aldrich, Dorset, U.K.) 
from triplicate stock solutions (Section 7.3.4.1) covering the range 256 µg/mL to 0.0039 
µg/mL. Each was filtered through a 0.45 µm nylon filter (Kinesis, Cambridgeshire, 
U.K.) into 8 mm screw cap HPLC vials (Kinesis, Cambridgeshire, U.K.). Samples were 
analysed using an Agilent 1200 series HPLC instrument (Agilent Technologies, West 
Lothian, U.K.) under a number of conditions to determine the most suitable for use. 
Three different columns were tested; an ODS-2 Hypersil reverse phase chromatography 
column (Thermo Scientific, Northumberland, U.K.) measuring 150 x 4.6 mm, with 5 
µm particle size; a Cyano chromatography column (Restek International, 
Buckinghamshire, U.K.) measuring 250 x 4.6 mm with 5 µm particle size; and a CPS-2 
Hypersil reverse phase chromatography column (Thermo Scientific, Northumberland, 
U.K.) measuring 150 x 4.6 mm, with 5 µm particle size. The ODS-2 and CPS-2 
columns were tested using MP at 75:25 and 65:35 ratios of methanol: water, while only 
65:35 was used with the Cyano column. On each occasion, the baselines of temperature, 
pH, pressure, flow rate and wavelength were monitored during the preliminary flushing 
with MP to ensure stability prior to sample running. The flow rate used in all 
experiments was 1.2 mL/minute for a duration of up to 12 minutes depending upon the 
elution time observed under each condition, with ultraviolet detection at 254 nm. 
 
7.4.1.2. Standard curve of chlorhexidine digluconate concentration and 
peak area generated by high performance liquid chromatography 
A range of triplicate CHG dilutions were prepared and filtered as described above 
(Section 7.4.1.1) from triplicate stock solutions. The samples were analysed on Agilent 
1200 series HPLC instrument (Agilent Technologies, West Lothian, U.K.) at room 
temperature through a CPS-2 Hypersil reverse phase chromatography column (Thermo 
Scientific, Northumberland, U.K.) measuring 150 x 4.6 mm, with 5 µm particle size. 
The flow rate used was 1.2 mL/minute for 9 minutes with ultraviolet detection at 254 
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nm. The isocratic MP was a 75:25 ratio of methanol:water with 0.2 % (v/v) 
diethylamine (Sigma-Aldrich, Dorset, U.K.), 0.005 M sodium 1-heptane sulfonate 
(Sigma-Aldrich, Dorset, U.K.) in double, distilled water, adjusted to pH 4 with HPLC 
grade glacial acetic acid (Fisher Scientific, Leicestershire, U.K.). Each sample was 
analysed using double injection and the results of peak area plotted against CHG 
concentration.  
 
7.4.1.3. Level of detection and quantification for high performance 
liquid chromatography 
The level of detection (LOD) and level of quantification (LOQ) were calculated from 
the standard curve using equations 8 and 11 described by Epshtein (2004). 
 
                     
                                  
        
 
 
                          
                                   




7.4.2. Gas chromatography 
7.4.2.1. Suitability of column 
Solutions were prepared of undiluted EO and 1,8-cineole, 0.1 % (v/v) EO or 1,8-cineole 
in HPLC grade hexane (Sigma-Aldrich, Dorset, U.K.), and hexane alone. One microlitre 
samples of each were injected into the GC (Hewlett Packard, Berkshire, U.K.) to 
determine retention time and good resolution between the solvent front and the EO/1,8-
cineole peak. 
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7.4.2.2. Preliminary extraction of eucalyptus oil using hexane 
Sterile universal bottles were set up each containing a section of 10 % EO with 2 % 
CHG wipe measuring 4 cm
2
. At set time intervals, 1 mL of HPLC grade hexane (Sigma-
Aldrich, Dorset, U.K.) was added to a universal bottle and mixed. The samples were set 
up such that the wipes were in hexane for 30 minutes, and 1, 2, 4, 6, 8, 10, 12, 18 and 24 
hours. After exposure to hexane, 1 µL samples of each were injected into the HP5890 
series II, capillary GC (Hewlett Packard, Berkshire, U.K.) and data analysed using HP 
Chemstation Software Rev.A.04.01 (Hewlett Packard, Berkshire, U.K.). Differences in 
the quantity of EO extracted from the wipes at each time point were observed by 
measuring the peak of 1,8-cineole as it passed through the column. 
 
7.4.2.3. Standard curve of eucalyptus oil concentration and peak area 
generated by gas chromatography 
From triplicate stock solutions of EO in HPLC grade hexane (Sigma-Aldrich, Dorset, 
U.K.) at a concentration of 512 mg/mL, a range of serial dilutions were made also in 
hexane to a concentration of 0.0078 mg/mL. Internal standard (IS) was spiked into each 
sample to give 0.02 g of IS per sample before they were filtered through a 0.45 µm 
nylon filter (Kinesis, Cambridgeshire, U.K.) into 8 mm screw cap HPLC vials (Kinesis, 
Cambridgeshire, U.K.). Controls of IS, EO and n-tetradecane each dissolved in hexane 
were prepared. Each sample was then injected into the HP5890 series II, capillary gas 
chromatograph fitted with an HP-INNOWax column (Hewlett Packard, Berkshire, 
U.K.) connected to an FID. Helium was the carrier gas and the flow rate was set to 10 
pound-force per square inch (psi). The oven temperature was pre-programmed to 150 
°C for 3 minutes, while the injector and detector temperatures were 200 and 250 °C 
respectively, with an injection of 1 µL and a 50:1 split ratio. Data were analysed using 
HP Chemstation Software Rev.A.04.01 (Hewlett Packard, Berkshire, U.K.). The 
experiment was repeated in triplicate and the results were plotted with peak area against 
EO concentration. 
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7.4.2.4. Level of detection and quantification for gas chromatography 
The level of detection (LOD) and level of quantification (LOQ) were calculated from 
the standard curve using equations 8 and 11 described by Epshtein (2004). (Section 
7.4.1.3). 
 
7.4.3. Biopatch film development and antimicrobial testing 
7.4.3.1. Polyvinyl and chitosan film optimisation 
Optimisation of PVA and chitosan films was carried out in an ordered and methodical 
manner, encompassing a range of powder concentrations and glacial acid content, with 
eliminations occurring at each stage based upon the resulting biopatch properties. Films 
were initially made from powder and water of each concentration. CHG, IPA and EO all 
purchased from Sigma-Aldrich (Dorset, U.K.) were then added alone and in 
combination to the more suitable films following assessment of their properties, and 
finally the quantity of HPLC grade glacial acetic acid within the chitosan films was 
reduced. Based upon methods described by Gal & Nussinovitch (2009), each of the 
three PVA powders were prepared in sterile, double distilled water to concentrations of 
1 % intervals, ranging 1 % (w/w) to 12 % (w/w) then dissolved with 4 hours of heated 
stirring at 95 °C. Once dissolved, the solutions were cooled to 30 °C and a variety of 5 
% (v/v) EO and/or 2 % (v/v) CHG and/or 1 % (v/v) tween-80 were added as required, 
before casting onto acrylic boards (Perspex Distribution, Tamworth, U.K.) to a 
thickness of 1000 µm using an Erichsen Film Applicator, Multicator 411 (Erichsen, 
Hemer, Germany). Chitosan films were prepared in sterile, double distilled water to 
concentrations of 0.5 % intervals, ranging 1 % (w/w) to 5 % (w/w) both without and 
with HPLC grade glacial acetic acid (Fisher Scientific, Leicestershire, U.K.) added in 
equal, corresponding concentrations at 0.5 % intervals from 1 % (v/v) to 5 % (v/v). The 
powder was allowed to dissolve at room temperature overnight before 5 % (v/v) EO, 2 
% (v/v) CHG and 1 % (v/v) tween-80 were added alone and in combination, and cast 
onto acrylic boards as previously described for PVA. The most suitable films for 
consideration in future studies were decided upon by a number of characteristics 
including flexibility, and the ability of powder to fully dissolve and antimicrobials to 
mix without separation. 
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7.4.3.2. Release study of eucalyptus oil and chlorhexidine digluconate 
from a polyvinyl alcohol biopatch film using Franz diffusion cells 
Biopatches were made from 7 % (w/w) PVA with Mw 47,000 Da containing 5 % (v/v) 
EO, 2 % (v/v) CHG and 1 % (v/v) tween-80; controls were absent of EO and tween-80. 
Verification of EO and CHG release was observed using Franz diffusion cells. The 
receptor chambers were filled with 29 mL of PBS (Sigma-Aldrich, Dorset, U.K.) which 
was held at 37 °C by heated water circulating through water jackets. A magnetic stirring 
bar was added to each receptor chamber before the chambers and sampling ports were 
sealed with moisture resistant film (Parafilm M
®
, Alcan Packaging, U.S.A.) until the 
temperature of the PBS was as required. Once at temperature, a section of biopatch was 
placed over each receptor chamber, triplicate contained CHG alone and acted as 
controls, another three contained EO and CHG. Samples of 1 mL receptor chamber 
fluid were taken through needles via the sampling port at time zero, 30 minutes, 1, 2, 4, 
6 and 24 hours, and replaced with 1 mL warmed PBS each time. Each sample was 
filtered, spiked with IS if required and processed by the HPLC or GC as appropriate to 
verify release of both agents from the patches and determine if the presence of EO has 
any effect on CHG release. 
 
7.4.3.3. Microbial inhibition by eucalyptus oil and chlorhexidine 
digluconate-containing polyvinyl alcohol and chitosan films using agar 
diffusion 
The following patches were made as described previously (Section 7.4.3.1), each was 
prepared with, and without 5 % (v/v) EO, 2 % (v/v) CHG and 1 % (v/v) tween-80; 
 7 % (w/w) PVA, Mw 47,000 
 9 % (w/w) PVA, Mw 47,000 
 7 % (w/w) PVA, Mw 125,000 
 7 % (w/w) PVA, Mw 205,000 
 9 % (w/w) PVA, Mw 205,000 
 2 % (w/w) chitosan with 2 % (v/v) HPLC grade glacial acetic acid 
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Cell suspensions containing 10
4
 cfu/mL of each microorganism were prepared in MHB 
or SDB from five identical colonies grown on MHA or SDA. Cotton wool swabs were 
used to inoculate the surfaces of MHA or SDA plates before squares of each biopatch 
measuring 20 mm by 20 mm were applied to triplicate plates. Plates were incubated 
overnight at 37 ºC; 30 ºC for C. albicans, and inhibition zone sizes were measured as 
the distance between the edge of the patch and visible growth. 
 
7.4.3.4. Bacteriostatic/bactericidal testing of eucalyptus oil and 
chlorhexidine digluconate-containing polyvinyl alcohol and chitosan 
films 
Following completion of the previous experiment (Section 7.4.3.3), the biopatches were 
removed from the surface of the agar and a section of agar measuring 10 mm by 10 mm 
was cut from underneath the patch and inserted into a bijou bottle containing 1 mL 
neutralising solution. The bijou bottle was mixed for 1 minute, then after 30 minutes 
contact with the neutralising solution, 1 mL was removed into a petri dish and a pour 
plate made with molten MHA or SDA containing 10 % (v/v) neutralising solution, 
cooled to 50 °C. Plates were incubated and microbial viability used to determine 
bacteriostatic or bactericidal mode of action. 
 





 catheter and hub (Beckton Dickinson, Oxford, U.K.) were fully 
submerged into Euclean
®
 solution (5 %) and assessed visually every 24 hours over a 5 
day period for evidence of fragmentation or disintegration. A control was also set up 
with an identical catheter and hub submerged in PBS (Sigma-Aldrich, Dorset, U.K.). 
After 5 days, the devices were removed and their texture assessed for signs of becoming 
sticky or softened.  
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7.4.5. Polyvinyl alcohol films on human skin 
7.4.5.1. Penetration of eucalyptus oil and chlorhexidine digluconate 
from a polyvinyl alcohol film into human skin 
The penetration of EO and CHG through human skin from the biopatch was assessed 
with the use of Franz diffusion cells. The receptor chambers were filled with 29 mL of 
PBS (Sigma-Aldrich, Dorset, U.K.) which was retained at 37 °C by heated water 
circulating through water jackets. A magnetic stirring bar was added to each receptor 
chamber before the chambers and sampling ports were sealed with moisture resistant 
film (Parafilm M
®
, Alcan Packaging, U.S.A.) until the temperature of the PBS was as 
required. Full thickness human skin was partially thawed at room temperature and cut 
into circular discs measuring 3 cm diameter. The moisture resistant film (Parafilm M
®
, 
Alcan Packaging, U.S.A.) was removed from the receptor chambers of the Franz 
diffusion cells, and the skin mounted in its place such that the stratum corneum (SC) 
was upward facing, and the underside was in contact with the PBS in the receptor 
chamber, having removed any air bubbles. The donor chambers were clamped on top of 
the skin and sealed with moisture resistant film (Parafilm M
®
, Alcan Packaging, U.S.A.) 
for around 30 minutes to allow the surface of the skin to reach 32 °C prior to 
commencement of an experiment. Once the skin had reached temperature, the donor 
chamber was temporarily removed and a section of biopatch placed over the skin, 
ensuring full contact, before the donor chamber was replaced. The biopatches tested 
were 7 % (w/w) PVA, Mw 47,000 Da, containing 5 % (v/v) EO, 2 % (v/v) CHG and 1 
% (v/v) tween-80, with triplicate skin discs used for the EO and CHG patch, and 
triplicate used with a CHG only patch as a control. Samples of 1 mL receptor chamber 
fluid were taken through needles via the sampling port at time zero, 30 minutes, 1, 2, 4, 
8 and 24 hours, and replaced with 1 mL warmed PBS each time. Each sample was split 
with half being filtered and processed by the HPLC for detection of CHG, and the other 
half spiked with IS, filtered and processed on the GC for EO presence. 
 
7.4.5.2. Detection of eucalyptus oil and chlorhexidine digluconate in 
layers of human skin 
Following 24 hour exposure of full thickness human skin to biopatches containing CHG 
with and without EO as described above (Section 7.4.5.1), the patches were removed 
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and discarded, and the six discs of skin were removed and frozen with cryospray (Bright 
Instruments, Cambridgeshire, U.K.) then stored at -20 °C until sliced. Duplicate punch 
biopsies measuring 8 mm diameter were cut from each of the discs and mounted onto 
cork with embedding compound (Bright Instruments, Cambridgeshire, U.K.). Each 
biopsy was sectioned horizontally using a Bright OFT cryotome (Bright Instruments, 
Cambridgeshire, U.K.) into five slices of 20 µm, five of 40 µm and five of 60 µm, then 
added to pre-weighted eppendorf tubes such that the duplicate punch biopsies from each 
disc were combined allowing the weight of each skin sample to be determined. PBS 
(Sigma-Aldrich, Dorset, U.K.) was added to each eppendorf tube and mixed before the 
samples were split and filtered as previously described (Section 7.4.5.1), and analysed 
using HPLC and GC. 
 
7.4.6. Testing of Euclean
®
 solutions using tissue culture 
7.4.6.1. Tissue culture technique 
Airway epithelial cells (AEC) and human pulmonary fibroblasts (HPF) were grown for 
48 hours at 37 °C, in 10 mL airway epithelial cell growth medium (AEM) and fibroblast 
growth medium 2 (FGM2) (both from PromoCell, Heidelberg, Germany) respectively, 
on the base of triplicate, 75 cm
2
 tissue culture flasks (Corning, Amsterdam, 
Netherlands). The medium was discarded and each flask washed once with PBS 
(Sigma-Aldrich, Dorset, U.K.) to prevent the medium inhibiting trypsin activity later 
on. The PBS was then also discarded. Cells were lifted from the base of the flasks by 
adding 2.5 mL of trypsin ethylenediaminetetraacetic acid (EDTA) (Sigma-Aldrich, 
Dorset, U.K.) to each flask. After 2 minutes contact at 37 °C, 6.5 mL AEM or FGM2 
was added as appropriate, to the flasks before being mixed gently to dislodge any 
remaining bound cells. The triplicate AEC and HPF cell suspensions were combined in 
universal bottles to give one large suspension of each cell line. Cell counts were 
performed using an improved, Neubauer double cell, standard chamber, 
haemocytometer (Fisher Scientific, Leicestershire, U.K.). Dilutions were performed in 
AEM or FGM2 accordingly and 500 µL seeded into wells of triplicate 24-well, tissue 
culture test plates (SPL Life Sciences Inc., Korea) such that the cell suspension gave 10
5
 
cfu/well. Plates were then incubated in air at 37 °C overnight before toxicity testing 
could begin. 
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7.4.6.2. Cell toxicity of Euclean
®
 solution to human airway epithelial 
cells and human pulmonary fibroblasts 
Triplicate 24-well tissue culture test plates (SPL Life Sciences Inc., Korea) were 
prepared as described previously (Section 7.4.6.1) with cell suspensions of AEC and 
HPF at a concentration of 10
5
 cfu/well and incubated overnight to allow the cells to 
adhere to the base of the wells. Following incubation, medium was removed and 
replaced with either 500 µL of the 5 % Euclean
®
 solution, 2 % Euclean
®
 solution or the 
CHG/IPA solution. Growth control wells were exposed to 500 µL fresh AEM or FGM2 
accordingly while negative controls containing 10 % (v/v) triton X-100 (Sigma-Aldrich, 
Dorset, U.K.) in AEM or FGM2 were also made. Cells were exposed to test and control 
solutions for time periods of zero, 10 and 30 minutes, 1, 2 and 4 hours with plates 
incubated at 37 °C between samples. After the allotted time period, 100 µL cell titre-
blue, cell viability assay (Promega, Southampton, U.K.) was added to the wells then 
plates were returned to the incubator for a further 90 minutes. Cell viability was 
determined by measuring fluorescence with a Spectra Max Gemini XS (Molecular 
Devices, California, U.S.A.). 
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7.5. Results 
7.5.1. High performance liquid chromatography 
7.5.1.1. Development of optimum high performance liquid 
chromatography methodology 
The CPS-2 Hypersil column with 75:25 MP was determined as most suitable for use 
with CHG samples in future experiments, as other column/MP combinations resulted in 
various complications such as limitations on detection of lower concentration samples, 
solvent front and peak too close together and irregular sized or shaped peaks.  
 
7.5.1.2. Standard curve of chlorhexidine digluconate concentration and 
peak area generated by high performance liquid chromatography 
The standard curve for CHG measured using HPLC produced a linear graph with an R
2
 
value of 1.0 over the range 0.03125 to 256 µg/mL CHG (Figure A15). 
 
7.5.1.3. Level of detection and quantification for high performance 
liquid chromatography 
The LOD and LOQ were calculated as 0.1588 µg/mL and 0.5293 µg/mL respectively. 
 
7.5.2. Gas chromatography 
7.5.2.1. Suitability of column 
The HP-INNOWax column (Hewlett Packard, Berkshire, U.K.) column was established 
as suitable for future use as the preliminary peaks revealed good resolution between the 
solvent front which had a mean retention time of 1.488 minutes, and the EO or 1,8-
cineole (Figures A16 and A17). The mean retention time for 1,8-cineole was 1.765 
minutes. EO generated many small peaks with retention times between 1.6 and 1.9 
minutes, however the largest peak, highlighted on Figures A16 and A17, was identified 
by retention time as being 1,8-cineole and was used to represent EO in future 
experiments. 
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7.5.2.2. Preliminary extraction of eucalyptus oil using hexane 
EO was extracted from wipes in hexane and quantified using GC, however there was no 
correlation between the duration in hexane and the quantity recovered from any sample, 
therefore future experiments will use the minimum extraction time tested of 30 minutes. 
 
7.5.2.3. Standard curve of eucalyptus oil concentration and peak area 
generated by gas chromatography 
The standard curve for EO in hexane measured by gas chromatography in relation to an 
IS produced a linear graph with an R
2
 value of 0.9973 over the range 0.078 mg/mL to 
256 mg/mL (Figure A18). 
 
7.5.2.4. Level of detection and quantification for gas chromatography 
The LOD and LOQ were calculated as 2 mg/mL and 6 mg/mL respectively. 
 
7.5.3. Biopatch film development and antimicrobial testing 
7.5.3.1. Polyvinyl and chitosan film optimisation 
The following six biopatches with 5 % (v/v) EO, 2 % (v/v) CHG and 1 % (v/v) tween-
80, were considered to have suitable properties required for use in future studies; 
 7 % (w/w) PVA, Mw 47,000 
 9 % (w/w) PVA, Mw 47,000 
 7 % (w/w) PVA, Mw 125,000 
 7 % (w/w) PVA, Mw 205,000 
 9 % (w/w) PVA, Mw 205,000 
 2 % (w/w) chitosan with 2 % (v/v) HPLC grade glacial acetic acid 
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7.5.3.2. Release study of eucalyptus oil and chlorhexidine digluconate 
from a polyvinyl alcohol biopatch film using Franz diffusion cells 
The GC and HPLC confirmed release of EO and CHG respectively from the biopatches 
over the 24 hour period. Both agents were detected over the entire 24 hour period, with 
a peak of EO and CHG release at 1 hour, and a second CHG peak at 4 hours (Figure 
7.1). Overall and at any given individual time point, there was no significant difference 
(P>0.05, ANOVA, Instat3, GraphPad) between the amount of CHG released by the 
biopatch containing EO and CHG, and the control containing CHG alone, therefore the 
presence of EO in the biopatch had no impact on the amount of CHG released. 
However, using the previously established LOD and LOQ results (Section 7.5.2.4) the 
concentration of EO release were established as accurately unquantifiable from 4 hours, 
and undetectable at 24 hours. 
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Figure 7.1. Mean (n=3) concentration and standard deviation of CHG and EO released over time from biopatches of 7 % PVA with Mw of 47,000 containing 2 % (v/v) CHG, with and 
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7.5.3.3. Microbial inhibition by eucalyptus oil and chlorhexidine 
digluconate-containing polyvinyl alcohol and chitosan films using agar 
diffusion 
Zones of inhibition were present around all biopatches containing 5 % EO and 2 % 
CHG for all microorganisms tested, however no visible zones were displayed by 
biopatches without EO and CHG, furthermore, microbial growth was clearly visible 
underneath many of the control biopatches (Table 7.1). Overall, the 9 % PVA of Mw 
205,000 demonstrated significantly enhanced (P<0.05, ANOVA, Instat3, GraphPad) 
antimicrobial efficacy against the panel of microorganisms, compared with the other 
biopatches tested.  
 
Table 7.1. The antimicrobial efficacy of various biopatches with and without 5 % (v/v) EO and 2 % (v/v) CHG, 
against a panel of six microorganisms expressed as mean (n=3) sizes of inhibition zones observed using the 
agar diffusion method. 
 
Inhibition zone (mm) for biopatches containing 5 % EO and 2 % 






























































































S. aureus 9/<1 10/<1 8/<1 10/<1 15/<1 8/<1 
S. epidermidis 11/<1 8/<1 13/<1 17/<1 20/<1 9/<1 
MRSA 8/<1 10/<1 11/<1 9/<1 17/<1 8/<1 
P. aeruginosa 7/<1 5/<1 6/<1 7/<1 15/<1 6/<1 
E. coli 13/<1 9/<1 10/<1 7/<1 7/<1 7/<1 
C. albicans 8/<1 10/<1 4/<1 5/<1 11/<1 8/<1 
 
 
7.5.3.4. Bacteriostatic/bactericidal testing of eucalyptus oil and 
chlorhexidine digluconate-containing polyvinyl alcohol and chitosan 
films 
Bactericidal antimicrobial activity was demonstrated against all six microorganisms by 
all biopatches containing EO and CHG, with no microbial growth revealed by culture. 
The control PVA biopatches (without EO and CHG) did not possess antimicrobial 
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activity, however no microbial growth was recovered from underneath the chitosan 
control biopatch therefore it was determined to possess bactericidal activity. 
 
7.5.4. Catheter tolerance to Euclean
®
 solution 
No visible change was observed between the Hydrocath Assure
TM
 catheter and hub 
submerged in Euclean
®
 solution and immersed in PBS over the 5 day period. 
Furthermore, at the end of the 5 days, no stickiness or softening of the CVC was 
apparent. 
 
7.5.5. Polyvinyl alcohol films on human skin 
7.5.5.1. Penetration of eucalyptus oil and chlorhexidine digluconate 
from a polyvinyl alcohol film into human skin 
No EO or CHG was detected in the receptor fluid of the Franz diffusion cells at any 
point during the 24 hour exposure of human skin to biopatches. 
 
7.5.5.2. Detection of eucalyptus oil and chlorhexidine digluconate in 
layers of human skin 
No EO or CHG were detected in sliced sections of human skin following 24 hour 
contact with biopatches. 
 
7.5.6. Testing of Euclean
®
 solutions using tissue culture 
7.5.6.1. Cell toxicity of Euclean
®
 solution to human airway epithelial 
cells and human pulmonary fibroblasts 
The 5 % Euclean
®
, 2 % Euclean
®
 and CHG/IPA solutions all exhibited toxicity towards 
both airway epithelial cells and human pulmonary fibroblasts when viable cells were 
measured with fluorescence after staining with cell titre-blue (Figures 7.2 and 7.3). For 
each cell line tested, there was a significant reduction (P<0.05, ANOVA, Instat3, 
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GraphPad) in the number of viable cells remaining after just 10 minutes exposure to the 
solutions, however there was no further significant decline (P>0.05, ANOVA, Instat3, 
GraphPad) in viability between this point and any other over the 4 hour exposure time. 
For the AEC, the reduction in viability observed by contact with the control solution 
demonstrated significance (P<0.05, ANOVA, Instat3, GraphPad) from the initial time 
zero value, at each time point except for the 1 hour measurement, which was not 
sufficient to be deemed significant. The decrease in cell viability between the control at 
time zero and subsequent time points was also significant (P<0.05, ANOVA, Instat3, 
GraphPad) for the HPF cell line. It can therefore be assumed that the process of 
removing old media and replacing with new, accounted for some loss in cell viability. 
Finally, whilst toxicity was observed, there was no significant difference (P>0.05, 
ANOVA, Instat3, GraphPad) between that induced by either of the Euclean
®
 solutions 
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Figure 7.2. Mean (n=3) toxicity and standard deviation of 5 % Euclean®, 2 % Euclean® and CHG/IPA solutions to AEC during 4 hours exposure, measured by fluorescence (arbitrary units) 
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Figure 7.3. Mean (n=3) toxicity and standard deviation of 5 % Euclean®, 2 % Euclean® and CHG/IPA solutions to HPF during 4 hours exposure, measured by fluorescence (arbitrary units) 
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7.6. Discussion 
Previous research within this thesis has used an array of methods to assess the 
properties of, and subsequently confirm the superior benefits achieved by, the addition 
of EO to CHG and CHG/IPA. Current EPIC guidelines suggest the use of 2 % CHG in 
70 % alcohol for skin antisepsis however recent findings suggest that while this may be 
adequate for the surface of the skin, the deeper layers can persist in harbouring 
microbial colonisation within pores and hair follicles which remain unreached 
(Karpanen et al., 2008a; Pratt et al., 2007). Therefore, enhanced penetration is required. 
However new research has confirmed that the presence of EO can induce deeper 
penetration of CHG into the skin (Karpanen et al., 2010). This is possibly due to the 
„pull‟ effect whereby CHG may be carried into the deeper layers of the skin by EO, as a 
result of its permeation properties, however application of the EO/CHG/IPA 
combination in the study by Karpanen et al. (2010) was means of a solution, therefore 
potentially maximising the resultant depth to which the agents could permeate. 
Irrespective of the underlying mechanisms, this research offers additional benefits, as it 
is now clear that the EO/CHG combination not only results in synergistic antimicrobial 
efficacy and improved biofilm removal, but also provides enhanced skin penetration. 
Biopatches or transdermal drug-delivery systems (TDDS) are a highly developed means 
of delivering many different agents through the skin via the application of an agent-
containing patch to the skin. They provide many advantages over conventional delivery 
mechanisms, to include evasion of liver metabolism which can reduce the final 
circulating concentration, controlled release eliminating dosing errors or complications 
regarding use, and reduced systemic side effects (Ghafourian et al., 2004). Their slow 
release over time periods of up to a week reduces the need for hourly, or daily attention 
therefore often improves patient compliance (Tanner & Marks, 2008). There is however 
some important considerations for using TDDS, of which one central but often 
overlooked aspect, is the adhesive properties, which are often reported within TDDS 
information leaflets as not yet tested (Wokovich et al., 2006). Effective delivery relies 
upon complete contact between the patch and the skin. Breaches in contact can lead to 
inadequate dosing, as the results of any laboratory efficacy testing and therefore the 
quantity of drug contained, are based upon the entire surface making full contact. 
Furthermore, poor adhesion can ultimately result in the TDDS falling off, which itself 
can lead to additional complications from under dosing or breaches in safety following 
accidental contact between a patch and persons other than the intended patient. Reports 
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of injury and even death have followed improper dispensing/administration of, or 
accidents involving, fentanyl-containing patches intended for chronic pain relief, 
including reports of patients who have fatally injected the patch contents, and a one-year 
old child killed following ingestion of a discarded patch (Teske et al., 2007; Tharp et 
al., 2004). However, reports of this nature are fortunately rare and few medications used 
in TDDS are as lethal as fentanyl, with delivery more frequently consisting of nicotine 
replacement therapy and hormonal contraceptives (Tanner & Marks, 2008).  
There are a number of ways in which TDDS can be composed however all are compiled 
from layers. Reservoir and matrix systems are the two main types used for large scale 
production, with two types of matrix systems produced, either with, or without a 
membrane to control release rate (Wokovich et al., 2006). All have a basal backing and 
an adhesive surface covered by a removable protective liner, however the inner layers 
differ. The major difference is that reservoir patches contain drug mixed with excipients 
in the layer above the backing. The excipients carry the drug, releasing it through the 
rate-controlling membrane and adhesive into the skin. Matrix patches contain the drug 
within the adhesive however if there is a rate-controlling membrane present, a second 
layer of drug-containing adhesive is applied over its surface (Padula et al., 2007; 
Wokovich et al., 2006). 
This study focused on a simplified variation of a TDDS in which EO and CHG were 
added to polyvinyl alcohol and chitosan before being cast into film biopatches, and 
tested for skin antisepsis suitability. The ultimate aim of the biopatch was to provide 
dermal antisepsis from the delivery of synergistic antimicrobial agents to the deeper 
layers of skin where microorganisms reside in pores and hair follicles, rather than 
transdermal delivery, as systemic distribution of the agents was not desirable. PVA is a 
transparent, nontoxic and biocompatible polymer, and one of the most frequently used 
polymers for skin application and its development into PVA hydrogels has been widely 
employed (Kim et al., 2008; Valentia & Auner, 2004). Chitosan is also a polymer, 
naturally derived from chitin, which has previously been studied as an aid for dermal 
delivery in particular its combination with essential oils has been explored in both 
microcapsules and films (Pedro et al., 2009; Zivanovic et al., 2005). The natural 
properties of chitosan lend it favourably to this type of application as it is a permeation 
enhancer, antimicrobial and mucoadhesive, therefore forms optimal attachment to 
mucosal surfaces while aiding drug delivery and preventing microbial contaminants. 
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The results of this study concluded a number of PVA concentrations and one chitosan 
formulation possessed potential as a biopatch for enhanced skin antisepsis, displaying 
suitable qualities of thickness, flexibility and compatibility with EO and CHG. By 
varying the molecular weight and the quantity of PVA used, it was possible to formulate 
films exhibiting different qualities, ranging from thin and electrostatically charged, to 
thick and brittle. Release studies subsequently confirmed that EO and CHG were 
discharged from the PVA biopatch tested, with both agents reaching a peak of release 
after 1 hour which reduced at 2 hours. While the concentration of EO continued to 
reduce reaching a plateau at around 6 hours, the CHG showed a further release peak 
after 4 hours before gradually declining up to 24 hours. However, it appears that the 
presence of EO within the biopatch, led to slightly slower release of CHG, with twice as 
much CHG in the receptor fluid of the EO/CHG patch as in that of the patch containing 
CHG alone. Contact between the PBS of the receptor chamber and the patch instigated 
swelling and therefore increased release of EO and CHG, demonstrated by the first 
peak. While most of the EO appeared to have been released here, the second peak of 
CHG may be due to early stages of disintegration as the biopatches began to dissolve 
into the receptor chamber. EO is volatile and light sensitive therefore alterations 
occurring after release may cause it to become undetectable by the GC. This may also 
explain the low concentrations of EO being classed as accurately unquantifiable from 4 
hours and undetectable at 24 hours, as established from the LOD and LOQ calculations 
performed previously, something that was unexpected as the 5 % EO added to the 
biopatch was above the limit of detectable and quantifiable concentrations from the GC, 
as well as above that of all the MIC and MBC results established previously (chapter 2). 
The presence of EO in the biopatch created variation in the stability of the film 
compared to those without EO; this could possibly reduce breakdown of the PVA 
structure and prolong the ability of the EO/CHG biopatch to release CHG. The 
manipulation of quantity and molecular weight can alter the extent to which films of the 
same polymer swell once moistened, therefore result in differences in permeation 
profiles (Padula et al., 2007). It is therefore possible that this manner of testing could 
produce differences between the release profiles of the six films, however it remains 
unclear if the 2 % variation in PVA composition would be sufficient to cause noticeable 
differences to the findings. 
When tested against the panel of microorganisms, it was clear that the PVA biopatches 
alone did not elicit antimicrobial efficacy however there was an obvious improvement 
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with the addition of EO and CHG, further supported by the bactericidal activity of all 
the EO/CHG-containing biopatches. As discussed previously (chapters 3 & 4), it is 
possible that some inactivation of CHG may have occurred from the presence of tween-
80 to aid in EO dissolution. Although unlikely due to the concentrations involved, this 
occurrence would act only to provide improved results if tween-80 were substituted 
with another mixing agent. Whilst PVA alone exhibited no antimicrobial efficacy, the 
chitosan-only film did possess bactericidal properties. This is no surprise as chitosan is 
well known to possess antimicrobial activity against Gram-positive and -negative 
bacteria, as well as fungi, and has been used within the food industry for many years as 
edible, biodegradable, nontoxic, protective coatings for food (Dutta et al., 2009). With 
its positively charged amino group, chitosan targets the membranes of cells, which are 
negatively charged, however one study has noted that increases in the molecular weight 
of the chitosan favour targeting of Gram-positive microorganisms, and decreases 
favourability towards Gram-negative (Zheng & Zhu, 2003). In clinical practice it cannot 
always be predicted which microorganisms are most likely to infect a wound site, 
therefore unless a compromise could be established, the development of two opposing 
biopatches may be needed; one for each Gram type. 
The combination of EO and CHG has demonstrated enhanced penetration into the 
deeper layers of the skin when applied to the surface as a solution (Karpanen et al., 
2010). However, the results of this study established that neither EO nor CHG were 
detected in the receptor fluid of the Franz diffusion cells therefore had not passed 
through the full thickness of the skin. Subsequent slicing of the surface layers also 
revealed absence of EO and CHG within the tissue. It is possible that release issues 
ensued however this is doubtful as the prior experiments confirmed these capabilities. 
Inadequate concentration on or in the skin to permit detection is a more likely cause, 
though this is also dubious as the antimicrobial efficacy experiments proved sufficient 
EO and CHG were released to kill microorganisms, therefore would be of detectable 
and quantifiable concentrations. The most probable cause lies with imperfect contact 
between the biopatch and the skin. The biopatch studied here became more adhesive 
when dampened; something that has been previously reported for other patches and aids 
patch to skin contact therefore improves delivery (Gal & Nussinovitch, 2009; Wokovich 
et al., 2006). However in this study, the skin was almost completely dry increasing the 
possibility of only partial contact thus breaking the transportation route from biopatch to 
skin. The improved release and flexibility provided by moisture could form a basis for 
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future developments of the biopatch by coupling it with an adhesive, conductive 
solution or adding a gel layer to provide this function. Alternatively, plasticisers could 
be added to the biopatch to increase flexibility therefore adhesion and delivery, but their 
molecular weight is known to alter the physical properties of the final product, 
especially in chitosan films therefore their inclusion may not always the best option 
(Srinivasa et al., 2007).  
The final investigation within this series, examined toxicity of the solutions 
incorporated into the biopatch developed here and impregnated onto the Euclean
®
 wipes 
discussed in the preceding chapters. Application of any agent to the skin must undergo 
strict testing to ensure the safety of the user. Absence of allergy and toxicity risks need 
to be verified before clearance of wide-scale use can be given. Chlorhexidine is EPIC-
recommended for skin antisepsis, and whilst reported incidents of adverse reactions to it 
are extremely low, some incidents of delayed hypersensitivity including contact 
dermatitis have been made, but of more concern are the fortunately infrequent cases 
depicting instant responses such as asthma and anaphylactic shock (Krautheim et al., 
2004; Sachs et al., 2007). EO is quite different by comparison with frequency and array 
of undesirable consequences greater than those related to CHG. Exposure to EO can 
lead to widely ranging effects from skin irritation, drowsiness, and seizures, to even 
fatality if more than 3.5 mL is ingested. Furthermore, prolonged exposure can have 
toxic outcomes (Tovar & Petzel, 2009). 
Combining EO and CHG would potentially induce irritation for a user of Euclean
®
 
wipes or a patient exposed to an EO-containing biopatch therefore it was imperative that 
initial toxicity testing be carried out. The results of tissue culture confirmed that the all 
the solutions tested resulted in a significant reduction in the number of viable cells 
remaining after exposure. However, there was no difference observed between the 
CHG/IPA which is the same formulation as ChloraPrep
®
 and EPIC recommended for 
skin antisepsis, and either of the two Euclean
®
 solutions. Therefore it can be assumed 
that the level of irritancy would be similar to that reported for ChloraPrep
®
. 
Furthermore, the results concluded that prolonged exposure had no additional adverse 
effects. 
The airway epithelial cells used during this study were human bronchial in origin and 
isolated from a cystic fibrosis (CF) sufferer. However, they are corrected from CF-type 
by transfection of the deficient cyclic AMP-mediated protein kinase-A responsible for 
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activation of chloride conductance. Epithelial cells are the interface between the 
external environment and the inside of the body and line the respiratory tract. They also 
cover the outside of the body however the use of AEC in this study will depict the worst 
possible outcome of application of the EO-containing biopatch, as these cells, unlike 
external epithelial cells, are offered no protection by the keratinised cells of the stratum 
corneum (Crystal et al., 2008). The second cell line chosen were human pulmonary 
fibroblasts isolated from human lung tissue. Fibroblasts make collagen which is another 
component of skin therefore provide a realistic representation of the likely effect of skin 
contact with the Euclean
®
 solution on Euclean
®
 wipes and in the EO/CHG biopatch. 
These results suggest favourable findings regarding the potential skin toxicity of the 
biopatch, and imply that its application to skin would be unlikely to cause any greater 
level of irritation than the most currently used and recommended skin antiseptic. 
However some studies have confirmed 1,8-cineole, which is present in EO, is capable 
of inducing apoptosis in KB cells though the exposure time was more than double that 
tested here and the difference in cell line may bestow alterations in susceptibility 
therefore highlighting that the experiments explained here could benefit from further 
expansion (Cha et al., 2010).  
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7.7. Conclusion 
In this study, previous work has been elaborated upon, and led to the development and 
testing of a prototype dermal biopatch containing EO and CHG, for enhanced skin 
antisepsis. Optimising formulations of PVA and chitosan resulted in a panel of six 
potential compositions for biopatch testing. Release of EO and CHG from a PVA 
biopatch was confirmed using GC and HPLC respectively, and bactericidal activity of 
all shortlisted biopatches, against six clinically important microorganisms was verified. 
Whilst compatibility of the Euclean
®
 solution with CVC plastic was determined, skin 
studies highlighted the failure of EO or CHG to be recovered from any depth skin slice 
following 24 hours biopatch contact, therefore bringing awareness to possibilities of 
release, contact or detection flaws. Finally, tissue culture techniques confirmed that 
while the Euclean
®
 solution induced some cell death amongst human epithelial and 
fibroblast cells, the extent of the toxicity was no more severe than that revealed by CHG 
in alcohol; the current recommended solution for skin antisepsis. Overall, this study 
confirms that the combination of EO and CHG could have potential for use within a 
biopatch aimed at delivering enhanced skin antisepsis however further studies are 
warranted to develop and refine the ideas trialled in this chapter. 
  




Final Discussion and Further Work 
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Healthcare associated infections (HAI) exert significant financial burdens and time 
constraints upon health service resources through the need for additional medication and 
treatment procedures, extended patient hospitalisation, and increased morbidity and 
mortality rates (Vilela et al., 2007; Weigelt et al., 2010). Responsible for an estimated 
15 % of HAI, surgical site infections (SSI) represent a considerable proportion of all 
nosocomial infections, and are the most common infection occurring in surgical patients 
(Stevens, 2009). Whilst post operative care can reduce infection rates, an effective pre-
operative procedure is crucial to avoid development of many preventable infections 
(Heath Protection Agency, 2010). 
Skin associated microorganisms such as S. aureus and S. epidermidis are amongst the 
most frequent causative pathogens of infections derived from surgical sites, as breach of 
the skins‟ defences during insertion provides a point of entry for otherwise harmless 
commensal microorganisms, providing opportunity for infection to commence (Stevens, 
2009; Weigelt et al., 2010). Furthermore, the ability of these microorganisms to grow 
within biofilms, both in the environment and within the skin, creates additional 
complications due to their reduced susceptibility to antimicrobial agents. It is therefore 
vital that adequate environmental disinfection and skin antisepsis be delivered prior to 
commencement of any surgical procedure to remove skin microflora and aid in 
preventing infection. 
Current EPIC and Centres for Disease Control and Prevention (CDC) guidelines for 
skin antisepsis prior to insertion of any intravascular device, recommend the use of 2 % 
CHG in 70 % IPA for the U.K. and U.S.A. respectively (O‟Grady et al., 2002; Pratt et 
al., 2007). Both CHG and IPA are potent antimicrobial agents with broad spectrum 
efficacy (Hemani & Lepor, 2009). However, recent studies have highlighted concerns 
over the poor penetration properties exhibited by this combination, with awareness 
concentrated towards the potential persistent viability of remaining microorganisms 
within the deeper layers of skin after antisepsis has been performed (Karpanen et al., 
2008a). Therefore, the development of novel antiseptic agents and formulations with 
enhanced penetration and antimicrobial properties is desired to prevent onset of such 
infections. 
In this study, the antimicrobial efficacies of eucalyptus oil, its major component 1,8-
cineole and chlorhexidine digluconate were assessed alone and in combinations. The 
initial aim of this research was to select the more efficacious agent between EO and 1,8-
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cineole, with which to continue further research. The results given in chapter 2 of this 
thesis demonstrate that whilst both agents possessed antimicrobial activity, EO 
possessed significantly greater (P<0.05) antimicrobial efficacy than 1,8-cineole against 
planktonic cultures, however no difference was observed between the two against 
biofilm modes of growth. In addition to this, the subsequent results of chapter 2 
confirmed synergistic antimicrobial efficacy could be achieved against planktonic and 
biofilm cultures when EO or 1,8-cineole were combined with CHG; these results 
corroborate with previous findings by Karpanen et al. (2008b) who also reported the 
synergistic activity when EO and CHG were combined. 
Comparisons between crude EO and its most abundant constituent, 1,8-cineole, 
established that crude EO possessed superior antimicrobial activity, in particular against 
biofilm modes of growth, and therefore was determined as the better agent with which 
to progress future studies. This may offer additional benefits as it is possible that EO 
would be less likely to permit development of microbial resistance due to the presence 
of numerous constituents which may target cells in a variety of ways. These findings 
suggest the collaborative presence of other constituents within EO has an impact on the 
resultant properties and activity. Other research supports this hypothesis having arisen 
to the same conclusion, including a study by Delaquis et al. (2002) who established 
synergistic antimicrobial effects could be accomplished by combining different 
fractions of crude oils, and another by Santana-Rios et al. (2001) who speculated that 
synergistic actions between the major and minor constituents within different varieties 
of tea, are responsible for enhanced anti-mutagenic and anti-chemotherapeutic activity. 
Records of biofilm presence date back to the early fossil records, though appreciation of 
them as clinical complications is a relatively modern concept, with their significance 
only recently being fully appreciated (Asikainen, 2009; Hall-Stoodley et al., 2004). 
Biofilm development around surgical sites can lead to potentially severe complications, 
however not all infections originate from the flora of patient‟s skin; the hands of 
healthcare workers are known to aid dissemination of microorganisms within the 
healthcare setting, therefore satisfactory levels of hand hygiene are fundamental in the 
prevention of HAI (Messina et al., 2008). Within the clinical environment, hands can 
act as vectors, picking up microorganisms from one location and depositing them at 
another, providing a link in the cycle of infection transmission between patients, and 
surfaces or objects (Bjerke, 2004). Therefore it follows that one colonised patient can 
easily bring about microbial contamination of a nearby surface, which can consequently 
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colonise or infect subsequent patients, healthcare workers or visitors, resulting in rapid 
and considerable spread as witnessed in infection outbreak cases. Cleanliness of 
surfaces is therefore also important in infection control. 
Progressing from the studies focussing on the antimicrobial efficacy of EO, 1,8-cineole 
and CHG within chapter 2, the subsequent research in this thesis began to develop the 
potential applications for the EO and CHG combination, into a prototype, and then a 
commercial wet wipe intended for hard surface disinfection (chapters 3 and 4 
respectively). 
In chapter 3, antimicrobial testing against a panel of clinically important 
microorganisms (S. aureus, S. epidermidis, MRSA, P. aeruginosa, E. coli and C. 
albicans) revealed the wipe solution comprising 10 % EO, 2 % CHG and 70 % IPA 
possessed rapid (within 30 seconds) bactericidal activity against all planktonic cultures, 
but that large variations existed in the time required for the impregnated wipes to 
eliminate microbial biofilms, from less than 2 minutes for E. coli, to within 4 hours for 
MRSA. The subsequent experiment in this chapter revealed these wipes demonstrated 
significantly better (P<0.05) removal of all microorganisms from the surfaces of 
stainless steel discs compared with wipes devoid of EO, with the achievement of 
complete elimination of E. coli and C. albicans from the discs. However, the capability 
of the 10 % EO, 2 % CHG and 70 % IPA wipes to induce microbial transfer on up to 
eight successive surfaces led to concerns about suitability for clinical use. These 
findings were in line with those reported by Williams et al. (2007) whose methods were 
adapted for the purpose of this experiment, and cited that grapefruit extract-containing 
disinfectant wipes removed significantly more cells from surfaces than control wipes, 
but that they too demonstrated microbial transfer onto eight subsequently contacted agar 
surfaces. 
Formulation development of the prototype 10 % EO, 2 % CHG and 70 % IPA 
disinfectant wipe (chapter 3) produced improvements in the mixing of the individual 
agents within the solution and therefore potentially a more even distribution over the 
Euclean
®
 wipes (chapter 4). This modification of the formulation involved increasing 
the tween-80 content from 0.1 % to 1 %, and decreasing the EO content from 10 % to 5 
% and 2 %, and resulted in enhanced antimicrobial efficacy of the Euclean
®
 wipes 
compared to the prototype. Similar to results in chapter 3, the 5 % and 2 % Euclean
®
 
wipes removed significantly more microorganisms (P<0.05) from the stainless steel 
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discs than the control. However, one obvious improvement conferred by the Euclean
®
 
wipes became apparent through confirmation via the adpression test, that they did not 
induce cross contamination between surfaces and moreover, the viability of 
microorganisms removed from the surface, was not sustained. In addition to these 
findings, improvements were also apparent in their rapid, bactericidal activity which 
extended across all microbial biofilms. A maximum of 5 minutes contact time was 
required by the 5 % Euclean
®
 wipes to completely eradicate all biofilms, except P. 
aeruginosa which required up to 10 minutes. The 2 % Euclean
®
 wipes demonstrated 
bactericidal and fungicidal activity against S. aureus, MRSA and C. albicans biofilms in 
less than 5 minutes, and the remaining three in fewer than 10 minutes. All of these 
properties make Euclean
®
 wipes suitable as an adjunct to environmental cleaning and 
disinfection in the healthcare setting, thus aiding the prevention of nosocomial 
infections. However the presence of spills and soil loads within the health service can 
prove particularly challenging for cleaning and disinfection products, in particular PVP-
I which is inactivated by proteinaceous products, therefore future studies are warranted 
to establish the efficacy of Euclean
®
 wipes under these conditions. 
Spills within the healthcare setting of bodily secretions and excretions are common 
place, and not only introduce microorganisms into the environment, but also provide a 
source of nutrients while the very presence of a soil load acts to trap further potential 
pathogens (French et al., 2004; Rebmann et al., 2009). Therefore, the ability of 
Euclean
®
 wipes to remain efficacious against microorganisms in planktonic and biofilm 
modes of growth whilst a soil load is present, is more than simply desirable. 
Investigations using artificial soil loads added to cell suspensions, whereby the 
simulated spills are produced with bovine serum albumin and bovine mucin (Perez et 
al., 2005), would provide an understanding of the impact posed by bodily fluids upon 
the efficacy of Euclean
®
 wipes, particularly if the same series of experiments as 
performed within chapters 1 to 5, were repeated with the soil load addition. Cleaning 
and disinfection of environmental surfaces within the healthcare environment plays an 
important role in the prevention of nosocomial infections (Dancer, 2008). However, 
there are as yet no standards outlining which products should be used and no guidelines 
on the numbers or types of microorganisms permissible before a surface is considered 
„dirty‟, though five or more colony forming units per square centimetre of high touch 
surface, could indicate an increased risk of infection (Dancer et al., 2009; Diab-
Elschahawi et al., 2010). Suggestions made by Dancer (2009) promote the conversion 
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of healthcare cleaning to an „evidence-based science‟ whereby standards can be set and 
outcomes monitored. As a result of no legislative policies, the choice of which cleaning 
and disinfection products to use is often left up to the individual hospital or ward, 
resulting in many different agents being used within the same trust. Over recent years, 
this has led to the development of numerous novel products and solutions, as well as 
many ideas and trials involving alternative strategies for preventing microbial 
contamination of surfaces.  
A number of smart surfaces have been developed and subsequently tested, which either 
repel soiling thus preventing initial microbial attachment, or contain antimicrobials built 
into their surface that are capable of eliminating any deposited microorganisms (Bartley 
et al., 2010). Those which repel and prevent adhesion of microorganisms include, 
amongst other non-stick surfaces, diamond-like carbon films which have high water 
resistance and low friction coefficients reducing the adhesion potential (Page et al., 
2009). These can also be coated with silver or copper to instil antimicrobial properties 
(Kwok et al., 2007). However, use of polyethylene glycol (PEG) polymeric coatings is 
one of the most renowned methods for preventing microbial attachment, and is based 
upon repulsive osmotic interactions (Page et al., 2009). Antimicrobial agents used to 
infuse surfaces, include light activated agents such as titanium dioxide photocatalysts, 
and metals including silver and copper. Also in this category is triclosan, which is 
possibly the most commonly marketed agent and has been widely used within hospitals 
for a number of applications. Some studies however, have reported poor efficacy, 
including one in which the antimicrobial properties of a triclosan-containing floor 
cleaner used within a poultry processing plant was reported to be „very low‟ (Moretro et 
al., 2006). 
Some other approaches for eliminating microbial surface contamination have also been 
tested and include replacing high touch surfaces such as taps and door handles with 
silver or copper ones, using antimicrobial moulded plastics to cover keyboards, and 
even copper paints for walls which have been shown to successfully reduce microbial 
counts of S. aureus, E. coli, P. aeruginosa and Enterococcus faecalis within 24 hours 
(Casey et al., 2010; Cooney, 1995; Markarian, 2009). However, none of these ideas 
have as yet, been implemented throughout all U.K. health services as a permanent 
feature therefore, at present, stringent cleaning regimes must be upheld as the major 
means of reducing surface contamination of a microbial nature. 
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Whilst development of novel strategies to eliminate microbial contamination persist, the 
increasing emergence of multi-drug resistant microorganisms poses great concern to the 
health service and has created an escalating need for new antimicrobial drugs and 
cleaning agents. Traditional development of new antimicrobial drugs relies upon 
microbiological testing, often encompassing conventional laboratory techniques such as 
determination of MIC and MBC, to establish the ability of the agent to inhibit microbial 
multiplication (Coates et al., 2002). The use of genomic studies to find targeted 
antimicrobials has also been employed following the successful sequencing of over 100 
microorganisms. It is considered a more modern and advanced technique however this 
has only generated the oxazolidinone group of antibiotics within the past 30 years 
(Norrby et al., 2005). Surface disinfection development follows a different testing 
protocol, with genomic techniques surplus to requirement. The systems employed 
within Europe for surface disinfection development and subsequent testing, involve 
three stages which incorporate a number of suspension tests initially, followed by 
simulated-condition experiments and finally field trials (Luppens et al., 2002). 
In chapter 5 of this thesis, isothermal calorimetry (IC) was used as an alternative to the 
conventional laboratory techniques and culture methods described above, to assess the 
antimicrobial efficacy of 5 % Euclean
®
 wipes. This method has been used for 
determination of antimicrobial activity in only a small number of published papers, 
despite its potential value in such applications (von Ah et al., 2009; O‟Neill et al., 
2003). The precise sensitivity, real time monitoring and passivity of IC are well suited 
to the study of microorganisms, enabling accurate determination of changes to growth 
rates almost instantaneously, without damage to the sample under observation (O‟Neill 
et al., 2003). The results of this study supported previous findings from chapter 4, that 
Euclean
®
 wipes possess bactericidal activity against all six clinically important 
microorganisms tested (S. aureus, S. epidermidis, MRSA, P. aeruginosa, E. coli and C. 
albicans), and furthermore, it established that such occurrences were rapid, taking place 
in less than 30 minutes. However, one fundamental downfall to using this method was 
highlighted. The duration required for the ampoules to reach equilibrium with the 
surrounding temperature, resulted in the loss of the initial data covering roughly the first 
30 minutes. As a result, conventional culture techniques were required to simulate the 
environment within the IC in order to determine the time needed by 5 % Euclean
®
 
wipes to instigate bactericidal activity, and fill in the missing data up to 30 minutes. A 
possible solution would be to investigate the activity using a flow calorimeter whereby 
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the wipe could be added to a continually circulating microbial suspension. This would 
provide data on the speed of activity from the time the wipe is inserted, however 
continued complications with microbial contamination during the use of this method in 
the first experiments of chapter 5, eliminated its use on the grounds of unreliability of 
results. 
IC has also been used to establish the effect application of sub-inhibitory concentrations 
of antimicrobials, has upon microbial growth rates. In a recent study by von Ah et al. 
(2009), E. coli and S. aureus were subjected to concentrations of 12 antibiotics below 
that of the MIC value. The resultant heat production profiles of the curves generated 
were compared with growth curves absent of antibiotics, to determine the mode of 
action of each drug. Using findings by Antoce et al. (1997) they were able to attribute 
delays to the instigation of a heat curve, followed by the resultant slope shape matching 
that of the control, to the antimicrobial under examination reducing the number of 
viable cells initially, therefore possessing a bacteriostatic mode of action. This method 
could be used in future studies to extend the current knowledge regarding the 
antimicrobial activity of EO, by establishing the effects generated by exposing 
microorganisms to subinhibitory concentrations, and therefore possibly provide an 
insight into the potential development of microbial resistance to EO or other 
antimicrobials as a result of EO tolerance. This could prove particularly important for 
EO use within the clinical setting as a study by Walsh et al. (2003b) cited that creating 
microbial mutants of E. coli with induced tolerance to the essential oils thymol and 
eugenol, could result in cross-resistance to other biocides and reduced susceptibility to 
some antibiotics. In addition, soil loads could be incorporated into the suspension to 
assess the impact of bodily fluids and spills on the activity of Euclean
®
 wipes. 
Essential oils have previously demonstrated potential for application within the clinical 
setting, including tea tree oil, which has been exhaustively studied for its antimicrobial 
efficacy against MRSA (Carson et al., 2006). The results from the first four chapters of 
this thesis confirmed that the antimicrobial activity and microbial removal properties of 
EO and Euclean
®
 wipes, lend favourably towards their use within the healthcare 
environment. It therefore followed that clinical audit of the 5 % Euclean
®
 wipes was 
necessary to determine the opinions of healthcare workers who would use the final 
product daily. 
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The results from the Euclean
®
 wipe clinical audit (chapter 6) undertaken at Birmingham 
Children‟s Hospital, brought about mixed opinions towards the products currently used 
for cleaning and disinfection, as well as Euclean
®
 wipes. The cross-over audit 
investigated opinions on current cleaning and disinfection products following their use 
for one week, then repeated the questions following a second week of exclusive 
Euclean
®
 wipe use. This style of cross-over study is frequently used within scientific 
research as it enables direct comparisons to be made between treatments however it is 
most commonly used to assess patient opinion rather than that of staff. In this study the 
term cross-over referred to a controlled trial in which there was balance but the 
sequence of treatments was not random. 
Hospital cleaning and disinfection includes the use of many different chemicals and 
agents, usually designed for specific surfaces and requiring diverse preparations; 
however it became apparent during the Euclean
®
 audit that healthcare workers value 
ease of use products. Mixing and dilution of cleaning agents is often required prior to 
use, with a range of concentrations recommended for different uses, for example 
chlorine-based agents are frequently diluted for floor mopping and managing spillages, 
however the concentration suggested for blood spills is ten-times greater than that for 
urine  (Health Protection Agency, 2010b). This is not only time consuming, but can 
easily result in inappropriate dilution, and therefore inadequate efficacy due to sub-
lethal concentrations. Numerous previous studies have demonstrated that microbial 
exposure to subinhibitory concentrations of biocide can alter microbial growth and 
induce tolerance to not only the agent being used, but also bring about cross-resistance 
to other biocides and antibiotics (Maillard, 2007; Walsh et al., 2003a; Walsh et al., 
2003b). Disinfectant wipes, such as Euclean
®
 wipes, eliminate complications posed by 
dilution and preparation as are pre-impregnated with the desired concentrations of 
cleaning agents. 
The daily use of disinfectant wet wipes within Birmingham Children‟s Hospital 
encompassed all five wards partaking in the audit, with staff nurses accounting for the 
majority of users (chapter 6). Alcohol based wipes, in particular Sanicloth-70, were 
identified as the most abundant used during clinical practice, with equipment and 
furniture within close proximity to the patient most frequently cleaned. Such surfaces, 
including bed rails, bedside cabinets, chairs, cots and machinery are classified as hand 
contact, or high touch surfaces and are often found harbouring microbial contamination, 
including MRSA and VRE (Boyce, 2007). In both phases of the trial, there was 
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relatively little difference between the cleaning frequency of plastic, metal, wood and 
stainless steel surface materials. The material used for surfaces is known to have an 
impact on the number of microorganisms it can potentially harbour and the degree of 
efficiency with which it can be cleaned. Plastic and plastic laminate surfaces are 
particularly prone to harbouring microorganisms for long durations, whilst glass and 
nonporous surfaces provide less hospitable environments therefore reduced 
contamination survival (Hota, 2004). One study by Milling et al. (2005) reported that 
microbial survival on wood and plastic was in part due to ambient temperature and 
humidity levels. In addition they added that different types of wood permitted survival 
to a greater or lesser extent, with pine and oak being significantly more hygienic than 
spruce, larch, maple, beech and poplar, having shown complete reduction in E. coli cell 
numbers over a seven day period. 
Cleaning interventions can reduce microbial contamination on surfaces and have also 
demonstrated cost effective benefits, with a recent study by Dancer et al. (2009) citing 
savings of between £30,000 and £70,000 following the addition of one extra cleaner 
reducing the incidence of infection. This supports the hypothesis that surfaces bear 
significance in the dissemination of infectious microorganisms and that cleaning is 
therefore a crucial part of its regulation. However, improved levels of cleaning can 
create alternative problems. As discussed by Chapman (2003), numerous reports have 
cited the increased observations over recent years in prevalence of disinfectant resistant 
microorganisms, with microbial tolerances reported towards chlorine, glutaraldehyde, 
iodophor, peroxides, phenols and QUATS. Furthermore, contaminated disinfectants 
have resulted in reports of infection outbreaks (Webber et al., 2007). In addition to 
microorganisms resistant to disinfectants, antiseptic-resistant microorganisms have also 
caused outbreaks with increased occurrence, including alcohol, chlorhexidine and 
povidone iodine (Bouallegue et al., 2004; Nasser et al., 2004; Tena et al., 2005). 
However, Meyer & Cookson (2010) concluded that the risks posed to the delivery of 
healthcare by biocide-related microbial resistance are low. 
The Euclean
®
 clinical audit raised awareness of potential skin irritation induced by 
currently used products, as well as the Euclean
®
 wipes. A known permeation enhancer, 
EO causes disruption to the intercellular lipids of the stratum corneum yet conversely, 
its use could potentially reduce skin irritation for some healthcare workers (Aqil et al., 
2007). Skin irritation has been linked with frequency of performing hand hygiene 
practices whilst carrying out patient care (Larson et al., 2006). The repeated washing 
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causes depletion of lipids, allowing sanitisers to penetrate further into the skin layers, 
both of which lead to, and then exacerbate drying of the skin on the hands. Essential oils 
such as EO possess some residual activity which could, if sufficient, prevent microbial 
contamination for a period of time after use, therefore increasing their favourability for 
skin disinfection amongst healthcare workers by means of reducing the frequency of 
hand hygiene required. CHG is also recognised as possessing residual activity thus 
providing prolonged antimicrobial protection on the skin for a longer duration after use 
than some other agents including povidone iodine (Milstone et al., 2008). One study 
evaluated disinfectants with residual activity for use on inanimate surfaces, and 
concluded that such products could offer considerable advantages over current products, 
with additional potential cost effective benefits (Rutala & Webber, 2001). In addition to 
this, hand sanitisers containing residual activity have also been tested including 
„PureHands‟ which is an alcohol-based antiseptic containing a mixture of herbs, plants 
and essential oils and has demonstrated significant reductions in microbial colonisation 
on the hands of healthcare workers over a seven day period of use (Das et al., 2005; 
Kavathekar et al., 2004). Investigations exploring the residual properties of EO and 
CHG alone and in combination are warranted to enhance their potential applications, as 
their ability to provide antimicrobial effects after use could prove a useful property for 
both skin antisepsis and surface disinfection. 
After each phase of the Euclean
®
 audit, participants were asked to provide an overall 
numerical rating of the wipes they currently use and the Euclean
®
 wipes. The final 
scores generated were 7.5 and 6.5 for the currently used and Euclean
®
 wipes 
respectively, however the highest frequency scores for each were 8/10 and 9/10 
respectively. This suggests that those in favour of the Euclean
®
 wipes scored them 
extremely highly, however the scores from the remaining participants were lower for 
the Euclean
®
 wipes than the current wipes, having the result of lowering the overall 
average score. This was further supported by the final questions of the audit which 
invited advantages and disadvantages, followed by other comments and feedback on the 
Euclean
®
 wipes. The most frequently mentioned advantage and disadvantage related to 
the smell of the wipes, clearly dividing opinion of the healthcare workers, for and 
against. The request for comments and feedback provoked some interesting points, with 
one comment mentioning they could be enticed into changing to Euclean
®
 wipes only if 
it was cost effective, while another comment revealed that whilst the smell was strong, 
the presence of fewer chemicals within the Euclean
®
 wipes was favourable.  
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The final studies of this thesis (chapter 7) assessed the potential for incorporating 5 % 
EO and 2 % CHG into PVA and chitosan biopatch films, and then investigated the 
ability of the one biopatch, containing 7 % PVA (Mw 47,000 Da), 5 % EO and 2 % 
CHG, to deliver enhanced skin antisepsis using a Franz diffusion cell model. The use of 
transdermal patches for delivery of agents via the skin has increased over recent years 
with many varieties now widely available for delivery of hormones and various 
medications (Kumar & Philip, 2007). However, prior to any product being considered 
safe for commercial production, thorough skin testing including assessment of the 
potential toxicity and irritancy, is required (Collins et al., 2008). Furthermore, whilst the 
addition of permeation enhancers to a transdermal biopatch can aid delivery of the 
incorporated agent through the skin, their presence can also instigate irritation from the 
temporary disruption they cause to the intercellular lipids of the SC (Sapra et al., 2008). 
EO is known to cause some degree of skin irritation however, many terpenes including 
1,8-cineole, the main constituent of EO, are generally regarded as safe, possessing no 
toxicity and low levels of irritancy (Aburjai & Natsheh, 2003; Aqil et al., 2007; Tovar 
and Petzel, 2009). This may however, not be the case if applied to damaged or broken 
skin, although knowledge concerning this is extremely limited with more research 
urgently required if application of such agents were to become routine within the health 
service. One recent study published by Karpanen et al. (2010) demonstrated that the 
addition of EO to an alcoholic CHG preparation significantly enhanced the depth of 
CHG penetration into human skin when applied to the surface as a liquid solution for 2 
minutes, therefore reiterating its potential benefits for dermal delivery and further 
signifying the need for further information regarding irritancy and toxicity. 
Implantation of a CVC can frequently result in the development of infection either 
around, or originating from, the site of insertion, with additional complications from 
biofilm development common (Frasca et al, 2010). The best preventative method 
involves the use of adequate skin antisepsis prior to insertion (Frasca et al, 2010). 
However, alternative options including antimicrobial-impregnated patch dressings 
which surround the insertion site, have been studied, with an assortment of products 
now commercially available. Examples of such dressings containing silver include the 
Algidex Ag
®
 silver alginate wound dressing from DeRoyal
®
, and the Silverlon
®
 
„lifesaverTM Ag‟ catheter dressing (Bhende & Rothenburger, 2007). In addition to these, 





 protective disk produced by Johnson & Johnson (Timsit et al., 
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2009). However, one study comparing the efficacy of four silver-containing dressings 
with a chlorhexidine gluconate covering, reported improved and sustained antimicrobial 
efficacy was conferred over a 7-day period by the chlorhexidine dressing (Bhende & 
Rothenburger, 2007). 
In chapter 7 of this thesis, 5 % EO and 2 % CHG were incorporated into PVA and 
chitosan biopatch films for potential use as CVC insertion site dressings. The results 
from this study confirmed that both 5 % EO and 2 % CHG could be successfully mixed 
into, and subsequently released from both types of biopatch. Furthermore, conventional 
laboratory culture techniques confirmed all PVA and chitosan biopatches containing EO 
and CHG possessed bactericidal antimicrobial activity against a panel of clinically 
important microorganisms (S. aureus, S. epidermidis, MRSA, P. aeruginosa, E. coli and 
C. albicans). This was not the case for the PVA biopatches without EO and CHG, 
however bactericidal activity was confirmed from the chitosan biopatch devoid of EO 
and CHG. Further studies could incorporate the use of isothermal calorimetry as used in 
chapter 5 of this thesis, to investigate the mode of activity of the biopatch further, as 
well as establish its rate of activity against microorganisms. In addition to this, concerns 
throughout chapters 3, 4 and 7 regarding the potential of tween-80 incorporated in the 
EO-containing wipes, Euclean
®
 wipes and biopatches to inactivate CHG could have 
reduced the antimicrobial properties of them, therefore investigations to determine the 
actual effect, if any, posed by the presence of tween-80 would be justified in future 
work. 
Polyvinyl alcohol is frequently used for applying agents to the skin, with adaption into 
PVA hydrogels widely utilised for their temperature stable, non-toxic, biodegradable 
and flexible properties (Kim et al., 2008). Furthermore, these transdermal patches 
enable a constant rate of medication to be released over prolonged time periods, 
reducing the need for regular dosing (Kulkarni et al., 2010). In addition to the use of 
PVA for transport of medication via the skin, chitosan has also been scrutinised in 
several investigations exploring transdermal drug delivery and wound dressings 
(Bhattarai et al., 2010; Jayakumar et al., 2011). One recent study discussed its use for 
transdermal delivery of insulin following encapsulation of insulin within nanoparticles 
of chitosan (Wong, 2009). It possesses a number of properties that could prove 
beneficial if used as a transdermal biopatch around CVC insertion sites, including the 
ability to reduce pain sensation by blocking nerve endings and aid natural blood 
clotting. Furthermore, gradual depolymerisation of chitosan releases N-acetyl-b-D-
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glucosamine which brings about ordered collagen deposition therefore promoting faster 
wound healing with reduced scaring (Paul & Sharma, 2004). 
In order for a transdermal patch to be suitable for commercialisation, it must provide the 
user with adequate levels of agent at the required site, for an appropriate duration. For 
example, a sufficient dose must be released continually, at a constant rate, and permeate 
through partial or full thickness of the skin depending upon the requirement for local, or 
bloodstream and therefore systemic targeted treatment. In chapter 7 of this thesis, 
analysis of sliced human skin sections following 24 hour contact with an EO and CHG-
containing PVA biopatch, failed to detect EO or CHG using GC and HPLC 
respectively, on either the surface or in the deeper layers of the skin. A recent study by 
Karpanen et al. (2010) has confirmed combining these two antimicrobials can result in 
enhanced penetration into the deeper layers of skin however there were two potentially 
significant differences in the design of their study compared to that of this thesis. The 
EO and CHG they used were made using an alcoholic base, and then applied directly 
onto the skin as a liquid preparation, however in this study an aqueous mixture was used 
and bound into a PVA polymer patch before being applied to the skin. It is possible that 
the presence of IPA in the solution had an effect on the solutions penetration into the 
skin; however one study reported increases to the permeation barrier of the SC when 
high concentrations of alcohol are applied to skin as a result of lipid extraction (Van der 
Merwe & Riviere, 2005). As the previous studies within this chapter confirmed the 
antimicrobial efficacy of the PVA biopatch, as well as the release and detection of EO 
and CHG from the biopatch, it is likely the most probable cause of the deficient 
penetration, was inadequate skin-to-biopatch contact. Therefore the properties of this 
PVA biopatch would benefit from further investigation and possible modification. 
Plasticisers could be used to reduce the brittleness of the biopatch, with the increase the 
flexibility providing improved contact over the contours of the skin. However, whilst 
their inclusion in a study by Gal & Nussinovitch (2009) demonstrated little impact on 
the roughness of a skin bioadhesive patch surface, alternative drawbacks including 
lower adhesion properties, diminished tensile strength, reduced pealing force and 
increased strain at failure were reported. In addition to this, alternative methods could 
be tested, including spray drying with microencapsulation of EO within small particles 
to overcome sinking of EO during drying of films, and oxidisation in air. Failing 
advances using such methods, alternative strategies for biopatch development could be 
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considered, include exploration of both reservoir and matrix patches, along with the 
addition of an adhesive layer to improve patch-skin adhesion. 
To conclude chapter 7, toxicity studies were performed on human airway epithelial and 
human pulmonary fibroblast cell lines to establish the potential degree of skin irritation 
induced by the combination of 5 % or 2 % EO, 2 % CHG and 70 % IPA. Comparisons 
were made with 2 % CHG in 70 % IPA which is the current EPIC recommended 
solution for skin antisepsis (Pratt et al., 2007). The results confirmed that whilst the EO-
containing solution resulted in some cell death, it was not significantly different from 
the effects generated from the EIPC-recommended solution, therefore suggesting that 
skin irritation from the Euclean
®
 wipe solution (chapter 4) and the EO-containing 
biopatch (chapter 7) is likely to be no greater than that of the nationally approved agent. 
This confirms that whilst further development is required for the EO and CHG biopatch 
to obtain the required physical properties, the principle shows potential without the 
likelihood of skin irritation causing complications. 
The research within this thesis has confirmed the possession of antimicrobial efficacy 
by EO and CHG against planktonic and biofilm cultures. Through incorporation of 10 
% EO and 2 % CHG into wipes, and subsequent optimisation of the formulation into 5 
% and 2 % Euclean
®
 wipes, their potential for hard surface disinfection was assessed. 
Isothermal calorimetry was employed as an alternative method to conventional culture 
techniques for determination of antimicrobial efficacy of 5 % Euclean
®
 wipes, which 
were then audited at Birmingham Children‟s Hospital. Finally, 5 % EO, 2 % CHG and 
70 % IPA were incorporated into PVA and chitosan biopatches with penetration of the 
agents into human skin subsequently assessed for a 7 % PVA (Mw 47,000 Da) 
biopatch. Tissue culture techniques were then employed on two human cell lines to 
determine the potential toxicity posed by the 5 % EO, 2 % CHG and 70 % IPA solution 
used to impregnate the Euclean
®
 wipes and incorporated into the biopatch. Further 
studies are warranted to improve the penetration capabilities and physical properties of 
the PVA biopatch. 
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Figure A1. Mean (n=2) colony forming units (cfu) of S. aureus cell suspension correlated to turbidity measured 
at an absorbance of 570 nm. 
 
 
Figure A2. Mean (n=2) colony forming units (cfu) of S. epidermidis cell suspension correlated to turbidity 
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Figure A3. Mean (n=2) colony forming units (cfu) of MRSA cell suspension correlated to turbidity measured 
at an absorbance of 570 nm. 
 
 
Figure A4. Mean (n=2) colony forming units (cfu) of P. aeruginosa cell suspension correlated to turbidity 
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Figure A5. Mean (n=2) colony forming units (cfu) of E. coli cell suspension correlated to turbidity measured at 
an absorbance of 570 nm. 
 
 
Figure A6. Mean (n=2) colony forming units (cfu) of C. albicans cell suspension correlated to turbidity 
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Table A1. All MIC and MBC data categorised as high or low for statistical analysis, using the midpoint of the 
observed range as the cut off. 
 
 
S. aureus 4 4 4 256 256 256 8 8 8 512 512 512
S. epidermidis 4 4 4 256 256 256 8 8 8 512 512 512
MRSA 2 2 2 512 512 512 2 2 2 512 512 512
P. aeruginosa 256 256 256 >512 >512 >512 256 256 256 >512 >512 >512
E. coli 8 8 8 16 16 16 8 8 8 256 256 256
C. albicans 8 8 8 8 8 8 32 32 32 32 32 32
S. aureus 16 16 16 512 512 512 256 256 256 >512 >512 >512
S. epidermidis 32 32 32 512 512 512 128 128 128 >512 >512 >512
MRSA 64 64 64 >512 >512 >512 256 256 256 >512 >512 >512
P. aeruginosa >256 >256 >256 512 512 512 >256 >256 >256 >512 >512 >512
E. coli 64 64 64 128 128 128 64 64 64 256 256 256
C. albicans 8 8 8 4 4 4 64 64 64 8 8 8
S. aureus 1 1 1 128 128 128 2 2 2 >128 >128 >128
S. epidermidis 2 2 2 16 16 16 2 2 2 32 32 32
MRSA 2 2 2 128 128 128 2 2 2 >128 >128 >128
P. aeruginosa 16 16 16 >128 >128 >128 32 32 32 >128 >128 >128
E. coli 1 1 1 32 32 32 2 2 2 >128 >128 >128
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Figure A7. Mean (n=2) colony forming units (cfu) of S. aureus biofilms correlated relative light units measured 
using ATP bioluminescence. 
 
 
Figure A8. Mean (n=2) colony forming units (cfu) of S. epidermidis biofilms correlated relative light units 
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Figure A9. Mean (n=2) colony forming units (cfu) of MRSA biofilms correlated relative light units measured 
using ATP bioluminescence. 
 
 
Figure A10. Mean (n=2) colony forming units (cfu) of P. aeruginosa biofilms correlated relative light units 
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Figure A11. Mean (n=2) colony forming units (cfu) of E. coli biofilms correlated relative light units measured 
using ATP bioluminescence. 
 
 
Figure A12. Mean (n=2) colony forming units (cfu) of C. albicans biofilms correlated relative light units 
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Figure A14. Calorimetric response of C. albicans growth curve (blue line) and broth only control (green line) 
interrupted by 2 % (v/v) addition of 5 % Euclean® solution during the log phase of growth for C. albicans and 
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Image A1. Ethical approval granted by the Chair of Aston University’s Ethics Committee for the Euclean® 
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Image A2. Ethical approval for the completion of the Euclean® clinical audit from the Research and 
Development department, and infection control teams at Birmingham Children’s Hospital. 
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Image A3. Questionnaire used in the Euclean® disinfectant wipe clinical audit at Birmingham Children’s 
Hospital.  
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Image A4. Poster detailing completion instructions for the Euclean® disinfectant wipe clinical audit 
questionnaire, and suitable uses for the wipes. 
 


























Figure A15. Mean (n=3) peak area from double dilutions of chlorhexidine covering the range 0.03125 µg/mL 
to 256 µg/mL measured using HPLC. 
 
 
Figure A16. Chromatogram of hexane solvent front eluted from gas chromatograph with a retention time of 
1.492 minutes, and the various small and one large peak (identified as 1,8-cineole) of eucalyptus oil with 
retention times of between 1.616 and 1.864 minutes. 
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Figure A17. Chromatogram of hexane solvent front eluted from gas chromatograph after a retention time of 





























Figure A18. Mean (n=3) peak area comparative to internal standard, from double dilutions of eucalyptus oil in 
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